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5Preface
Chronic pain is a burden for society. For the individual patient and his family, it is even worse. In 2001, 
the European Federation of IASP Chapters (EFIC) launched its declaration on “Chronic Pain as a Major 
Healthcare Problem, a Disease in its own Right”. This declaration stated that “although comprehensive 
epidemiological data for the European Union are not available, chronic pain is clearly a very widespread 
condition”.  Despite this declaration, these epidemiological data on chronic pain are not systematically 
collected and available, because pain is considered only to be a symptom as part of a specific disease. 
Chronic pain is not considered as a disease on its own right. Experts all over the world demonstrate that 
chronic pain has no warning function and that the quality of life of the patient is severely reduced. Finally, 
chronic pain has major negative impact on national health care budget and expenses. Therefore, making 
pain more visible should be a major objective. 
Epidemiological data are important for decision and policymakers to decide about health care budget and 
to prioritize on health care issues. However, chronic pain and its impact on society seems to be absent 
on the agenda of most ministries of Health in Europe and in the Netherlands in  particular. Therefore, the 
present book written by Malgorzata Bala and colleagues is of upmost value and importance to make pain 
more visible in society. The authors describe the most recent and valuable data on epidemiology of chronic 
pain in the Netherlands. The following pain syndromes were included in their systematic analysis of the 
literature: musculo-skeletal pain, neuropathic pain, fibromyalgia, osteoarthritis and rheumatoid arthritis. 
For the Netherlands, important questions are answered such as what is the prevalence and the incidence of 
chronic pain conditions? What percentage of chronic pain patients are untreated or inadequately treated? 
How many patients present themselves for treatment and what is the compliance of treated chronic pain 
patients? What is the impact of chronic pain? What is the cost of chronic pain? Detailed information on 
chronic pain is categorized, selected and presented making this book to a very important resource for 
health care professionals, policymakers and patient organizations. For the first time, the real impact of 
chronic pain in the Netherlands can be considered, hopefully paving the way for  important decisions and 
actions to improve the care of pain patients and their quality of life.  
Despite specific treatment recommendations on chronic pain, about 18 % of the Dutch general population 
experience a moderate to severe pain condition and the prevalence of unexplained severe chronic pain in 
a general practice population is 0.8 %. More than 56 % of patients declare that their chronic pain problem 
is undertreated. Chronic pain has a high impact on activities of daily living, on depression and mental 
illnesses, on isolation and helplessness, on days of work and incapacity benefits and on costs in general. 
Finally, the awareness of patient and health care professionals shows different gaps in the knowledge,  
training and education on chronic pain. 
Epidemiology of chronic pain in the Netherlands
6Epidemiology of chronic pain in the Netherlands
The presented convincing data calls for the implementation of a coordinated national health program on 
the prevention, diagnosis and treatment of chronic pain in the Netherlands and in Europe. Health care 
professionals, patients organizations, scientific organizations, insurance companies and policymakers should 
cooperate to improve this important goal for the next few years. Consideration of epidemiological data on 
chronic pain and its impact on society, should lead to a better recognition of the most prevalent disease in 
society. For years, pain was the forgotten disease. But once you get it, you will never forget this disease! 
This book is a beautiful example of making pain visible in society. I recommend you to read it and to  
use this book as a basis for further discussions on the start of such a national health program. 
Prof. dr. Kris C.P. Vissers, MD, PhD, FIPP
Professor in Pain and Palliative Medicine
Chairman of the EFIC subcommittee on education
7De epidemiologie van chronische pijn in 
Nederland
Frank Huygen, centrum voor pijngeneeskunde Erasmusmc Rotterdam
f.huygen@erasmusmc.nl
Inleiding
In 2006 publiceerde Breivik de resultaten van een telefonisch interview in 15 Europese landen en Israel naar 
de prevalentie, impact op dagelijks leven en behandeling van chronische pijn(1). In dit onderzoek werden 
46.394 gescreend met een beperkte vragenlijst. 8815 patiënten voldeden aan de definitie langdurige pijn. 
Deze definitie was omschreven als pijn ≥ 6 maanden waarvan in de laatste maand ≥ 2 aanvallen per week en 
≥ 5 op een 10 punt NRS. Van deze patiënten werd bij 4839 patiënten een diepte interview afgenomen. De 
vastgestelde prevalentie van chronische pijn in Europa is gemiddeld 19%. De prevalentie varieerde van 12% in 
Spanje tot 30% in Noorwegen. In Nederland werd een prevalentie vastgesteld van 18% (zie figuur 1). 
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Figuur 1. Breivik et al. 2006. Prevalentie chronische pijn in 15 landen in Europa en Israel
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8Een belangrijke vraag is hoe het komt dat er deze verschillen zijn? Om deze vraag te beantwoorden is een 
systematische review uitgevoerd waarin gekeken is naar epidemiologische data uit studies die verricht 
waren met populaties uit Europa als geheel en separaat uit Denemarken, Frankrijk, Duitsland, Italie, Spanje, 
Nederland, Zweden en Groot Brittanie. In totaal zijn 21 onderzoeksvragen geformuleerd. Onderzoeksvragen 
bij de verschillende populaties betroffen: het verzamelen van informatie over de incidentie en prevalentie van 
chronische pijn; het verkrijgen van inzicht in behandelingen voor chronische pijn; het verkrijgen van inzicht in de 
impact van chronische pijn op kwaliteit van leven, algemene dagelijkse levensverrichtingen, verzuimdagen en 
kosten. Alhier wordt de analyse van studies die zijn verricht in de Nederlandse populatie beschreven.
Methode
In augustus 2009 is gezocht in MEDLINE, EMBASE, CDSR, CENTRAL, DARE, HTA, en GIN naar relevante 
artikelen over chronische pijn. Primair zijn titels en abstracts beoordeeld door 2 onderzoekers. Indien er 
consensus was over bruikbaarheid en indien er onduidelijkheid was werden de volledige artikels opgevraagd 
voor nadere beoordeling. Deze werden gesorteerd op de uitgangsvragen en geanalyseerd op kwaliteit. 
Geincludeerd werden primaire studies en systematic reviews vanaf 1995. Chronische pijn werd gedefinieerd 
als pijn ≥ 3 maanden of passend bij een ziekte met een chronisch karakter zoals osteoarthritis, fibromyalgie 
of reumatoide arthritis. Geexcludeerd werden kinderen en adolosenten, hoofdpijn/migraine, Angina 
Pectoris en pijn bij specifieke ziekten zoals Parkinson en multiple sclerose. Nadere selectie vond plaats op 
basis van representativiteit, grootte, datum en kwaliteit van de onderzoeken. Data extractie vond plaats 
door 1 onderzoeker en werd gecontroleerd door de 2e onderzoeker. De 3-5 meest relevante artikelen per 
onderzoeksvraag zijn gebruikt voor de analyses.
Resultaten
In totaal werden voor heel Europa 16.619 artikel geïdentificeerd. Na analyse voldeden 119 artikelen die 
Nederlandse patiënten beschrijven aan de gestelde eisen. Deze werden gebruikt voor de nadere analyse. 
De analyses zijn weergegeven in het onderliggende rapport. De eerste uitgangsvraag ging over wat we weten 
over de incidentie van chronische pijnsyndromen in Nederland. Er zijn eigenlijk slechts 2 onderzoeken die iets 
zeggen over incidentie. Beide onderzoeken zijn verricht in de IPCI database, een databank waar huisartsen 
elektronisch hun patientendossiers in bijhouden. Een van de onderzoeken heeft gekeken naar neuropathische 
pijn en de andere heeft gekeken naar het Complex Regionaal Pijn Syndroom (2,3). Van belangrijke andere 
pijnsyndromen zoals lage rugpijn, schouder en nekpijn, arthritis en reumatoïde arthritis hebben we geen cijfers 
over de incidentie. Rugpijn met radiculopathie komt het vaakst voor, gevolgd door diabetische polyneuropathie 
en postherpetische neuralgie.
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Figuur 2. Dieleman et al 2008, de Mos et al 2007 Incidentie specifieke chronische pijnsyndromen in Nederland
De uitgangsvraag naar de prevalentie laat met name data zien voor rugpijn, schouder nekpijn arthritis en 
rheumatoide arthritis en in tegenstelling tot de incidentie weten we hier niets over neuropathische pijn. Lage 
rugpijn, schouder/nek pijn en osteoarthritis van de knie hebben de grootste prevalentie (1, 4, 5) (zie figuur 3). 
Van patiënten met kanker had 55% pijn en 44% matige of ernstige pijn.
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Figuur 3. Breivik et al 2006, Kersssens et al 2002, Picavet et al 2003. Prevalentie van chronische pijn in 
Nederland
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Patiënten met matige tot ernstige chronische pijn algemeen hebben een gemiddelde leeftijd van 51,3 jaar, de 
man/vrouw verdeling is 40/60 (1). Bij postherpetische neuralgie is de gemiddelde leeftijd 55 jaar en de man/
vrouw verdeling 42/58 (6). Bij patiënten met pijn aan de bovenste extremiteit en nek is de gemiddelde leeftijd 
65 en de man/vrouw verdeling 71/29 (7).
De gemiddelde duur van chronische pijn in Nederland is 6,5 jaar (1). De gemiddelde pijn bij patiënten met 
Reumatoïde Arthritis is gemeten op de NHP vragenlijst 13,4 (8). De pijnintensiteit bij chronische RSI is 41,3 mm 
op een 100 mm VAS schaal (9). 
Van alle patiënten met chronische pijn met een VAS van 5 of hoger wordt 57% behandeld (1). Van patiënten 
met chronische pijn die opgenomen liggen in een verpleeghuis wordt 61% behandeld (10). Respectievelijk 74% 
en 69% van de patiënten met chronische lage rugpijn en chronische nekpijn wordt behandeld (11,12) en 53% 
van de patiënten met neuropathische pijn wordt behandeld (2) .
41% van de patiënten met chronische pijn gebruikt een analgeticum. In Nederland zijn de NSAIDs het meest 
populair (1). In de Breivik studie worden grote verschillen gezien in de zin dat in Noord europa opiaten erg 
populair zijn en in de middellandse zee gebieden nauwelijks voorgeschreven worden. Dit geeft aan dat guidelines 
nauwelijks gevolgd worden en voorschrift meer afhankelijk lijkt van de lokale folklore en het geloof (zie figuur 4). 
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Figuur 4. Breivik et al. Percentage patienten met chronische pijn (VAS ≥ 5) met een medicamenteuze 
behandeling in Europa (linksonder) en in Nederland (boven)
Meest populair bij de niet medicamenteuze behandeling zijn fysiotherapie, acupunctuur en massage. Het is 
opvallend dat cognitieve gedragstherapie nauwelijks of niet wordt toegepast (zie figuur 5). 
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Figuur 5. Breivik et al. Percentage patienten met chronische pijn (VAS ≥ 5) met een niet medicamneteuze 
behandeling in Nederland
Onderzoek naar de medicamenteuze behandeling van neuropathische pijn toont als opvallendheid dat het 
merendeel van de patiënten behandeld wordt met een NSAID, een middel dat niet direct geïndiceerd is bij 
neuropathische pijn (2) (zie figuur 6).
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Figuur 6. Dieleman et al. Percentage patienten met neuropathische pijn met een medicamenteuze 
behandeling in Nederland
78% van de chronische pijnpatiënten met een VAS groter of gelijk aan 5 ervaart zijn behandeling als inadequaat, 
34% van de patiënten in verpleeghuizen ervaart zijn behandeling voor pijn als inadequaat (1,10) (zie figuur 7).
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Figuur 7. Breivik et al. 2006 en Herk et al 2009. Percentage chronische pijn patienten die hun behandeling als 
inadequaat ervaren
In een onderzoek van Lame is gekeken naar de impact van chronische pijn op kwaliteit van leven bij patiënten 
in een universitair pijnbehandelcentrum. De chronische pijnpatiënt scoort in alle dimensies significant lager 
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in vergelijking met een normale controle groep. In vergelijking met migraine en kankerpatiënten scoort 
de chronische pijnpatiënt ook significant lager (13) (zie figuur 8). Bij chronische musculoskeletale klachten 
scoren patiënten ook lager ten opzichte van de normale controlegroep in een aantal dimensies, hoewel 
niet zo indrukwekkend als bij de vorige studie. Kwaliteit van leven gemeten bij patiënten met chronische 
musculoskeletale pijn middels de euroqol toont slechtere scores op alle dimensies(14). In een studie van Alonso 
uit 2004 wordt de kwaliteit van leven van arthritis patiënten vergeleken met de normale populatie en een 
aantal andere chronische aandoeningen. De afname van kwaliteit van leven is vergelijkbaar met patiënten met 
chronisch hartfalen (15).
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Figuur 8. Lame et al 2005. Impact op kwaliteit van leven (SF36) bij chronische pijn patienten in een 
Nederlands universitair pijnbehandelcentrum
Uit de studie van Breivik blijkt dat van de patiënten met chronische pijn met een VAS ≥ 5 18% niet voor zich zelf 
kunnen zorgen en 54% niet normaal functioneren (1). Borghouts toont aan dat 38,3% van de patiënten met 
chronische nekpijn beperkingen ervaart in het dagelijks leven (12). In een studie van Rupp uit 2006 bij patiënten 
met chronische pijn bij reumatoïde arthritis blijkt dat pijn de belangrijkste predictor is voor beperkingen (16). Bij 
chronische pijn VAS ≥ 5 blijkt in 19% sprake van stemmingsstoornissen (1). In een studie van De Meyttenaere 
wordt aangetoond dat patiënten met chronische pijn ten opzichte van de normale populatie vaker last hebben 
van een depressie, gegeneraliseerde angst, agorafobie of paniekstoornis, sociale fobie, posttraumatische stress 
en alcoholisme en verslaving (17).
In een studie van Borghouts is specifiek gekeken naar het aantal dagen ziekteverlof bij musculoskeletale pijn 
en nekklachten. In 1 jaar bedroeg het aantal ziekteverlofdagen in Nederland ten gevolge van musculoskeletale 
pijn meer dan 19 miljoen. Voor nekklachten was dit bijna 1 ½ miljoen (12). Huisstede heeft gekeken naar 
ziekteverlof bij chronische CANS. Vaak is er sprake van langdurig ziekteverzuim (7). Dit geldt ook voor 
musculoskeletale aandoeningen, vaak is er sprake van langdurig ziekteverzuim (5).
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In 1996 bedroegen de totale kosten van chronische nekklachten in Nederland meer dan 680 miljoen 
amerikaanse dollars. Opvallend is dat het overgrote deel (77%) veroorzaakt wordt door indirecte kosten. Het 
honorarium van medisch specialisten bedroeg slechts 0,2% (12). Boonen heeft gekeken naar de kosten van 
musculoskeletale aandoeningen. Bij fibromyalgie en chronisch lage rugklachten zit het merendeel in de niet 
medische kosten. Een aanzienlijk deel van de kosten wordt bepaald door verlies aan productiviteit. Specifiek 
gekeken naar kosten van verschillende soorten gezondheidszorg bij lage rugklachten blijkt ook het merendeel 
te zitten in niet medische kosten (18). In een studie van Kemmler is gekeken naar het gemiddeld besteedbaar 
inkomen voor en na de diagnose Complex regionaal pijn Syndroom. Het besteedbaar inkomen zakt aanzienlijk. 
Kemmler heeft ook gekeken naar extra kosten door ziekte die niet elders te verhalen zijn. Zeker in relatie tot het 
gemiddelde netto besteedbaar inkomen zijn dit aanzienlijke bedragen (19).
Discussie 
Er is een hoge incidentie en prevalentie van chronische pijn in Nederland. Niet iedereen wordt behandeld, 
er is een grote variatie aan behandelingen, relatief veel patiënten ervaren de behandeling als inadequaat. 
Chronische pijn heeft een forse impact op kwaliteit van leven, ADL, stemming, ziekteverlof en gaat gepaard 
met aanzienlijke directe en indirecte kosten.
De huidige epidemiologische data tonen echter een aantal beperkingen. Er zijn forse leemtes in data. De 
kwaliteit van de studies is beperkt: er is beperkte duidelijkheid over representativiteit; het betreft beschrijvende 
studies zonder aanpassingen voor verstorende variabelen of studies van zelfrapportage zonder bevestiging van 
de diagnose.
Lastig bij epidemiologisch onderzoek naar chronische pijn zijn de verschillen in definitie en classificatie. 
Een ander lastig aspect is dat onder de term chronische pijn een aantal verschillende aandoeningen vallen. 
Chronische pijn is niet als aparte ziekte entiteit erkend. Chronische pijn komt niet als zodanig voor in de ICD 10.
Hoe moeilijk het is om juiste epidemiologische data te verkrijgen mag blijken uit het onderzoek van de Mos 
die primair een incidentie toonde van 26, 2 per 100.000 persoonsjaren maar later deze incidentie toch weer 
bij moest stellen naar een lager getal nadat de patiënten bezocht waren door de onderzoeker zelf (3). Ook het 
onderzoek van Dieleman vertoont vergelijkbare beperkingen, door Dieleman werd voor trigeminus neuralgie 
een incidentie vastgesteld van 28,9 per 100.000 persoonsjaren die in het onderzoek van Koopman bijgesteld 
moest worden naar 12,9 per 100.000 persoonsjaren (2, 20)
In vergelijking met andere chronische aandoeningen komt chronische pijn heel vaak voor. Toch heeft het geen 
of onvoldoende aandacht van beleidsmakers. Diabetes, chronisch hartfalen, COPD en kanker krijgen veel meer 
middelen. Door de beleidsmakers wordt een actief beleid gevoerd ten aanzien van preventie en terugdringen 
van deze aandoeningen. Voor chronische pijn is weinig tot geen aandacht. Chronische pijn wordt niet gezien 
als een ziekte in zijn eigen recht. 
Aanbevelingen zijn dan ook: vergroot awareness, ontwikkel duidelijke definities en een classificatiesysteem, 
ondersteun research naar epidemiologie en pathophysiologie, verbeter kennis van diagnostiek en interventies, 
includeer training in chronische pijn in de curricula van alle medische opleidingen en ontwikkel zorgstandaarden 
voor kwaliteit en uitkomsten.
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Executive summary - Epidemiology of chronic pain in the Netherlands
Chronic pain is very common but good data are scarce about the prevalence, incidence, diagnosis, severity, 
treatment, utilization of health care, and the impact of chronic pain on society, health care systems and the 
patient. Information about the epidemiology of chronic pain can help decision and policy makers decide about 
health budgets and prioritization, patient segmenting and budget fencing, and therapy budgets, including 
behavioural therapy and drug budgets. This report aims to provide epidemiological information about chronic 
pain in the Netherlands using the most representative, recent, comprehensive and valid studies.
Out of 16 619 retrieved titles and abstracts, we selected 155 studies from the Netherlands that were relevant 
to the project questions. From these, we selected at least three studies per question that provided the most 
recent, representative and valid data. A summary of the results for each project question follows:
Q1. What are the population and demographics of the Netherlands?
The Dutch population is 16 485 787029 individuals (per October 2009) with a nearly 1:1 male to female sex 
ratio. The mean age is 39.9 years. The mean standardized annual income in 2008 was 24 400 Euros; 27 200 
Euros for the working population and 21 200 for the non-working population. The employment rate in 2009, 
was 70.7%, with an unemployment rate of 4.9%.
Q2/3. What is the prevalence/incidence of chronic 
pain conditions in the Netherlands?
The Dutch population is approximately 16.5 million people in 2009.
The percentage of individuals with chronic pain is 18% (NB this refers to moderate to severe chronic pain). 
The prevalence of chronic low back pain 21.2%, of shoulder pain 15.1% and of neck pain 14.3%. No data are 
available for back pain overall or back pain without radiculopathy.
The prevalence of back pain with radiculopathy can be estimated to be 8.3% for females and 10.3 for males 
(refers to herniated disc or back).
The prevalence of osteoarthritis of the knee is 13.6 and 10.1 for females and males respectively and the 
prevalence of osteoarthritis of the hip, these figures are 9.6 and 3.9%. The prevalence of RA is 4.6 and 1.6% 
for females and males respectively. The prevalence of CRPS is 5.2%
No data were found on the incidence of back pain or arthritis in the Netherlands.
The incidence of neuropathy is 820/100,000 PY. Of all neuropathies, ischias occurs most frequent, with 
an incidence of 210.4. Incidence of diabetes neuropathy is 72.3, PHN 41.8, trigeminal neuralgia 28.9 and 
phantom pain 2.2, all per 100,000 PY. The incidence of CRPS is 26.2/100,000PY.
No data were found on prevalence or incidence of post-thoracothomy pain, post-mastectomy pain and CVPS.
Q4. What percentage of chronic pain patients from the 
Netherlands are untreated or inadequately treated
Four studies reported data regarding Dutch patients untreated for their pain problem. Two were performed in 
nursing home populations and the definition of untreated was similar – patients who did not receive analgesics. 
The percentages of such patients varied between 25 and 36%. Two studies were performed in general practice, 
regarded musculoskeletal pain and reported that 31–36% of patients with neck pain or low back pain visiting 
their GP received no treatment for their pain. 
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Three studies reported percentages of inadequately treated patients, which ranged between 34% and 79%. It 
should be noted that inadequacy of treatment was defined differently in these studies. Smalbrugge et al. 2007 
reported on the percentage of patients with inadequate analgesics dosing and van Herk et al 2009 reported 
inadequate treatment as indicated by Pain Management Index in 34% of nursing home residents, while Breivik 
et al. 2006 reported inadequate pain relief according to patient assessment. 
Q5. How many chronic pain patients from the 
Netherlands present themselves for treatment?
The five included studies reported data regarding patients having contacts with healthcare due to their pain. 
The studies reported that around 20% of population had used healthcare services due to low back pain 
and among patients with low back pain between 30–40% contacted their GP. Among patients with other 
musculoskeletal pain GP contacts were reported for 40–50% of patients, while for more than 60% of patients 
with CRPS contacted GP as their first physician. Contacts with other health professionals were also common 
among patients with pain.
Q6. How many chronic pain patients from the Netherlands 
get treated, broken down by treatment?
Two studies on treatments for general chronic pain were found. One study, including patients with moderate to 
severe chronic pain, reported that 14% had seen a pain management specialist and that 33% were prescribed 
medicines. Furthermore, 52% had tried physiotherapy, 21% acupuncture and 17% massage for their pain. 
The other study reported on frequency of invasive procedures carried out in Dutch hospitals. 85% of the 
respondents performed such procedures and performed approximately 63,000 procedures in 1991-1992.
Two other studies reported on chronic musculoskeletal pain in general practice. Among patients who visited 
their GP for low back or neck pain, 36% and 31% did not receive any treatment, respectively. For both 
indications, medication was most frequently applied treatment (22% of patients with low back pain received 
medication and 58% of patients with neck pain received paracetamol/aspirin/ NSAIDs). The most frequent used 
non-drug treatments for low back pain were (bed)rest (6%) and postural advice (6%) and for neck pain heat 
application (20%) and postural advice (18%). 
The last study on neuropathic pain reported only types of medication as treatment. 53% of the patients with 
neuropathic pain were prescribed medication and 47% were not. NSAIDs were the most commonly used drug; 
about 35% received this.
Q7. What is the compliance of treated chronic 
pain patients in the Netherlands?
No studies were located.
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Q8. What is the duration and severity of chronic 
pain conditions in the Netherlands?
Breivik et al. (2006) measured the mean duration of general chronic pain for Dutch participants at 6.5 years. 
Mean pain scores among the 268 Dutch patients with recently diagnosed Rheumatoid arthritis were  
13.4 (SD: 2.1); while scores ranged from 8 to 16.
Pain intensity as measured on a 100mm VAS scale for patients with chronic RSI was 41.3 (SD: 25.4).
Q9. What are the demographics of chronic 
pain sufferers in the Netherlands?
The mean age of moderate to severe chronic pain sufferers in the Netherlands was 51.3 years and 60% were 
female. 47% of all HZ patients were at least 55 years old and 58% were female. 
63% of persons with chronic complaints of the upper extremity and neck were female and 29% were 65 years 
or older.
Q10. What are the co-morbidities of chronic 
pain sufferers in the Netherlands?
The three included studies reported comorbidities in several pain conditions. In general pain condition 
depression was reported in 19% of respondents, in patients with back or neck pain mood disorders were 
reported by 4.5–9.4% (major depressive disorder was reported by the highest percentage of respondents) 
of pain sufferers, anxiety disorders by 1.7–7.4% of respondents and alcohol abuse by 1.7%. In patients with 
musculoskeletal pain coexistence of pain in several locations was reported by 5–7% and more widespread pain 
including combinations of upper and lower extremities, back or neck and in left and right was reported by 
4–6% of respondents.
Q11. How many sufferers in the Netherlands have inadequate pain control?
Breivik et al. 2006 reported inadequate pain control from medication according to patients assessment in 79% 
and inadequate overall pain control in 56%. 
Q12a. In the Netherlands what is the impact 
of chronic pain on quality of life?
The three included studies reported on quality of life in several pain populations. Quality of life scores were 
low for patients with pain or musculoskeletal diseases. Patients with back pain, other pain and multiple pain 
locations experienced more functional limitations (physical functioning and role limitations physical) than the 
other pain groups. In addition, patients with multiple pain localizations scored significantly lower on mental 
health, vitality and general health. 
Patients with osteoarthritis had lower scores on physical summary component than patients not reporting any 
chronic conditions. 
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For all musculoskeletal diseases and all quality of life dimensions it was found that having the disease was 
associated with a worse health related quality of life. The dimensions typically affected by musculoskeletal 
diseases were physical functioning and pain on the SF36, and the dimensions ‘‘mobility’’ and ‘‘pain’’ on the 
EQ-5D.
Q12b. In the Netherlands what is the impact of 
chronic pain on activities of daily living?
The four included studies reported on prevalence of limitation in daily life due to pain or associations between 
socio-demographic characteristics or disease characteristics and disability in rheumatoid arthritis. In patients 
with musculoskeletal pain limitation in daily life were reported by 8.5–53% of patients. In patients with 
rheumatoid arthritis pain was the most important predictor for disability, significant associations were also 
found for depressive symptoms, radiographic damage and disease activity. Female sex, older age, RF positivity, 
disease activity and somatic and psychological co-morbidities were found to be risk factors for poor outcome 
with respect to disability.
Q12c. In the Netherlands what is the impact of chronic 
pain on depression and other mental illnesses?
The three included studies reported on prevalence of depressive symptoms or associations between disability 
and health-related quality of life rheumatoid arthritis radiographic joint damage, disease activity, pain, and 
depressive symptoms. In general pain condition depression was reported in 19% of respondents, in patients 
with back or neck pain mood disorders were reported by 4.5–9.4% (major depressive disorder was reported 
by the highest percentage of respondents) of pain sufferers, anxiety disorders by 1.7–7.4% of respondents and 
alcohol abuse by 1.7%. 
Q12d. In the Netherlands what is the impact of 
chronic pain on isolation and helplessness?
Only two studies were found that reported on isolation or helplessness. One study was on patients with early 
RA and the other on patients with unexplained chronic pain attending an interdisciplinary treatment centre. 
Patients with early RA seem to be satisfied with their social support and patients with unexplained pain seem to 
experience at most moderate helplessness. Resting, however, a passive pain coping strategy seems to be used 
sometimes to frequent.
For both studies it’s unclear whether the populations are representative of the target population. Together with 
the difficulties interpreting the data, we should conclude that the current data give only a limited view on the 
impact of chronic pain on isolation and helplessness.
Q12e. In the Netherlands what is the impact 
of chronic pain on days off work?
The four included studies reported either the number of days off work or the percentage of patients leaving 
work due to pain for a certain length of time. Mean time lost from work due to general chronic pain in the past 
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6 months was 6.8 days. One cost-of-illness study reported total number of sick days related to neck disorders as 
1 435 044 days. Two studies based on DMC3 data reported the percentages of patients with work leave due to 
musculoskeletal pain during last year between 4 and 32% depending on the subgroup.
Q12f. In the Netherlands what is the impact of 
chronic pain on incapacity benefits?
The three included studies reported the proportion of patients receiving disability pension or recognized 
as being fully or partially disabled for work purposes or incidence of disability claims. In 1996 2.5% of the 
Netherlands population were receiving disability pension in relation to the neck pain. Over ninety percent of 
analysed patients with rheumatoid arthritis who had withdrawn from the labour force were officially recognised 
as being fully or partially disabled for work purposes. The annual incidence rate of low back disability in self-
employed medical professionals increased between 1977 and 1989 and the incidence. When incidence of low 
back disability exceeding one year was compared with general working population the risk for the latter was 
three times higher. 
Q13. In the Netherlands, what are the costs of chronic pain 
from societal, health care system and patient perspective?
Costs for society due to neck pain in 1996 were estimated to be $686.2 million. It’s not clear what proportion 
of it refers to chronic neck pain. Cost for three chronic musculoskeletal diseases ranged between 3205 and 
8533 euro’s per patient per year. Cost for compensation of low back pain disability was 8.0 million in 1989 
for a group of self-employed health care professionals. Direct medical costs accounted for 23% for neck pain 
and between 13 and 32% for the chronic musculoskeletal diseases, depending on the type. For neck pain, 
paramedical care accounted for the majority of costs (19 of 23%). For the chronic musculoskeletal diseases, 
large proportions of costs were used for specialist physicians, physiotherapists and prescription drugs. Only one 
study reported costs for patients; patients with CRPS have a decreased income and the mean out-of-pocket 
expenses were reported to be $`350 euro per patient per year.
Q14. What are the issues/determinants of patients’ 
awareness of chronic pain in the Netherlands?
Two quantitative studies reported determinants of awareness of chronic pain or disability. Patients who are 
able to work, who have a better physical role or better physical functioning have less pain. Also, those who 
experience fewer consequences and symptoms and are less concerned about their illness have less pain. Fear of 
injury and catastrophizing was associated with more disability.
A qualitative study showed 3 phases in the process of living with chronic pain: first patients aim to be normal, 
ignoring the pain and with unchanged activities. Then they aim to control and reduce the pain by withdrawing 
from activities. The pain is in control here. Last, they aim to collaborate with the pain. To do this they have to 
constantly face dilemmas of prioritizing activities in order to incorporate pain in everyday life. 
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Q15. What are the issues/determinants of health care 
professionals’ awareness of chronic pain in the Netherlands?
Nursing home staff respondents showed knowledge deficits about several aspects of pain, even though they 
were satisfied about the way pain was assessed and treated at their wards. Specific knowledge deficits were 
found regarding pain treatment and medication in elderly nursing home residents. Staff educational level 
seemed to influence their beliefs and knowledge about pain in elderly nursing home patients.
Q16. What are the main symptoms and complaints with which patients 
present themselves to health care professionals in the Netherlands?
No studies were located.
Q17. What are the frequencies of drug, non-drug and 
combined treatments in the Netherlands?
In two out of three studies data for this question referred only to the frequency of drug treatment. The 
percentage of people that currently were prescribed medicines varied between 33 to 75% in the selected 
studies. Most of the patients were prescribed NSAIDs. One study reported that specific non-drug treatments 
had been tried by 21 to 52% of Dutch patients. No data, specifically for the Netherlands, was available on the 
frequency of overall non-drug or combined drug/nondrug treatments.
Q18. What are the determinants of treatment choice between 
drug treatment and non-drug treatment in the Netherlands?
Factors influencing choice of treatment for fibromyalgia differ per discipline. The choice is mainly made on the 
basis of subjective, professional group-bound factors such as EBM, protocols, courses, own experience and 
experiences of colleagues. For GPs, dynamic patient factors are an important motive in the management of FM. 
Q19. What are the determinants of treatment choice 
within drug treatments in the Netherlands?
No studies were located.
Q20. What are the determinants of compliance/
adherence to drug treatment in the Netherlands?
No studies were located.
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Q21. What is patients’ satisfaction about drug 
treatments in the Netherlands?
Only one low quality study, performed in a Dutch nursing home population was found reporting on satisfaction 
about drug treatment. 60% were satisfied and 21% were not.
Epidemiology Epidemiological data on: Numbers on chronic pain: 
1. Prevalence 
2. Diagnosis 
3. Treatment 
choice 
4. Brand choice 
5. Compliance 
Population 16 485 000 total population 
Prevalence 18% 
Diagnosis: 12% traumatic 
injury, 13% herniated / 
deteriorating disc and 19% 
arthritis or osteoarthritis 
Brand choice
Compliance – Pharmacy Rx ﬁll
Compliance – Patient persistence
No datafound
No data  found
Patient awareness
Patient presentation
Disease diagnosis
Treatment choice, drug 
choice 
33% prescribed medicines, 52% 
physiotherapy,  21% acupuncture 
and 17% massage. WHO I:  36% 
NSAIDs, 11% paracetamol, 16% 
Cox-2 inhibitor; WHO II: 14% 
weak opioids; WHO III: 5% strong 
opioids
Figure 1. Netherlands epidemiology flow for moderate to severe chronic pain
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Estimates of the prevalence of chronic pain vary widely and typically range between 10-30% of the adult 
population, although studies exist reporting prevalence as low as 2% or as high as 50% [IASP 2003, Breivik 
2006]. This wide variation may reflect true differences between populations, but also the use of different 
definitions of chronic pain in epidemiological studies. Most definitions include continuous or intermittent 
pain, persisting for more than 3 months. Also, assessment methods vary, mostly involving a survey either by 
telephone or with data collection in person, using a range of different questionnaires and rating scales. 
Typical locations of chronic pain include upper and lower back, head and neck, and joints. Surveys of the 
location of chronic pain also report sometimes considerable variations. Chronic pain is often reported to be 
more common among women, in older age groups and in lower income groups.
Severity of chronic pain is another element which is not straightforward to assess, both in terms of definitions 
of various grades of severity, and in terms of which measurement instruments are used. Compared with chronic 
pain of mild intensity and minimal disability, individuals with severely disabling chronic pain are more likely 
to have co-morbid health conditions, poorer self-rated health, problems with mental well-being and social 
functioning, activities of daily living, work loss, isolation, helplessness, and high health care costs and utilization.
Chronic pain is very common but good data about prevalence, incidence, diagnosis, severity, treatment and 
utilization of health care are scarce. National statistics in Europe do not tend to focus on chronic pain as a 
discrete entity, but rather see pain as part of other underlying diseases, a symptom. This approach ignores 
the insight of clinicians specialised in pain treatment that chronic pain is considered a discrete entity in itself, 
with clear characteristics of symptoms, disability and mental health aspects which are largely independent of 
the underlying disease or trauma. Many studies of chronic pain prevalence have been based in particular care 
settings, such as pain clinics, or in particular subgroups with certain underlying diseases.
Information about the epidemiology of chronic pain can be important for decision and policy makers, so 
that they can decide about health budgets and prioritization, patient segmenting and budget fencing, and 
therapy budgets, including behavioural therapy and drug budgets. Compared with cardiovascular disease, 
oncology, diabetes and mental health there often seems to be limited appreciation by decisions makers about 
the importance of chronic pain, so data about all aspects of the epidemiology of chronic pain from prevalence 
to cost impacts will be useful for proper information. Chronic pain is an important and frequent medical and 
public health issue, and there seems to be a need for better understanding of the burden of disease and current 
treatment practice of chronic pain.
This report aims to provide information about chronic pain in the Netherlands. It is a part of a larger project 
addressing chronic pain in a range of European countries and Europe as a whole. Our method is a review of the 
available published and unpublished data, using the principles of systematic reviews in searching and identifying 
relevant studies, and summarizing their findings. Given the types of questions to be addressed, we aimed to 
use the most representative, recent, comprehensive and valid studies, rather than summarizing the results of all 
studies that were found. 
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Objective of project
To undertake a literature review on the most recent epidemiological data on chronic pain. 
Questions to be addressed
Epidemiology flow 
1. What are the population and demographics of the Netherlands?
2. What is the prevalence of chronic pain conditions?
3. What is the incidence of chronic pain conditions?
4. What percentage of chronic pain patients are untreated or inadequately treated?
5. How many chronic pain patients present themselves for treatment?
6. How many chronic pain patients get treated broken down by treatment?
7. What is the compliance of treated chronic pain patients?
Questions leading to in depth information to the numbers mentioned in the Epidemiology flow
8. What is the disease duration of chronic pain conditions?
9. What are the demographics of pain sufferers?
10. What are the co-morbidities of pain sufferers?
11. How many sufferers have inadequate pain control?
12. What is the impact of chronic pain on:
a. Quality of life
b. Activities of daily living
c. Depression and other mental illness
d. Isolation, helplessness
e. Days off work
f. Incapacity benefits
13. What are the costs of chronic pain from a
a. Societal perspective?
b. Health care system perspective?
c. Patient perspective?
14. What are issues/determinants of patients’ awareness of chronic pain?
15. What are issues/determinants of health care professionals’ awareness of chronic pain?
16.  What are the main symptoms and complaints with which patients present themselves to health care 
professionals?
17. What are the frequencies of drug (per WHO class), non-drug, and combined treatments?
18. What are determinants of treatment choice between drug treatment and non-drug treatment?
19. What are determinants of treatment choice within drug treatments?
20. What are determinants of compliance / adherence to drug treatments?
21. What is patients’ satisfaction about drug treatments?
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Inclusion criteria
Study characteristics
Primary studies (epidemiologic, qualitative, cost analyses etc.) or systematic reviews of primary studies published 
1995 onwards. Only relevant primary data used in any systematic reviews identified and fulfilling the inclusion 
criteria were used in the data analysis. 
Exclusions: non-systematic reviews, studies examining the effectiveness of treatments, comments, letters, 
editorials; any studies not showing any original data but just expressing opinions.
We expected to use the following types of data: national statistics (question 1), data from national health 
surveys (questions 2, 3), epidemiological studies (cohort, cross-sectional etc.) (questions 2 to 21), insurance data 
(data on early retirement, service use, prescriptions etc.) (questions 2, 12, 17), qualitative studies (questions 12, 
13, 14, 15, 16, 18, 19, 20, 21), economic analyses (question 13), RCTs (e.g. of specific interventions to increase 
awareness, adherence with awareness/adherence as main outcome, possibly treatment satisfaction) (questions 
14, 15, 20, 21)
Patients
Patients with chronic moderate and/or severe pain from the Netherlands.
Chronic pain includes:
• musculo-skeletal pain: back pain / low back pain / shoulder pain / neck pain
• neuropathic pain (e.g. diabetic, post herpetic)
• fibromyalgia
• osteoarthritis
• rheumatoid arthritis
Exclusions:
• children and adolescents
• patients with mild pain
• patients with headache / migraine
• patients with angina pectoris
• pain associated with very specific medical conditions, e.g. Parkinson's disease, multiple sclerosis etc. 
•  studies of non-European participants – unless European data or data for relevant European countries are given 
separately
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Literature searches
We aimed to identify all relevant studies regardless of publication status (published, unpublished, in press, and 
in progress), or language.
The search strategies (keywords) were developed specifically for each database (appendix).
We searched the following databases:
• MEDLINE (1995 to August 2009)
• EMBASE (1995 to August 2009)
• CDSR (Cochrane Library issue 2 2009)
• CENTRAL (Cochrane Library issue 2 2009)
• DARE (August 2009, CRD website)
• HTA (August 2009, CRD website)
• Guidelines International Network database (August 2009, GIN website)
Furthermore, references in retrieved articles and systematic reviews were checked. Supplementary searches 
were undertaken as appropriate. Relevant websites were searched for national statistics, insurance data, 
health surveys and other relevant data. Relevant sites are shown in the appendix. Identified references were 
downloaded in Reference Manager software for further assessment and handling.
The proposed search strategies (Ovid) are shown in the appendix. 
Methods of study selection, quality assessment and data extraction
This literature review followed the methods and processes recommended in the Centre for Reviews and 
Dissemination (CRD) “Systematic Reviews: Guidance for undertaking reviews in health care”.
Study selection
Two reviewers independently inspected the title and abstract of each reference identified by the search and 
determine the potential relevance of each article. For potentially relevant articles, or in cases of disagreement, 
the full article was obtained, independently inspected, and inclusion criteria will be applied. Any disagreement 
will be resolved through discussion. Justification for excluding studies from the review (after having retrieved 
potentially relevant articles) was documented.
Included studies were categorised in order to get a list of relevant studies per question. Where there were 
more than three studies addressing a single aspect of any question, then for each question the most relevant 
studies were extracted using the following criteria: size (large preferred), recency (most recent preferred), quality 
(highest quality preferred), representativeness (populations representative of the general target population 
preferred). Studies were ranked by these criteria and the three or four highest ranking studies were extracted.
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Assessment of methodological quality
Quality assessment was carried out by one reviewer and checked by a second, using checklists as outlined 
below. Any disagreements were resolved by consensus. The results of the quality assessment have been used 
for descriptive purposes to provide an evaluation of the overall quality of the included studies and to provide a 
transparent method of recommendation for design of any future studies. Based on the findings of the quality 
assessment, recommendations have been be made for the conduct of future studies.
The following quality criteria were used for the assessment of the different study types: 
(criteria to be answered with yes / no / unclear)
Observational studies:
• Adequate description of study design and setting
• Adequate description of eligibility criteria (incl. description of diagnostic criteria for chronic pain condition)
• Study population is representative of target population (sample size, sample selection, demographics)
• Adequate description of outcomes (and how / how often measured), exposures, predictors
•  Adequate description of statistical methods (incl. description of potential confounders and effect modifiers 
and how they were dealt with)
• Adequate description of study participants
•  Adequate description of losses to follow-up (for longitudinal studies), loss to follow-up less than 10% at 12 
months or less than 25% for longer follow-up 
• Results reported as unadjusted and confounder-adjusted including precision
RCTs:
• Adequate method of randomisation
• Adequate allocation concealment
• Adequate blinding (if appropriate)
• Adequate handling of losses to follow-up
•  Adequate description of eligibility criteria (incl. description of diagnostic criteria for chronic pain condition), 
interventions and outcome measurement
• Study population representative of target population (sample size, sample selection, demographics)
• Groups comparable at baseline
Qualitative studies:
• Adequate description / justification of study design and setting 
• Adequate description of eligibility criteria (incl. description of diagnostic criteria for chronic pain condition)
• Study population representative of target population (sample size, sample selection, demographics)
• Adequate description of outcomes / questions / procedures
• Adequate description of study participants
• Methods of data summary described and sound (quotes used, data categorisations, theory)
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SRs of observational studies:
• Adequate description of inclusion criteria (study design, participants, interventions / exposure, outcomes)
• Adequate description of search strategy (sources, keywords, time period, limits)
• Adequate description of study selection
• Adequate description of assessment of confounding
• Adequate description of quality assessment 
• Adequate description of data analysis and heterogeneity assessment
• Description of study flow
• Study characteristics of each study included
• Quality of each study included
• Results of each study included and overall
SRs of RCTs:
• Adequate description of inclusion criteria (study design, participants, interventions, outcomes)
• Adequate description of search strategy (sources, keywords, time period, limits)
• Adequate description of study selection
• Adequate description of quality assessment of included studies
• Description of trial flow
• Description of data analysis / summary (including heterogeneity)
• Description of study characteristics of the included studies
• Quality of each study included
• Results of each study included and overall
Data extraction and presentation
For each study, data were extracted by one reviewer and checked by a second reviewer. Any disagreements 
were resolved by consensus. 
We employed a narrative method to present the data and for any synthesis. Typically, narrative synthesis 
involves the use of narrative text and tables to summarise data in order to allow the reader to consider 
outcomes in the light of differences in study designs and potential sources of bias for each of the studies 
being reviewed. This involves organising the studies by (as appropriate) intervention, population, or outcomes 
assessed, summarising the results of the studies, summarising the range and size of the associations these 
studies report, and describing the most important characteristics and the quality of the included studies. 
Study characteristics and quality were presented in tables. Tables of results (including basic demographics of the 
populations assessed) are presented in tables subdivided by questions. 
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Search, selection and allocation of studies
We retrieved and selected 117 studies from the Netherlands that were relevant to the project questions. Of 
these, 102 studies were on non-cancer pain and 15 were (also) on cancer pain. The selection process can be 
viewed in Figure 2. The allocation and number of studies for specific project questions for non-cancer pain can 
be viewed in Figures 3a-c.
Duplicates: 4
Europe: 47 
Denmark: 65 
Germany: 169
France: 69 
Italy: 51 
Netherlands: 117
Spain: 112 
Sweden: 157 
UK: 236 
Unclear –
keep for 
later: 997 
Clearly not 
relevant 
(titles, 
abstracts): 
14 974 
Selected for
retrieval of 
full text 
articles: 1056
 
17 027 hits 
Dutch search 
including 
cancer pain:  
408 hits 
Main search: 
16 619 hits 
Figure 2. Search and selection of studies
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Figure 3. Project questions 
Q7 What is the compliance
of treated chronic 
pain conditions? 
0 studies 
Q11 How many suﬀerers  
have inadequate 
pain control?  
1 study 
Q4 What percentage of chronic pain
patients are untreated or 
inadequately treated?  
5 studies
Q6 How many chronic pain patients
get treated broken 
down by treatment?  
14 studies 
Q1 What are the population 
and demographics 
of each country? 
1 source (CBS) 
Q2 What is the prevalence of
chronic pain conditions?  
61 studies 
Q3 What is the incidence of chronic
pain condition?  
5 studies 
Q5 How many chronic pain
patients present 
themselves for treatment?  
13 studies 
Q8 What is the disease
duration of chronic pain 
conditions?  
16 studies 
Q9 What are the demographics
of pain suﬀerers?  
28 studies 
Q10 What are the co-morbidities
of pain suﬀerers?  
18 studies 
Figure 3a. Epidemiology flow for the Netherlands - number of studies located per question
Epidemiology of chronic pain in the Netherlands - Results 
36
Q12 What is the impact of chronic pain 
on quality of life, activities of daily 
living, depression and other mental 
illness, isolation and helplessness, days 
oﬀ work and incapacity beneﬁts?  
28 studies 
Q13 What are the costs of chronic pain 
from diﬀerent  perspectives? 
4 studies 
Q14 What are issues/determinants
of patients’ awareness 
of chronic pain? 
9 studies 
Q15 What are issues/determinants 
of health care professionals’ 
awareness of chronic pain? 
1 study 
Q16 What are the main symptoms 
and complaints with which 
patients present themselves to 
health care professionals? 
6 studies 
Figure 3b. Symptoms, awareness, impact and costs – number of studies located per question
Q17 What are the frequencies of
drug (per WHO class), non-drug 
and combined treatments? 
11 studies 
Q18 What are the determinants of
treatment choice between drug treatment 
and non-drug treatment? 
2 study 
Q19 What are determinants of treatment 
choice within drug treatments? 
1 study 
Q20 What are determinants of compliance 
/adherence to drug treatments? 
1 study 
Q21 What is patients’ satisfaction 
about drug treatments? 
1 study 
Figure 3c. Treatment – number of studies located per question
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Q1. What are the 
population and 
demographics of the 
Netherlands?
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To answer this question, the online database of the National Office of Statistics [Centraal Bureau voor Statistiek, 
CBS] was used. Population characteristics and data sources for each category can be viewed in Table 1.
The Dutch population as of October 2009 is 16 485 787029 individuals with a nearly 1:1 male to female 
sex ratio. The population by age range is as follows: there are 3.9 million people below 20 years, 4.2 million 
between 20 and 40 years, 5.8 million between 40 and 65 years, 1.8 million between 65 and 80 and 0.6 million 
above 80 years. The mean age is 39.9 years.
The mean standardized annual income in 2008 was 24 400 Euros. This includes the gross income from work, 
income from own company, and incomes through social insurances. It is standardized for differences in size and 
composition of a household. For the working population the income is 27 200 Euros and for the non-working 
population 21 200 Euros. The employment rate, percentage of persons who live in the Netherlands with a paid 
job of at least 12 hours/week in 2009, was 70.7%, with an unemployment rate of 4.9%. Approximately 6.1 
million people work as employer in a private company, 903 000 are self-employed and over 656 000 work as 
civil servant. 
Regarding education, 8.4% of adults aged 15 to 65 years in The Netherlands have no qualifications (only 
elementary school) and 26.4% have completed higher education (high vocational education [in Dutch: Hoger 
Beroepsonderwijs, HBO] or university).
Ethnicity data was collected for the Netherlands using country of origin in 2009. 80% is native Dutch, 8.5% 
comes from other European countries, 4.4% comes from Asia, 3.6% from America and 3.3% from Africa. 0.8% 
originates from Oceania. 
The Body Mass Index (BMI) data is based on self-reported height and weight in individuals aged 20 and higher. 
In 2008, 52% of males and 41% of females were overweight. Of these, 10% of men and 12.2 of women were 
severely overweight, defined as a BMI above 30kg/m². Forty-two percent of men and 29% of women were 
moderately overweight, defined as a BMI above 25kg/m² and below 30kg/m². 
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Table 1. Population characteristics for the Netherlands
Population Characteristics Numbers  Per cent
Source of data 
collection
General Population Data (2009, N and %) 1
Total population 16 485 787 100%
Females 8 329 391 50.5%
Males 8 156 396 49.5%
Population by age range (2009, N and %)
Below 20 years 3 933 585 23.9%
20 to 40 years 4 233 861 25.7%
40-65 years 5 846 526 35.5%
65-80 years 1 840 607 11.1%
Above 80 years 631 208 3.8% 
Mean personal annual Income in 2008 (Euros) 2
Total population 24 400
Working population 27 200
Non-working population 21 200
Employment in 2009 (N and %) 3, 4
Employment rate 7 753 000 70.7%
Unemployment rate 379 000 4.9%
Occupation 5
Employer private company 6 068 000
Civil servant 656 000
Director / large shareholder 180 000
Self-employed 903 000
Other job 120 000
Not working 4 442 000
Education (population between 15-65 years) (N and %) 6
Persons with higher education (at least high vocational education) 2 898 000 26.4%
Persons with only elementary school 924 000 8.4%
Country of origin (N and %) 7
Dutch 13 198 081 80.0%
Africa 543 649 3.3%
America 598 936 3.6%
Asia 726 646 4.4%
Europe (other than Dutch) 1 398 450 8.5%
Oceania 20 025 0.1%
Self-reported weight (aged 20+; 2008) 8
BMI >30 (Severely overweight) (% Males) 10.0%
BMI >30 (Severely overweight) (% Females) 12.2%
BMI 25-30 (Moderately overweight) (% Males) 42.3%
BMI 25-30 (Moderately overweight) (% Females) 29.2%
Epidemiology of chronic pain in the Netherlands - Q1 
40
Source of data collection
1.
http://statline.cbs.nl/StatWeb/publication/?DM=SLNL&PA=37296ned&D1=a&D2=50,l&HDR=G1&STB=T&VW=T
2. 
http://statline.cbs.nl/StatWeb/publication/?VW=T&DM=SLNL&PA=70957ned&D1=a&D2=0&D3=0&D4=0&
D5=0,54-68&D6=l&HD=080523-1734&HDR=G3,G2,G1,G5,T&STB=G4
3. 
http://statline.cbs.nl/StatWeb/publication/?DM=SLNL&PA=70173NED&D1=0-1,4,6-
7,9,13&D2=0&D3=0&D4=l&VW=T
4.
http://statline.cbs.nl/StatWeb/publication/?DM=SLNL&PA=70173NED&D1=11,14&D2=0&D3=0&D4=l&HDR=T,G
2&STB=G1,G3&VW=T
5.
http://statline.cbs.nl/StatWeb/publication/?VW=T&DM=SLNL&PA=70957ned&D1=a&D2=0&D3=0&D4=0&
D5=0,54-68&D6=l&HD=080523-1734&HDR=G3,G2,G1,G5,T&STB=G4
6. 
http://statline.cbs.nl/StatWeb/publication/?DM=SLNL&PA=71822NED&D1=0-1&D2=0&D3=0&D4=0-4&D5=0-
1,8-10&D6=0&D7=l&HDR=T,G2,G1,G5,G6&STB=G4,G3&VW=T
7.
http://statline.cbs.nl/StatWeb/publication/?DM=SLNL&PA=37325&D1=0&D2=0&D3=0&D4=0&D5=0,2-9,46,95-
96,137,152,194,215,232&D6=l&HDR=T,G2,G3,G5&STB=G1,G4&VW=T
8. 
http://statline.cbs.nl/StatWeb/publication/?DM=SLNL&PA=03799&D1=242,254,267-270&D2=0-2,4-7&D3=0&D
4=l&HDR=G2,T&STB=G1,G3&VW=T
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Q2. What is the 
prevalence of chronic 
pain conditions in the 
Netherlands?
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Q2 - Epidemiology of chronic pain in the Netherlands
From 61 studies, we selected the three studies that were most relevant to this question (Breivik et al. 2006, 
Kerssens et al. 2002 and the DCM3 study, for which we extracted two papers (Picavet and Schouten 2003 Pain / 
Picavet and Hazes 2003 Ann Rheum Dis).
Breivik et al. (2006) performed a large telephone survey to explore the prevalence, impact on daily life and 
treatment of chronic pain in Israel and 15 European countries, among which the Netherlands were included. 
Persons received an initial screening questionnaire comprising twelve questions and those who suffered from 
long-lasting pain were subsequently interviewed in-depth using a second structured questionnaire. From the 
Netherlands, 300 persons suffering chronic pain were interviewed. Kerssens et al. (2002) performed a cross-
sectional study using data from a registration network to estimate the prevalence of unexplained severe chronic 
pain in general practice and to report medical as well as psychological descriptions of patients suffering from this 
condition.
The Dutch Musculoskeletal Complaints and Consequences Cohort (DCM3) study is a population-based cohort 
study on musculoskeletal pain in the Netherlands, performed in 1998 (Picavet and Schouten 2003, Picavet 
and Hazes 2003). Respondents who reported musculoskeletal pain were asked to answer questions on pain 
characteristics and consequences, for each pain location. This study included 3664 persons (response or 
46.9%), of which 74.5% reported any musculoskeletal pain during the past 12 months. See Table 2 for study 
characteristics. 
Table 2. Characteristics of the studies selected for question 2
Study details Population Outcomes and analysis
Breivik et al. 2006
Study design
Cross-sectional study
Study method
Telephone survey in two 
parts. First, persons were 
screened for chronic 
pain. Those who qualified 
were interviewed in-
depth
Type of chronic pain
Long-lasting pain: chronic pain for at least 6 months, 
and pain in last month, and pain at least 2 times/
week, and rating pain intensity at least 5 on 10-point 
NRS
Confirmation of diagnosis
Not reported
Sample size and demographics
3197 respondents, among which 300 persons with 
long-lasting pain
Of the pain-sufferers, 60% were female with a mean 
age of 51.3 years
(Refusal rates to telephone survey – 51%, screening 
refusal rate – 4%)
Patient selection
Subjects with long-lasting pain (see definition above). 
Mean duration of pain at time of in-depth interview 
– 6.5 yrs
Outcomes measured
Duration, location, intensity of pain. Tolerance, 
time course of pain, impact pain on activities daily 
life, employment status, emotional status. Visits 
to doctors, visits to pain management specialist, 
treatment (medication and non-medication), 
effectiveness of treatment, satisfaction with doctors, 
respondents’ attitudes and beliefs about pain and 
pain treatment, respondents’ perception of the 
attitude of others to their pain
Pain severity
18% reported severe pain
Analyses
Descriptive analysis only. No subgroups were 
reported (for the Netherlands)
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Study details Population Outcomes and analysis
Kerssens et al. 2002
Study design
Cross-sectional study
Study method
Data were collected 
from the Dutch Sentinel 
Practice Network. GPs 
included patients based 
on the study’s inclusion 
criteria and researchers 
searched the database 
using relevant codes from 
classifications regarding 
pain syndromes or pain 
medication
Type of chronic pain
Unexplained severe chronic pain
Confirmation of diagnosis
Not reported
Sample size and demographics
N= 586
Age between 18 and 75
71% female
Patient selection
Between 18 and 75 years of age; pain which had 
lasted at least 6 months; pain is the most prominent 
aspect in the clinical presentation; pain is serious 
enough to justify clinical attention; pain has led to 
obvious discomfort and disability in daily life for at 
least 1 month
Outcomes measured
MPI (Multidimensional Pain Inventory) including 
scales for: Pain Severity; Interference; Life Control; 
Affective Distress; Support; Punishing Response; 
Solicitous Response;
Distracting Response; Household Chores; Outdoor 
work; Social Activities; General Activities
Pain severity
Mean (SD) on scale 0-6
current pain: 3.7 (1.7)
average in last week: 4.1 (1.5)
Analyses
Descriptive statistics, association between variables 
using nonparametric correlation coefficient for 
interval variables and Chi-square for nominal 
variables
DMC3 study (Picavet 
& Schouten 2003, 
Picavet & Hazes 2003)
Study design
Cross-sectional study, 
cohort study
Study method
Mailed questionnaire 
with general and health 
questions. 
Screening question for 
each anatomical area: 
Did you have had pain 
in ‘anatomical area’ 
during the past 12 
months? Screen positives 
were asked to answer 
questions on pain 
characteristics and its 
consequences for each 
area
Type of chronic pain
Self-report musculoskeletal pain (screening question: 
Did you have had pain in ‘anatomical area’ during 
the past 12 months?
Confirmation of diagnosis
Not reported
Sample size and demographics
N= (respondents) 3664 
Gender 50.9% females, 49.1% men
Age: 47% 25-44 yrs, 34.6% 45-64 yrs, 18.4%  
65+ yrs
(NB weighted to present a distribution of sex, age, 
marital status and region of living equal to that of 
the Netherlands in 1998)
Patient selection
Dutch inhabitants of 25 years and older, who 
completed the questionnaire
Outcomes measured
period prevalence, point prevalence, prevalence of 
chronic pain, course of pain, consequences of pain 
(utilization of health care, sick leave and limitation in 
daily life)
Pain severity
roughly 15% reported severe pain and 70% mild 
pain
Analyses
descriptive, frequencies, multivariate logistic 
regression
Q2. Study quality
The quality of Breivik et al. (2006) was rated as moderate. The methods were clearly stated in this study, with 
clear eligibility criteria and an adequate description of study participants. However, it was not clear if the 
population participating in the study was representative of target population. Outcomes and their measurement 
were adequately described; but there was no description of statistical methods used and results were not 
reported as unadjusted and confounder-adjusted including precision.
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The quality of Kerssens et al. (2002) was rated moderate. The study design, outcomes and statistical methods were 
adequately described and the sample was representative of the target population of general practice. However, 
the eligibility criteria were unclear because of lacking diagnostic criteria, the description of study participants was 
poor and included only age and gender and the results were presented without measures of precision.
Picavet (2003 Pain) is a high quality study and Picavet (2003 Ann Rheum Dis) a moderate quality study. The 
methods were clearly stated in both papers with clear eligibility criteria and a clear description of study 
participants. However, it was not clear if the population participating in the study was representative of target 
population. Outcomes and their measurement and statistical methods were adequately described and results 
were clearly reported as unadjusted and confounder-adjusted including precision. In the follow-up study 
(Picavet 2003 Ann Rheum Dis) the loss to follow-up was 15% at 6 months. Therefore this paper was rated 
moderate quality while the other paper (Picavet 2003 Pain) was rated high quality.
Q2. Results
General chronic pain
Breivik et al. 2006
The prevalence of moderate to severe chronic pain in Netherlands was 18% among 3197 adults (>18 years) 
responding to a computer-aided telephone screening interview. Chronic pain was defined as pain lasting more 
than 6 months, having pain during the last month, several times during the last week, and last experienced pain 
having an intensity 5 or more on a Numeric Rating Scale: 1 (no pain) to 10 (worst pain imaginable). The most 
common causes for chronic pain were: arthritis/osteoarthritis (19%), herniated/deteriorated discs (13%) and 
traumatic injury (12%).
Kerssens et al. 2002
The overall prevalence of unexplained severe chronic pain was 7.91 per 1000 enlisted patients in general 
practice. It was highest in the subgroup of patients aged 50 to 54 (see table 3). The prevalence of unexplained 
severe chronic pain was low in patients below 34 years.
Table 3. Age specific prevalence estimates of unexplained severe chronic pain in general practice. Estimates 
are based on 344 patients
Age Estimate per 1000 patients
18-24 yrs
25-29 yrs
30-34 yrs
35-39 yrs
40-44 yrs
45-49 yrs
50-54 yrs
55-59 yrs
60-64 yrs
65-69 yrs
70-75 yrs
1.87
1.59
3.52
8.98
10.71
10.35
16.95
13.50
10.33
8.82
11.26
Total 7.91
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Chronic musculoskeletal pain
DMC3 study (Picavet and Schouten 2003 Pain / Picavet and Hazes 2003 Ann Rheum Dis).
Almost three-quarter (74.5%) of the Dutch population aged 25 years and over reported any musculoskeletal 
pain during the past 12 months (Picavet 2003 Pain). 44.4% reported musculoskeletal pain lasting longer than 
3 months. This pain was most frequently located in the lower back (prevalence 21.2%) and in the shoulders 
(15.1%) and neck (14.3%). More detailed locations are reported in Table 4 below. The prevalence of chronic 
widespread pain in upper and lower extremities, in back or neck and in left and right side of the body is 5.2%. 
Table 4. Prevalence (% and 95% confidence limits) of chronic musculoskeletal pain by anatomical area and 
site (Picavet 2003 Pain)
Pain location Prevalence of chronic pain
Neck
Shoulders
Higher back
Elbow
Wrist/hand
Lower back
Hip
Knee
Ankle
Foot
14.3 (±1.1)
15.1 (±1.2)
6.2 (±0.8)
5.3 (±0.7)
9.3 (±0.9)
21.2 (±1.3)
7.4 (±0.8)
11.7 (±1.0)
3.5 (±0.6)
5.0 (±0.7)
No pain
One site
2-3 sites
4 or more
Upper and lower extremities and back or neck, left and right
Upper and lower extremities and back, left and right 
Upper and lower extremities and back or neck
Upper and lower extremities and back
55.6 (±1.6)
21.6 (±1.3)
15.6 (±1.2)
7.2 (±0.8)
5.3 (±0.7)
3.8 (±0.7)
5.8 (±0.8)
4.2 (±0.6)
Another paper based on the same cohort (Picavet 2003 Ann Rheum Dis) presented the prevalence of self-
reported chronic musculoskeletal diseases, separately for females and for males. The most prevalent disease 
was tendinitis or capsulitis (17.2 and 15.4% for females and males, respectively). Other diseases with a 
prevalence of at least 10% were: herniated disc or back in females, and epicondylitis and osteoarthritis of the 
knee in both males and females. The percentage of patients that still reported these diseases after 6 months 
varied between 42.5 and 77.1%. Table 5 presents the figures per disease.
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Table 5. Prevalence of self-reported musculoskeletal diseases (%) and percentage of patients still reporting 
these diseases after 6 months (Picavet 2003 Ann Rheum Dis)
Disease
Prevalence 
(95%CI) in 
women
Prevalence 
(95%CI) in
men
Patients still 
reporting the disease 
after 6 months (%)
Herniated disc of back
Gout
RSI
Epicondylitis
Osteoarthritis of knee
Osteoarthritis of hip
Osteoporosis
Whiplash
Rheumatoid arthritis
Other chronic arthritis
Fibromyalgia
Tendinitis or capsulitis
Other*
8.3 (±1.2)
2.3 (±0.7)
2.0 (±0.6)
11.6 (±1.4)
13.6 (±1.5)
9.6 (±1.3)
9.9 (±1.3)
2.6 (±0.7)
4.6 (±0.9)
4.4 (±0.9)
2.1 (±0.6)
17.2 (±1.7)
22.3 (±1.8)
10.3 (±1.5)
3.7 (±0.9)
1.9 (±0.7)
10.4 (±1.5)
10.1 (±1.5)
3.9 (±0.9)
1.9 (±0.7)
1.6 (±0.6)
1.6 (±0.6)
2.2 (±0.7)
0.2 (±0.2)
15.4 (±1.8)
20.1 (±2.0)
73.0
64.0
42.5
66.0
77.1
67.5
64.6
70.9
56.7
47.4
67.7
60.4
Combinations reported by >3% of the population
epicondylitis and tendinitis or capsulitis 
osteoarthritis of knee and hip
osteoarthritis of knee with osteoporosis
osteoarthritis of knee with tendinitis or capsulitis
osteoarthritis of hip with osteoporosis
Total population
4.2%
5.3%
3.6%
3.6%
3.0%
* Most of these were (pain) complaints listed later in the questionnaire or fractures/accidents. Other mentioned 
diseases were osteoarthritis (19 times), sciatica (14), scoliosis (13), pelvis instability (8), herniated disc in the 
neck (8), ankylosing spondylitis (6), stroke (5), bursitis (5), Scheuermann’s disease (4), spondylitis, and some 
neurological diseases like chronic polyneuropathy (3),myasthenia gravis (2), and Ménière’s disease (2). Once 
only were mentioned, for instance, polymyalgia rheumatica, Dupuytren’s disease, hammer toe, psoriatic 
arthritis, Tietze’s syndrome, and Paget’s disease.
0 10 20 30 40 50
general chronic pain
(Breivik et al 2006)
unexplained chronic pain
(Kerssens et al 2002)
chronic musculoskeletal pain
(Picavet and Schouten 2003)
Figure 4. Summary of prevalence (in percentages) of different types of chronic pain in the Netherlands
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Population
~12 552 000 adults (≥20 years)
Chronic pain prevalence
Moderate to severe general chronic pain: 2 260 600 adults (18%)
Back pain
no data
Neuropathic pain
no data
Rheumatoid arthritis
F 4.6/m 1.6%
Patients with cancer
55% had any pain
44% had moderate
to severe pain
Chronic regional
pain syndromes
5.2%
Osteoarthritis
Knee F 13.6/m 10.1%
Hip F 9.6/m 3.9%
Arthritis
no data
Back pain with 
radiculopathy
F 8.3/m 10.3%
Phantom limb pain
no data
Diabetic neuropathy
no data
Trigeminal neuralgia
no data
Post-herpetic neuralgia
no data
Low back pain
21.2%
Shoulder/Neck pain
15.1%/14.3%
Back pain w/o 
radiculopathy
no data
Figure 5. Taxonomy of prevalence chronic pain conditions in the Netherlands
Q2. Summary
The prevalence of chronic musculoskeletal pain is 44.4% in the Netherlands. Frequently, low back pain, 
shoulder pain and neck pain are locations for such pain. Common underlying causes are tendinitis or capsulitis, 
epicondylitis and osteoarthritis of the knee for females and males and herniated disc or back in females.
The prevalence of general chronic pain in the Netherlands is 18% and the prevalence of unexplained severe 
chronic pain in a general practice population 0.8.
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Q3. What is the 
incidence of chronic 
pain conditions in the 
Netherlands? 
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We selected four studies that were relevant to this question (De Mos et al 2007, Dieleman et al 2008, Opstelten 
et al 2005 and Steenstra et al 2006).
De Mos et al (2007) aimed to estimate the incidence of complex regional pain syndrome (CRPS) in the general 
population during 1996–2005. For this purpose, a retrospective cohort study was conducted using the 
Integrated Primary Care Information (IPCI) database, a general practice research database with records from 
600,000 patients. Potential CRPS cases were identified by a sensitive search algorithm including synonyms and 
abbreviations for CRPS. Subsequently, cases were validated by electronic record review, supplemented with 
original specialist letters and information from an enquiry of general practitioners.
Dieleman et al. (2008) used the same general practice research IPCI database containing longitudinal patient 
data to retrieve data retrospectively, and aimed to estimate the incidence and assessed treatment approaches 
of neuropathic pain conditions in the general population between 1996 and 2003. Case definition relied on GP 
and specialists symptoms and diagnosis recorded in the medical record with the GP.
Opstelten et al (2005) aimed to determine the incidence of Herpes Zoster (HZ) and Post-herpetic Neuralgia 
(PHN) in a primary care population and to identify risk factors for the occurrence of PHN. This study used 
data from the database of the “Huisartsen Netwerk Utrecht” a different general practice research database 
comprising 22 general practices and representing 49,000 people, from 1994 to 1999. Cases were identified by 
searching the database using an ICPC code and free text and medical records were reviewed for confirmation.
Steenstra et al (2006) performed a retrospective descriptive study at population level to compare the incidence 
of occupational disability as a result of back and neck pain in 1980–1985 to 1999–2000 and to explain the 
findings. Occupational disability can be claimed after 52 weeks of sick leave. Statistics from the National 
Institute of Social Insurance in the Netherlands are used to calculate age and gender specific incidence rates for 
back pain diagnoses based on the ICD-classification. See Table 6 for study characteristics. 
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Table 6. Characteristics of the studies selected for question 3
Study details Population Outcomes and analysis
Dieleman et al. 2008
Study design
Retrospective cohort 
study
Study method
A search conducted in 
the IPCI database - a 
longitudinal general 
practice research 
database
Type of chronic pain
Neuropathic pain
Confirmation of diagnosis
Case definition relied on GP and specialists symptoms 
and diagnosis recorded in the medical record with 
the GP. GP diagnoses were accepted if they recurred 
in the patient record and if typical neuropathic pain 
symptoms were present
Sample size and demographics
362,693 persons (1,116,215 person years)
Age and gender distribution similar to Dutch 
population
9810 incident cases
Patient selection
Potential cases were identified in the database 
between 1996 and 2003 though an inclusive search 
on free text and ICPC code. Then the medical records 
were reviewed by medically trained persons
Outcomes measured
incidence rates of 13 subtypes of neuropathic pains, 
prescribed treatments
Pain severity
Not reported
Analyses
Age and gender specific incidence rates of different 
types of neuropathic pain, Cox-regression analysis 
for the relative risk and 95% confidence interval of 
neuropathic pain for women versus men
De Mos et al. 2007
Study design
Retrospective cohort 
study
Study method
A search conducted in 
the IPCI database - a 
longitudinal general 
practice research 
database
Type of chronic pain
Complex regional pain syndrome
Confirmation of diagnosis
3 sets of criteria: IASP, Bruehl and Veldman
Sample size and demographics
The database contains records of >600,000 
patients from more than 150 GPs. This population 
is representative of the Dutch population regarding 
age and sex
Source population: 217,653 people from 52 
practices
Patient selection
Potential cases between 1996 and 2005 were 
identified by a sensitive search and subsequently 
validated by means of electronic record review, 
specialists’ letters and information from an enquiry 
of GPs
Outcomes measured
Incidence rate, standardized morbidity ratios
Pain severity
Not reported
Analyses
Descriptive statistics, (Chi-square test, univariate 
logistic regression, Student’s t-test), K-statistics for 
interrater agreement for diagnostic criteria
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Study details Population Outcomes and analysis
Opstelten et al 2005
Study design
Cross-sectional / survey 
(Retrospective data 
collection)
Study method
A search conducted in 
the Huisartsen Netwerk 
Utrecht” database, a 
general practice research 
database over a 5-year 
period
Type of chronic pain
Herpes zoster (HZ) and post herpetic neuralgia (PHN). 
PHN was defined as any pain that persisted at least 1 
month after HZ diagnosis
Confirmation of diagnosis
GP diagnosis (ICPC code 32 S70 (HZ) or GP 
confirmation of HZ)
Sample size and demographics
N=837
58% female
Patient selection
All HZ patients diagnosed between 1 August 1994 
and 31 July 1999 were identified by searching the 
database for ICPC code 32 S70 (HZ) and for free 
text (‘zoster’). Medical records were reviewed for 
confirmation
Outcomes measured
Incidence of HZ (in different age groups), risk of PHN 
1 and 3 months after HZ diagnosis, potential risk 
indicators for PHN 
Pain severity
Severity not reported.
Persistent pain 3 months after HZ diagnosis was 
reported in the medical records of 2.6% (95% CI: 
1.7, 4.0) of the HZ patients
Analyses
Univariate and multivariate logistic regression 
models, Spearman’s correlation coefficient
Steenstra et al. 2006
Study design
Cross-sectional/ survey 
(Retrospective data 
collection)
Study method
Descriptive study using 
statistics from the 
National Institute of 
Social Insurance between 
1980-1985 and 1999-
2000
Type of chronic pain
Persons who claimed occupational disability due to 
back disorders. Persons can claim this after 52 weeks 
of sick-leave
Confirmation of diagnosis
A benefit is granted after a disability evaluation, 
which includes a health examination by an insurance 
physician
Sample size and demographics
In 1999-2000, the number of insured persons was 
6,710,551
57% males
Patient selection
Diagnoses were coded using ICD-10
Outcomes measured
incidence of occupational disability as a result of 
back disorders
Pain severity
Not reported
Analyses
incidence rates per 1000 person years, incidence rate 
ratios, percentages in-/decrease
Q3. Study quality
The study of Dieleman et al. (2008) was rated moderate quality. The study reported on a representative sample 
and study design, eligibility criteria, outcomes and statistical methods were adequately described. However, the 
study population and loss to follow-up were not reported adequately. 
The study of De Mos et al (2007) was rated moderate quality. The study reported on a representative sample 
and study design, eligibility criteria, study population and outcomes were adequately described. However, the 
description of statistical methods was inadequate as no information was given about potential confounders 
and it was not clear whether results were reported as adjusted or unadjusted.
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The study of Opstelten et al (2002) was rated as moderate quality. It was unclear whether the study sample 
was representative of the target sample and the description of participants was inadequate. However, study 
design, eligibility criteria, statistical methods and outcomes were adequately described. Also results were clearly 
reported as adjusted or unadjusted with precision.
The study of Steenstra et al (2006) was rated moderate. The study design, outcome and statistical methods 
were adequately described and the study used a representative population. However, the eligibility criteria and 
study participants were inadequately described and results were presented without precision. 
Q3. Results
Neuropathic pain
Dieleman et al. 2008
The total amount of follow-up time for the 362,693 eligible patients was 1,116,215 years (on average three 
years per person). A total of 9810 first-time diagnoses of various types of neuropathic pain in 9311 persons 
were identified during the study period. The overall incidence rate of neuropathic pain was 8.2 per 1000 person 
years (95%CI 8.0 to 8.4). Mononeuropathy and carpal tunnel syndrome were the most common types of 
neuropathic pain with the incidence rates of 4.3 and 2.3 per 1000 person years, respectively. 
The incidence rate of neuropathic pain gradually decreased over calendar time from 9.8 per 1000 person years 
(95%CI 9.1 to 10.6) in 1996 to 7.5 per 1000 person years (95%CI 7.1 to 8.0) in 2002 and was consistently 
higher in women. A peak incidence was observed between the ages 50 and 90 with a maximum of 18.1 per 
1000 person years between age 70 and 79. Men and women had a similar age dependent incidence rate. 
Women were, however, significantly more often affected than men with 10.1 female cases per 1000 person 
years (95%CI 9.9 to 10.4) versus 6.2 male cases per 1000 person years (95%CI 6.0 to 6.4).
Table 7. Incidence rates of various types of neuropathic pain between 1996 and 2004
Type of neuropathic pain Incidence rate per 100,000 PY 95% confidence interval
Mononeuropathy (excluding ischias)
Ischias
Carpal tunnel syndrome
Diabetic peripheral neuropathy
Post-herpetic neuropathy
Trigeminal neuralgia
Cervical radiculopathy
Phantom limb syndrome
209.8
210.4
233.1
72.3
41.8
28.9
16.6
2.2
 199.7 to 216.6
 202.1 to 219.1
 222.0 to 239.8
 67.3 to 77.2
 38.1 to 45.7
 25.8 to 32.1
 14.3 to 19.1
 1.5 to 3.3
Total* number of first-time diagnoses 878.9  861.6 to 896.4
* Not all types reported in the paper have been extracted here, so numbers may not add up to total
Epidemiology of chronic pain in the Netherlands - Q3 
54
Complex Regional Pain Syndrome (CRPS)
De Mos et al. 2007
In the final population of 217,653 persons registered with at least 1 year of valid history at one of the 52 active 
practices in the IPCI database, 238 incident cases of CRPS could be identified and validated. The incidence rate 
of CRPS in the Netherlands was 26.2 per 100,000 person years (95%CI 23.0 to 29.7).
Gender-specific incidence rates based on the reconfirmed diagnoses for females and males were
40.4 (95% CI 34.8 to 46.8) and 11.9 (95% CI 9.0 to 15.4) per 100,000 person years, respectively. The
incidence of CRPS was more than threefold higher in females than in males (RR 3.4, 95% CI
2.9 to 3.9). The incidence rate of CRPS did not change significantly over time between 1996 and 2005
(results not reported). The incidence varied profoundly with age, the highest incident rate was observed in the 
group 61 to 70 years (see table 8 below).
Table 8. Age-specific incidence rates (per 100,000 PY) of complex regional pain syndrome
Age group
Males
IR per 100,000 PY
Females
IR per 100,000 PY
Total
IR per 100,000 PY
<10
10-19
20-29
30-39
40-49
50-59
60-69
70-79
>80
2.0
1.8
6.2
9.0
15.5
24.4
31.4
12.2
0.0
2.0
14.9
28.0
27.7
27.2
72.1
121.3
58.1
47.5
2.0
8.2
16.8
18.1
21.4
47.9
77.2
38.4
31.9
Total 11.9 (9.0 to 15.4) 40.4 (34.8 to 46.8) 26.2 (23.0 to 29.7)
Herpes zoster and postherpetic neuralgia
Opstelten et al. 2002
Over the five-year period, a total of 837 patients have been diagnosed with herpes zoster. The calculated 
incidence of HZ was 3.4/1000 patients/year (95%CI 2.9 to 3.9). Persistent pain 3 months after HZ diagnosis was 
reported in the medical records of 2.6% (95%CI 1.7 to 4.0). Both incidence and risk of PHN increased with age 
(see table 9 below).
Table 9. Incidence of herpes zoster and risk of postherpetic neuralgia after diagnosis of herpes zoster in 
different age groups
Age group (n persons)
Incidence per 1000 PY 
(95%CI)
Risk of PHN after 
3 months
<45yrs (n=30605)
45-54 years (n=6987)
55-64 years (n=4782)
65-74 years (n=3700)
>74 years (n=2925)
2.1 (1.9 to 2.2)
3.6 (3.2 to 4.1)
5.8 (5.2 to 6.5)
6.5 (5.8 to 7.4)
9.1 (8.1 to 10.2)
0.3% (0.01 to 1.7)
0.8% (0.02 to 4.3)
2.9% (0.8 to 7.2)
3.3% (0.9 to 8.3)
9.0% (4.8 to 15.2)
Total 3.4 (2.9 to 3.9) 2.6% (1.7 to 4.0)
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Back disorders
Steenstra et al. 2006
In 1999-2000, incidence of occupational disability as a result of all back disorders was 2.02 per 1000 workers 
per year for men. Among these, the incidence of non-specific back pain (dorsalgia) was 0.54 and 0.06 for 
non-specific neck pain (cervicalgia). The total incidence for women was 2.14 per 1000 workers per year. The 
incidence of non-specific back pain was 0.76 and non-specific neck pain 0.10 for women.
Table 10. Total incidence per 1000 person years of occupational disability as a result of back disorders 
(deforming dorsopathies, spondylopathies or other dorsopathies) over 1999-2000 per age group
Age group Men Women
<25 yrs
25-34 yrs
35-44 yrs
45-54 yrs
>55 yrs
0.21
1.15
2.30
3.10
4.57
0.52
1.71
2.32
3.66
4.81
Total 2.02 2.14
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Figure 6. Summary of incidence rates (per 1000 person years) for several indications
Q3. Summary
Four studies were selected that reported on different types of chronic pain. 
The overall incidence rate of neuropathic pain was 8.2 per 1000 person years (95%CI 8.0 to 8.4). Women have 
a consistently higher incident rate than men and mononeuropathy and carpal tunnel syndrome were the most 
common types of neuropathic pain. 
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The overall incidence rate of Complex Regional Pain Syndrome was 26.2 per 100,000 person years (95%CI 23.0 
to 29.7). The incidence of CRPS was more than threefold higher in females than in males (RR 3.4, 95% CI 2.9 
to 3.9). The incidence varied profoundly with age, the highest incident rate was observed in the group 61 to 70 
years .
The incidence rate of Herpes Zoster (HZ) was 3.4/1000 patients/year (95%CI 2.9 to 3.9). Persistent pain 3 
months after HZ diagnosis was reported in the medical records of 2.6% (95%CI 1.7 to 4.0). Both incidence of 
HZ and risk of persistent pain after diagnosis increased with age.
The incidence of occupational disability as a result of back disorders was 2.02 and 2.14 per 1000 workers per 
year for men and women, respectively. 
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Q4. What percentage of 
chronic pain patients 
from the Netherlands 
are untreated or 
inadequately treated
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We located five studies that were relevant to this question (Borghouts et al. 1999, Breivik et al. 2006, 
Smalbrugge et al. 2007 and Van Herk et al. 2009, van Tulder et al. 1998).
Borghouts et al (1999) performed a retrospective study with the aim to describe the management in patients 
with chronic neck pain in general practice. Results on 517 patients were collected using questionnaire 
completed by PGs and patients.
Breivik et al. (2006) performed a large telephone survey to explore the prevalence, impact on daily life and 
treatment of chronic pain in 15 European countries and Israel, among which the Netherlands. Persons received 
an initial screening questionnaire and those who suffered from long-lasting pain were subsequently interviewed 
in-depth using a second structured questionnaire. From the Netherlands, 300 persons suffering chronic pain 
were interviewed. 
Smalbrugge et al. 2007 used data from 350 participants of Amsterdam Groningen Elderly Depression (AGED) 
cohort study performed in 14 Dutch nursing homes to determine prevalence, course, correlates, recognition 
and treatment of pain among Dutch nursing home-patients and to make a comparison with international data.
Van Herk et al. (2009) performed a cross-sectional multicenter study of 233 residents of Dutch nursing homes. 
The study aimed to assess the prevalence and intensity of pain in older adults living in Dutch nursing homes and 
assess the characteristics of pain and the analgesics prescribed as well as impact of pain on daily functioning.
Van Tulder et al. (1998) described the course of chronic low back pain and the performed diagnostic and 
therapeutic procedures for 524 patients with chronic low back pain in general practice. GPs and patients were 
asked to complete questionnaire at baseline and at 4, 8 and 12 months follow-up. 
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Table 11. Characteristics of the studies selected for question 4
Study details Population Outcomes and analysis
Borghouts et al. 1999 
(Scand J Prim Health 
Care)
Study design
Descriptive retrospective 
study
Study method
GPs provided information 
on procedures provided 
and patients completed 
a self-administered 
questionnaire covering a 
12-month period
Type of chronic pain
Chronic neck pain
Confirmation of diagnosis
Patients with ICPC code L01 or L83 were included; 
medical records of patients were checked by the GPs 
on inclusion and exclusion criteria
Sample size and demographics
517 eligible, 487 assessed (253 responders – data 
from GPs and patients, 234 non-responders – data 
from GPs)
Responders: median age 51 (IQR 41-60), 60% 
females
Non-responders: median age 55 (IQR 44-62), 56% 
females
Patient selection
patients with neck pain (ICPC code L01 or L83), 
registered with GPs participating in the Registration 
Network of Family Practices of the Maastricht 
University, aged between 18 and 70 years, symptoms 
present for at least 6 months before baseline
Outcomes measured
GP questionnaire: diagnosis, frequency of GPs visits, 
diagnostic modalities, therapeutic interventions 
and referrals to medical specialists or paramedical 
therapists
The patients’ questionnaire: patient characteristics, 
pain intensity, sickness related to work and visits to 
medical specialists and paramedical therapists, onset 
and frequency of pain episodes during the previous 
12 months, severity of current pain
Pain severity
mean severity for responders 4.9 (SD 2.4)
Analyses
Descriptive statistics, Mann-Whitney tests for 
differences between responders and non-responders, 
t-tests for differences in mean age and chi-square 
test to compare sex in the two groups
Breivik et al. 2006
Study design
Cross-sectional study
Study method
Telephone survey in two 
parts. First, persons were 
screened for chronic 
pain. Those who qualified 
were interviewed in-
depth
Type of chronic pain
Long-lasting pain: chronic pain for at least 6 months, 
and pain in last month, and pain at least 2 times/
week, and rating pain intensity at least 5 on 10-point 
NRS
Confirmation of diagnosis
Not reported
Sample size and demographics
Total sample: 4839; Netherlands: 300 persons with 
long-lasting pain
Demographics for all countries together: 52% female 
mean age 50 years.
For the Netherlands: female 60%, mean age 51.3 
years
Patient selection
Subjects with long-lasting pain (see definition above)
Outcomes measured
Duration, location, intensity of pain. 
Tolerance, time course of pain, impact pain on 
activities daily life, employment status, emotional 
status
Visits to doctors, visits to pain management 
specialist, treatment (medication and non-
medication), effectiveness of treatment, satisfaction 
with doctors, respondents’ attitudes and beliefs 
about pain and pain treatment, respondents’ 
perception of the attitude of others to their pain
Pain severity
18% reported severe pain
Analyses
Descriptive analysis only. No subgroups were 
reported (for the Netherlands)
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Study details Population Outcomes and analysis
Smalbrugge et al. 
2006
Study design
Longitudinal-cohort study
Study method
data collected in the 
Amsterdam Groningen 
Elderly Depression (AGED) 
study; twice face to face 
interview; pain measured 
with pain-subscale 
Nottingham Health 
Profile; recognition of 
pain and treatment – 
chart review
Type of chronic pain
Self-reported pain
Confirmation of diagnosis
Self-reported pain according to the pain subscale of 
the Dutch version of the Nottingham Health Profile 
(8 items with a yes-no format and a score ranging 
from 0 to 8 (0 = no pain symptoms))
Sample size and demographics
n = 350 at baseline 229 at follow up
mean age 79.3; SD 8.3; range:55–99, female 68.9%
Patient selection
subjects in 14 nursing homes aged 55 years and 
over, speakers of Dutch and able to communicate 
sufficiently, without serious hearing problems or 
severe cognitive impairment (Mini-Mental State 
Examination >= 15)
Excluded: patients with at baseline an expected stay 
of less than 6 months
Outcomes measured
Prevalence of pain, course of pain; Recognition 
and treatment of pain (nursing home physician 
and chart review); Cognitive functioning (MMSE); 
Depressive symptoms (Geriatric Depression Scale); 
Anxiety (Schedules for Clinical Assessment in 
Neuropsychiatry); Sleep (SCAN); Presence of physical 
illness (questionnaire of 13 somatic diseases)
Functional limitations (Groningen Activity Restriction 
Scale)
Pain severity
At baseline 27.5% (n = 94) serious pain symptoms 
(“unbearable pain” or “constant pain”) and 40.5% 
(n = 138) mild pain symptoms (reported positive on 
other items but had no ”unbearable pain” and no 
“constant pain”) 
At follow up 58.6% “unbearable pain” and 66.0% 
“constant pain” still present at 6 months
Analyses
descriptive, chi square, crude odds ratios (OR) 
and corresponding 95% confidence intervals (CI), 
multiple logistic regression to calculate adjusted odds 
ratios
Van Herk et al. 2009
Study design
cross-sectional / survey
Study method
A standardized pain 
questionnaire was used 
based on the McGill Pain 
Questionnaire to measure 
aspects on pain. The 
use of analgesics was 
extracted from medical 
charts
Type of chronic pain
Self-reported pain in previous week. For 72% the 
pain was chronic (at least 3 months)
Confirmation of diagnosis
Not reported
Sample size and demographics
233 residents completed questionnaires
Median age 79 years (IQR 73-84)
70% were female
Patient selection
residents without cognitive impairment
Outcomes measured
Characteristics of pain, pain treatment, pain 
management index (how well is pain managed), 
impact pain on sleep and ADL, satisfaction pain 
treatment
Pain severity
Median pain intensity was 5 (IQR 2-7), 88 reported 
moderate or severe pain (>= 4 on NRS)
Analyses
Nonparametric data are given as median 
and interquartile range (IQR). Differences in 
demographics between the nursing homes are 
analyzed by chi-squared tests and Kruskall-Wallis 
tests. The multiple linear regression method was 
used to indentify interferences with sleep and 
ADL, with pain intensity for the previous week as 
dependent variable
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Study details Population Outcomes and analysis
Van Tulder et al. 1998
Study design
longitudinal / cohort 
study
Study method
GPs provided information 
on diagnosis and 
treatments. Patients 
completed questionnaires 
at baseline and during 
follow-up
Type of chronic pain
Chronic low back pain
Confirmation of diagnosis
Patients with ICPC code L03 or L86 were included; 
researchers checked patient questionnaire if patients 
met inclusion criteria with respect to the duration of 
the back pain
Sample size and demographics
524 patients (368 participants - data from GPs and 
patients, 156 non-participants -data from GPs)
Mean age of participants: 41.1 years (SD 10), 51% 
men
Patient selection
GPs selected prevalent cases from computer files: 
included were patients with low back pain with or 
without radiating symptoms, aged between 20-
60 years, had had current symptoms for at least 3 
months
Outcomes measured
frequency of diagnostic modalities, therapeutic 
interventions and referrals to paramedical therapists 
and medical specialists, patient characteristics, 
average pain intensity (10-p ordinal scale), global 
measurement of improvement, number of episodes 
of low back pain, absenteeism from work, functional 
status (Roland Disability Questionnaire), general 
health perception (Nottingham Health Profile), visits 
to paramedical and complementary therapists and 
medical specialists
Pain severity
mean (SD) 10-p scale at baseline 5.6 (2.9)
median (IQR) NHP pain subscale at baseline 40.5 
(10.5-69.8)
Analyses
Descriptive statistics, differences between groups 
using Mann-Whitney tests or t-tests
Q4. Study quality
Borghouts et al (1999 Scand J Prim Health Care) was rated moderate. Although the study design was clear, the 
dates of recruitment were lacking. Furthermore, it was unclear whether the sample was representative – the 
paper stated that the patient population in the network reflect the Dutch general population but it was not 
clear on which variables that is. Lastly, it was not clear whether the results were adjusted or unadjusted for 
confounders.
The quality of the Breivik et al. study was rated as moderate; in this study it was not clear that the population 
was representative and the statistical methods were not clearly described. 
The Smalbrugge et al. 2007 study quality was rated as moderate mainly because it was unclear if the sample 
was representative of all nursing home residents and loss to follow up was over 30% at 6 months.
The Van Herk et al. study was rated low mainly because it was not clear that the sample was representative of 
all nursing home residents, the eligibility criteria were not clearly described and nor were the statistical methods 
and it was unclear if the results were reported as unadjusted and confounder-adjusted including precision.
The quality of Van Tulder et al (1998) was rated moderate. The study included a sample of patients that was 
representative for the Dutch general population, but the time period of recruitment was not stated. Eligibility 
criteria, outcomes, included population and method of analysis were clearly described. It was unclear whether 
the results were adjusted or unadjusted for confounders.
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Q4. Results
Percentage of patients untreated
General pain
Breivik et al. 2006
One third of the chronic pain patients in Europe (31%) were not treated for their pain. These figures were not 
presented separate for the Netherlands. 
Smalbrugge et al. 2007
Of 197 patients who reported pain symptoms at baseline 36% did not receive any prescription for analgesics 
(Fig.1). Of these, forty-seven (38.8%) had mild pain symptoms and 23 (30.3%) had serious pain symptoms. 
Van Herk et al. 2006
Of 153 residents of nursing homes who reported that they had experienced pain in the previous week, 38 
(24.8) were not prescribed analgesics (Fig.1). Of the 88 residents with an NRS 4 for present pain, and the 
41 residents with intolerable pain at present, 19 (22%) and 12 (29%), respectively, did not receive any pain 
medication. 
Chronic musculoskeletal pain
Borghouts et al. 1998 (Scand J Prim Health Care)
This study assessed the treatment of 487 patients with chronic neck pain in general practice. In total population 
67% of patients had no therapy. Forty four percent of included patients visited the GP for neck pain in the 
previous year, of them 31% did not receive treatment (Fig.1). 
Van Tulder et al. 1998
This study assessed treatments of 524 patients with chronic low back pain in general practice, 72.8% (95% 
CI 68.8–76.8) of them received no treatment. Forty two percent of total population visited their GP during 12 
months follow up because of their low back pain and 36% of them received no treatment (Figure 7). 
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Figure 7. Percentage of patients with pain who did not receive prescription for analgesics or did not receive 
treatment from their GP
Percentage of patients inadequately treated
Breivik et al. 2006
Out of 119 respondents 79% reported inadequate pain control from medication (affirmative answer to the 
question: ‘‘Are there ever times when your pain medicines are not adequate to control your pain?) while a 
European average was 64%. Out of 274 respondents 56% reported inadequate pain control (affirmative 
answer to the question: ‘‘Would you say your pain is being adequately controlled?’’) while a European average 
was 40%.
Smalbrugge et al. 2007
Inadequacy of pain treatment was reported in terms of prescribed daily dose/defined daily dose ratio (PDD/
DDD-ratio) which is used an indication of the adequacy of dosing. According to the authors definition the ratio 
below 2/3 is indicative of underdosing. For opioids, 69.2% of the patients had a PDD/DDD-ratio lower than 2/3. 
For paracetamol a PDD/DDD-ratio was lower than 2/3 in 30.8% of the patients. 
Van Herk et al. 2006
Thirty-four percent of 159 residents were treated inadequately as reflected by the Pain Management Index 
(PMI), which reflects how well pain is managed with pharmacologic interventions by comparing the analgesic 
prescribed with the level of pain intensity. 
Q4. Summary
Four studies reported data regarding Dutch patients untreated for their pain problem. Two were performed in 
nursing home populations and the definition of untreated was similar – patients who did not receive analgesics. 
The percentages of such patients varied between 25 and 36%. Two studies were performed in general practice, 
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regarded musculoskeletal pain and reported that 31–36% of patients with neck pain or low back pain visiting 
their GP received no treatment for their pain.
Three studies reported percentages of inadequately treated patients, which ranged between 34% and 79%. It 
should be noted that inadequacy of treatment was defined differently in these studies. Smalbrugge et al. 2007 
reported on the percentage of patients with inadequate analgesics dosing and van Herk et al 2009 reported 
inadequate treatment as indicated by Pain Management Index in 34% of nursing home residents, while Breivik 
et al. 2006 reported inadequate pain relief according to patient assessment. 
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Q5. How many chronic 
pain patients from 
the Netherlands 
present themselves for 
treatment?
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We found 13 relevant studies and selected five studies for this question (de Mos et al. 2009, Huisstede et al. 
2008, Picavet et al. 1999, Picavet and Schouten 2003, Picavet et al. 2008).
De Mos et al. 2009 aimed to describe treatment (pharmacological and other) and referral patterns in a 
population-based selection of 102 CPRS patients during a study period (1996–2005) before issuing of the 
Dutch evidence-based treatment guidelines (2006).
Huisstede et al. 2008, Picavet and Schouten 2003 and Picavet et al. 2008 were based on DMC3 population 
survey data based on 3664 respondents. Huisstede et al. 2008 aimed to study the prevalence of upper 
extremity disorders(UEDs) and neck as a total and complaints of the arm, neck and/or shoulder (CANS) not 
caused by acute trauma or any systemic disease as defined in the CANS model in the open population and to 
assess socio-demographic and health characteristics of chronic symptoms. The aim of Picavet and Schouten 
2003 study was to present estimates on the prevalence of musculoskeletal pain of five different anatomical 
areas and ten anatomical sites, and their consequences and risk groups in the general Dutch population. Picavet 
et al. 2008 described the utilization of health care services among persons with low back pain on the basis of 
DMC3 survey and registration data from DNSGP-2 study based on 293,636 respondents.
Picavet et al. 1999 aimed to study the burden of illness of low back problems and prevalence and 
consequences in the working and the non-working population on the basis of cross-sectional MORGEN study.
Table 12. Characteristics of the studies selected for question 5
Study details Population Outcomes and analysis
de Mos et al. 2009
Study design
Retrospective 
observational
Study method
patient identified from 
The Integrated Primary 
Care Information Project
(IPCI) database; GP 
confirmation of 
diagnosis; patients 
questionnaire, 
interview and a physical 
examination (diagnostic 
verification); referrals 
also from IPCI database 
and specialist letters, 
prescriptions from IPCI 
and pharmacy dispensing 
data
Type of chronic pain
Complex regional pain syndrome (CRPS)
Confirmation of diagnosis
diagnostic criteria for CRPS as established by 
International
Association for the Study of Pain (IASP)
Sample size and demographics
N = 102
Mean age 51 years (range 12–86)
Female 79% 
Patient selection
Patients selected from an electronic general practice 
(GP) database (Integrated Primary Care Information 
Project) incident during study period with at least 1 
year of valid history within the IPCI database (1996–
2005) still active in the IPCI database in 2006 and 
able to provide additional
information, who participated in diagnosis verification 
(International Association for the Study of Pain 
criteria) and assessment of referrals and treatment
Outcomes measured
referrals, treatment for CRP
Pain severity
NR
Analyses
descriptive, frequencies, Kaplan-Meier survival 
analysis for time to treatment (from the index date)
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Study details Population Outcomes and analysis
Huisstede et al. 2008
Study design
Cross-sectional/ survey
Study method
DMC3 study - national 
health survey of 
musculoskeletal 
conditions; postal 
questionnaire – with 
general questions and 
health questions. After 
screening question for 
each of 5 anatomical 
areas
Additional questions 
regarding pain in 
this area and its 
consequences; general 
health was measured 
using the Short 
Form(SF)-36
Type of chronic pain
Upper extremity disorders (UED) and neck pain; 
complaints of the arm, neck
and/or shoulder (CANS; excluding UED caused by an 
acute trauma or a systemic disease) 
Confirmation of diagnosis
NR; only screening question: ‘‘did you have pain in 
‘anatomic area’ during the past 12 months?’’ 
Sample size and demographics
3664 respondents 
25–44 years 47.0%, 
45–64 years 34.6%, 
65+ years 18.4% 
Female 50.9%
chronic UED 996
chronic UED due to systemic disease or acute trauma 
299
chronic CANS 697
Patient selection
DMC3 - Dutch population aged 25 years and above; 
this study - persons with musculoskeletal upper 
extremity and neck disorders in 4 anatomic sites: 
neck, shoulder, elbow, and wrist/hand
Outcomes measured
12-month prevalence, point prevalence, and 
prevalence of chronic pain (pain at baseline and 
lasting more than 3 months in the last 12 months)
course of pain, consequences of pain (contact 
with general practitioner, medical specialist or 
physiotherapist, work leave, limitations in daily life), 
general health
Pain severity
self-reported - severe or mild 
chronic total UED 
Continuous severe pain 5.4% 
Recurrent severe pain 12.7% 
Chronic CANS
Continuous severe pain 3.9% 
Recurrent severe pain 12.8% 
Analyses
Descriptive analysis only
Picavet and Schouten
2003 
Study design
Cross-sectional study
Study method
DMC3 study - national 
health survey of 
musculoskeletal 
conditions; postal 
questionnaire – with 
general questions and 
health questions. After 
screening question for 
each of 5 anatomical 
areas
Additional questions 
regarding pain in 
this area and its 
consequences; 
socio-demographic 
characteristics 
Type of chronic pain
Neck, shoulder, higher back 44.5%
Elbow, wrist/hand 23.2%
Lower back 43.9% 
Hip, knee 28%
Ankle, foot 14.9%
Confirmation of diagnosis
NR; only screening question: ‘‘did you have pain in 
‘anatomic area’ during the past 12 months?’’ 
Sample size and demographics
Total sample: 3664 respondents 
weighted to present a distribution of sex, age, 
marital status and region of living equal to that of 
the Netherlands in 1998:
Sex
men 49.1%
women 50.9%
Age group
25-44 47.0%
45-64 34.6%
65+ 18.4%
Patient selection
Dutch inhabitants of 25 years and older 
Outcomes measured
Musculoskeletal pain period prevalence, point 
prevalence, prevalence of chronic pain, course of 
pain, consequences of pain (contact with general 
practitioner, medical specialist or physiotherapist,use 
of medicines, work leave, limitations in daily life, and 
work disability)
Pain severity
self-reported - severe or mild 
roughly 15% severe pain
Neck, shoulder or higher back
Continuous severe pain 3.1%
recurrent severe pain 8.3%
Elbow or wrist/hand
Continuous severe pain 4.0%
recurrent severe pain 11.0%
Lower back
Continuous severe pain 3.5%
recurrent severe pain 15.4%
Hip or knee
Continuous severe pain 5.2%
recurrent severe pain 10.1%
Ankle or foot
Continuous severe pain 6.1%
recurrent severe pain 12.4%
Analyses
descriptive, frequencies, multivariate logistic 
regression
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Study details Population Outcomes and analysis
Picavet et al. 2008
Study design
Cross-sectional survey 
and registration of 
general practice data
Study method
contact with health 
services: DMC3-cross-
sectional study - postal 
survey; 
Registration data –the 
second Dutch National 
Survey of General 
Practice (DNSGP-2) 
carried out in 104 
general practices with 
195 participating GPs 
Type of chronic pain
Low back pain
Confirmation of diagnosis
DMC3 – self reported chronic low back pain (lasting 
longer than 3 months)
Register - Low back pain was defined using ICPC-
codes L02, L03, and L86 that stand for back 
symptoms or complaints, and low back pain with 
and without radiation 
Sample size and demographics
Total sample: 3664 in DMC3 and 293,636 in register 
Mean age and percentage of male/female NR
Patient selection
Dutch population of 25 years and older
Outcomes measured
Utilization of health services due to low back pain 
- contact with GP, contact with medical specialist, 
contact with physiotherapist 
Pain severity
NR
Analyses
Descriptive 
Picavet et al. 1999
Study design
Cross-sectional study
Study method
data from the MORGEN-
study - questionnaires 
and for those who 
screened positive 
supplementary 
questionnaire and a 
medical examination at 
the regional Public Health 
Service (PHS) in each 
town
Type of chronic pain
Low back pain
Confirmation of diagnosis
Screening question illustrated by a drawing of a 
complete human figure indicating the area between 
L1 and the gluteal folds (painted black) as the area 
of interest
Sample size and demographics
Total sample: n = 13927
(weighted for the age and sex distribution of the 
Dutch population aged 20 ± 59 y in 1994)
working population n = 8482
male 60%
20–29 yrs 27.6%
30–39 yrs 32%
40–49 yrs 27.1%
50–59 yrs 13.3%
non working population n = 5340
male 34.4%
20–29 yrs 27.6%
30–39 yrs 21.4%
40–49 yrs 23.6%
50–59 yrs 27.3%
Patient selection
men and women aged 20 - 59 y who were living 
in three towns located in different regions in the 
Netherlands
Outcomes measured
The 12 month period prevalence of low back 
problems, chronic low back problems (longer than 
three months); low back problems
with radiation to the leg(s; 
low back pain consequences - activity limitation, use 
of health services, work disabled, work change or 
adaptation 
Pain severity
NR 
Analyses
descriptive, logistic regression analysis
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Q5. Study quality
The quality of the de Mos et al. 2009 study and Huisstede et al. 200 study was rated as moderate, as it in 
both studies was unclear that the population was representative and the statistical methods were not clearly 
described and the results were not reported as unadjusted and confounder-adjusted including precision. In de 
Mos et al. 2009 study it was unclear that the population was representative
In the Huisstede et al. 2008 study there was no adequate description of the eligibility criteria, 
Picavet et al. 1999 study and the Picavet and Schouten 2003 quality were rated as high quality. In both studies 
one item was missing – they did not provide adequate description of eligibility criteria.
The quality of the Picavet et al. 2008 study was rated as low, mainly because there was no adequate 
description of the eligibility criteria, it was unclear that the population was representative, there was no 
adequate description of study participants and the results were not reported as unadjusted and confounder-
adjusted including precision.
Q5. Results
Complex regional pain syndrome
De Mos et al. 2009
Most CRPS patients visited the GP as the first physician, before consulting a medical specialist. In 63% of these 
cases, the GP already suspected or made the CRPS diagnosis. Patients with CRPS following a soft tissue injury 
presented at the GP first instead of a medical specialist (75% vs. 25%), while patients with CRPS after surgery 
usually first presented at the medical specialist (17% vs. 83%). Cases precipitated by a fracture presented 
themselves at GP and specialist equally often (46% vs. 55%). GP and other physicians consulted as first – 
(figure 8).
Over 80% of the patients visited a medical specialist at some point during their disease course. On average, 
a patient consulted 2.4 different specialties of physicians. The anesthetist was the most commonly involved 
medical specialist, while rehabilitation medicine was the second most consulted specialty. Medical specialists 
referred to an anesthetist or to rehabilitation medicine in more than half of the cases, while GPs referred 
more to (orthopedic) surgeons. The most common referral pattern was from GP to (orthopedic) surgeon to 
anesthetist or to rehabilitation medicine. In most cases (>80%), the CRPS diagnosis had been made before 
consultation of the anesthetist or rehabilitation medicine specialist.
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Figure 8. Percentage of patients visiting specific health professional as first physician and anytime during 
disease course
Musculoskeletal pain
Huisstede et al. 2008
Half of the patients with chronic UED reported contact with the GP, 40% reported contact with medical 
specialist and over one third reported contact with physiotherapist in the last 12 months due to their 
symptoms. In the subgroups of patients with chronic UED due to acute trauma or systemic disease and chronic 
CANS similar percentages reported contact with the GP in the last 12 months, while more patients from the 
first subgroup reported contact with medical specialist and physiotherapist in the last 12 months. Among 
patients with chronic CANS 58% reported the contact with healthcare professional in the last 12 months – in 
most patients it was the GP, in more than half – medical specialist and physiotherapist (Figure 9).
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Figure 9. Percentage of patients visiting specific health professional in different subgroups of symptoms, DMC3 
study (UED – upper extremity disorders and neck pain, CANS – complaints of the arm, neck and/or shoulder) 
Picavet and Schouten 2003
Almost half of those reporting musculoskeletal pain in any of the 5 examined locations reported contact with 
any health professional because of their specific musculoskeletal pain during the last year (Fig. 3). Roughly 
between 30 and 40% reported contact with the GP, between 20 and 30% contact with a medical specialist 
and between 20 and 30% a contact with the physiotherapist (Figure 10). 
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Figure 10. Percentage of patients with musculoskeletal pain visiting specific health professional by anatomical 
area of pain, DMC3 study
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Low back pain
Picavet et al. 2008
In DMC3 survey 13% of respondents reported contact with GP due to low back pain. 
People reporting low back pain 12 month period prevalence had higher healthcare contact frequencies than 
those without low back pain. This was true for contact with GP (82.2% vs. 72.8%), contact with medical 
specialist (37.3% vs. 33.7%), and contact with physiotherapist (33.2% vs.16.5%). The most frequently 
mentioned medical specialists were the neurologist and occupational physician.
For people reporting point prevalence or chronic low back pain the frequencies were slightly higher – for GP 
contact 85.1% and 84.9%, for medical specialist 41.8% and 43.0%, for physiotherapist 40.2% and 41.8% 
respectively. 
Frequencies of contacts with healthcare services due to low back pain in people with 12 month low back pain 
period prevalence are presented in Figure 4. Contacts due to low back pain represented 37% of total contacts 
with GPs, 51% of total contacts with medical specialists and 76% of total contacts with physiotherapist. This 
figures were slightly higher among people reporting point prevalence or chronic low back pain – 44% of total 
and 46% of total for GP, for medical specialist 58% of total and 61% of total for medical specialist, 82% of 
total and 87% of total for physiotherapist.
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Figure 11. Percentage of patients with low back pain visiting specific health professional due to low back pain 
(LBP –low back pain), DMC3 study
In registration data 8.9% of population had contact with GP due to low back pain, on average 8.2 contacts 
in 1 year, 1.6 contacts due to low back pain (20% of total contacts). Among the patients with low back pain, 
28.5% were referred to medical specialist care of which 20% were due to low back pain (mainly neurology and 
orthopedics). Referral to physiotherapists or paramedical services was found by 25.9% of those with low back 
pain, and the majority was due to low back pain (83.8%).
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For both sources of data, the health services utilization was higher among women than among men, especially 
among the higher age groups. 
Health service utilization was higher among those with a low educational level compared with high educational 
level, especially for GP-contacts due to low back pain. These differences were more pronounced for the survey 
data (low: 17.1% vs. high: 8.7%) than for the registration data (low: 11.3% vs. high: 7.1%). The registration 
data show higher referral figures for those with a higher educational level: referral to physiotherapists due to 
low back pain is 18.7% for the lower educated and 24.2% for the higher educated.
Picavet et al. 1999
(values weighted for the age and sex distribution of the Dutch population aged 20 - 59 y in 1994)
The use of healthcare services due to low back pain was reported by less than 20% of male working population 
and more than 20% of male non-working population (unemployed, on early retirement, work disabled and 
other; Figure 12).
The use of healthcare services was reported by about 20% of female working population and one quarter of 
female non-working population (housewives, unemployed, work disabled, other ; Fig. 5).
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Figure 12. Percentage of respondents reporting the use of healthcare services due to low back pain in 
working and non-working (total and subgroups) population, MORGEN study
Q5. Summary
The five included studies reported data regarding patients having contacts with healthcare due to their pain. 
The studies reported that around 20% of population had used healthcare services due to low back pain 
and among patients with low back pain between 30–40% contacted their GP. Among patients with other 
musculoskeletal pain GP contacts were reported for 40–50% of patients, while for more than 60% of patients 
with CRPS contacted GP as their first physician. Contacts with other health professionals were also common 
among patients with pain.
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Q6. How many chronic 
pain patients from 
the Netherlands get 
treated, broken down 
by treatment?
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Of 14 relevant studies, we selected five studies for this question; two were on chronic non-cancer pain (Breivik 
et al. 2006, Vandasselaar 2002), two were on chronic musculoskeletal pain (Van Tulder 1998, Borghouts 1999 
Scand J Prim Health Care) and the remaining was on neuropathic pain (Dieleman et al. 2008).
Breivik et al. (2006) performed a large telephone survey to explore the prevalence, impact on daily life and 
treatment of chronic pain in Israel and 15 European countries, among which the Netherlands. Persons received 
an initial screening questionnaire and those who suffered from long-lasting moderate to severe pain were 
subsequently interviewed in-depth using a second structured questionnaire. From the Netherlands, 300 persons 
suffering chronic pain were interviewed. 
Van Dasselaar (2002) describes the results of a national enquiry to assess the number of invasive pain control 
procedures carried out in Dutch hospitals for chronic cancer and chronic non-cancer pain. In this report only 
results for non-cancer pain will be described. The response rate was 98%. In this study no patient data were 
collected.
Van Tulder et al. (1998) described the course of chronic low back pain and the performed diagnostic and 
therapeutic procedures for 524 patients with chronic low back pain in general practice. GPs and patients were 
asked to complete questionnaire at baseline and at 4, 8 and 12 months follow-up. 
Borghouts et al (1999) performed a retrospective study with the aim to describe the management in patients 
with chronic neck pain in general practice. Results on 517 patients were collected using questionnaire 
completed by GPs and patients.
Dieleman et al. (2008) performed a population based cohort study to estimate the incidence and assessed 
treatment approaches of neuropathic pain conditions in the general population. The study population included 
persons registered for at least one year in the Integrated Primary Care Information (IPCI) database between 
1996 and 2003. See Table 13 for characteristics of selected studies.
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Table 13. Characteristics of the studies selected for question 6
Study details Population Outcomes and analysis
Breivik et al. 2006
Study design
Cross-sectional study
Study method
Telephone survey in two 
parts. First, persons were 
screened for chronic 
pain. Those who qualified 
were interviewed in-
depth
Type of chronic pain
Long-lasting pain: chronic pain for at least 6 months, 
and pain in last month, and pain at least 2 times/
week, and rating pain intensity at least 5 on 10-point 
NRS
Confirmation of diagnosis
Not reported
Sample size and demographics
Total sample: 4839; Netherlands: 300 persons with 
long-lasting pain
Demographics for all countries together: 52% female 
mean age 50 years.
For the Netherlands: female 60%, mean age 51.3 
years
Patient selection
Subjects with long-lasting pain (see definition above)
Outcomes measured
Duration, location, intensity of pain. 
Tolerance, time course of pain, impact pain on 
activities daily life, employment status, emotional 
status
Visits to doctors, visits to pain management 
specialist, treatment (medication and non-
medication), effectiveness of treatment, satisfaction 
with doctors, respondents’ attitudes and beliefs 
about pain and pain treatment, respondents’ 
perception of the attitude of others to their pain
Pain severity
18% reported severe pain
Analyses
Descriptive analysis only. No subgroups were 
reported (for the Netherlands)
Van Dasselaar 2002
Study design
Retrospective study
Study method
Hospitals completed 
questionnaires about 
procedure
Type of chronic pain
Chronic non-cancer pain
Confirmation of diagnosis
Not reported
Sample size and demographics
All hospitals were invited, response rate was 98%
Patient selection
Invasive pain procedures for non-cancer chronic pain 
performed in hospitals during 1990-1991
Outcomes measured
The organisation of pain departments, availability of 
personnel, material and space facilities, the use of 
treatment protocols, type and number of cancer and 
non-cancer pain control procedures done
Pain severity
Not reported
Analyses
Descriptive analysis
Van Tulder et al. 1998
Study design
longitudinal / cohort 
study
Study method
GPs provided information 
on diagnosis and 
treatments. Patients 
completed questionnaires 
at baseline and during 
follow-up
Type of chronic pain
Chronic low back pain
Confirmation of diagnosis
Patients with ICPC code L03 or L86 were included; 
researchers checked patient questionnaire if patients 
met inclusion criteria with respect to the duration of 
the back pain.
Sample size and demographics
524 patients (368 participants - data from GPs and 
patients, 156 non-participants -data from GPs)
Mean age of participants: 41.1 years (SD 10), 51% 
men
Patient selection
GPs selected prevalent cases from computer files: 
included were patients with low back pain with or 
without radiating symptoms, aged between 20-
60 years, had had current symptoms for at least 3 
months
Outcomes measured
frequency of diagnostic modalities, therapeutic 
interventions and referrals to paramedical therapists 
and medical specialists, patient characteristics, 
average pain intensity (10-p ordinal scale), global 
measurement of improvement, number of episodes 
of low back pain, absenteeism from work, functional 
status (Roland Disability Questionnaire), general 
health perception (Nottingham Health Profile), visits 
to paramedical and complementary therapists and 
medical specialists
Pain severity
mean (SD) 10-p scale at baseline 5.6 (2.9)
median (IQR) NHP pain subscale at baseline 40.5 
(10.5-69.8)
Analyses
Descriptive statistics, differences between groups 
using Mann-Whitney tests or t-tests
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Study details Population Outcomes and analysis
Borghouts et al. 1999 
(Scand J Prim Health 
Care)
Study design
Descriptive retrospective 
study
Study method
GPs provided information 
on procedures provided 
and patients completed 
a self-administered 
questionnaire covering a 
12-month period
Type of chronic pain
Chronic neck pain
Confirmation of diagnosis
Patients with ICPC code L01 or L83 were included; 
medical records of patients were checked by the GPs 
on inclusion and exclusion criteria
Sample size and demographics
517 eligible, GPs completed data on 487  
(253 responders – data from GPs and patients,  
234 non-responders – data from GPs)
Responders: median age 51 (IQR 41-60), 60% 
females
Non-responders: median age 55 (IQR 44-62), 56% 
females
Patient selection
patients with neck pain (ICPC code L01 or L83), 
registered with GPs participating in the Registration 
Network of Family Practices of the Maastricht 
University, aged between 18 and 70 years, symptoms 
present for at least 6 months before baseline
Outcomes measured
GP questionnaire: diagnosis, frequency of GPs visits, 
diagnostic modalities, therapeutic interventions 
and referrals to medical specialists or paramedical 
therapists
The patients’ questionnaire: patient characteristics, 
pain intensity, sickness related to work and visits to 
medical specialists and paramedical therapists, onset 
and frequency of pain episodes during the previous 
12 months, severity of current pain
Pain severity
mean severity for responders 4.9 (SD 2.4)
Analyses
Descriptive statistics, Mann-Whitney tests for 
differences between responders and non-responders, 
t-tests for differences in mean age and chi-square 
test to compare sex in the two groups
Dieleman et al. 2008
Study design
longitudinal / cohort 
study
Study method
Study conducted in 
the IPCI database - a 
longitudinal general 
practice research 
database containing data 
of more than 500,000 
patients records
Type of chronic pain
Neuropathic pain
Confirmation of diagnosis
Case definition relied on GP and specialists symptoms 
and diagnosis recorded in the medical record with 
the GP. GP diagnoses were accepted if they recurred 
in the patient record and if typical neuropathic pain 
symptoms were present.
Sample size and demographics
362,693 persons (1,116,215 person years)
Age and gender distribution similar to Dutch 
population
Patient selection
All individuals from the IPCI database with at least 
one year of follow-up
Outcomes measured
incidence rates of 13 subtypes of neuropathic pains, 
prescribed treatments
Pain severity
Not reported
Analyses
Age and gender specific incidence rates of different 
types of neuropathic pain, Cox-regression analysis 
for the relative risk and 95% confidence interval of 
neuropathic pain for women versus men
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Q6. Study quality
The quality of the study of Breivik et al. (2006) was rated as moderate. The description of study design, eligibility 
criteria, outcome and study participants was adequate. However, it was not clear whether the population was 
representative and the statistical methods were not clearly described. 
The quality of the study of Van Dasselaar (2002) was rated low because the eligibility criteria and the outcomes 
were not clearly described. Furthermore, a description of statistical methods and study participants was lacking. 
Also it was not clear whether the results were adjusted or unadjusted.
The quality of Van Tulder et al (1998) was rated moderate. The study included a sample of patients that was 
representative for the Dutch general population, but the time period of recruitment was not stated. Eligibility 
criteria, outcomes, included population and method of analysis were clearly described. It was unclear whether 
the results were adjusted or unadjusted for confounders.
Borghouts et al (1999 Scand J Prim Health Care) was rated moderate. Although the study design was clear, the 
dates of recruitment were lacking. Furthermore, it was unclear whether the sample was representative – the 
paper stated that the patient population in the network reflect the Dutch general population but it was not 
clear on which variables that is. Lastly, it was not clear whether the results were adjusted or unadjusted for 
confounders.
The study of Dieleman et al. (2008) was also rated moderate quality. The study reported on a representative 
sample and study design, eligibility criteria, outcomes and statistical methods were adequately described. 
However, the study population and loss to follow-up were not reported adequately.
Q6. Results
General chronic pain
Breivik et al. 2006
300 Dutch patients with chronic moderate to severe pain were interviewed. Of these, 14% had ever seen 
a pain management specialist and 33% were currently prescribed medicines (36% NSAIDs, 16% a COX-2 
inhibitor, 14% weak opioids, 11% paracetamol and 5% strong opioids). For non-drug treatments: 52% had 
tried physiotherapy, 21% had tried acupuncture and 17% had tried massage for their pain.
Van Dasselaar 2002
Eighty-five per cent of the responding hospitals performed invasive procedures on patients with chronic non-
cancer pain. In a 1-year period, approximately 63,000 invasive procedures have been done. Of these, about 
16,000 trigger point injections and test procedures were carried out. Table 14 specifies the numbers for other 
procedures. 
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Table 14. Number of invasive procedure for chronic non-malignant pain in Dutch hospitals in 1990-1991
Type of treatment Number of procedures
Percutaneous facet denervation:
   Cervical region
   Thoracic region
   Lumbosacral region
Rhizotomy dorsal ganglion:
   Cervical region
   Thoracic region
   Lumbosacral region
Spinal injection:
   Cervical region
   Thoracic region
   Lumbosacral region
Highly specialized techniques:
   Injection Gasser’s ganglion
Temperature controlled radiofrequency lesion of:
   Gasserian ganglion
   Stellate ganglion
   Sphenopalatine ganglion
4150
1645
6142
2915
955
2535
4016
4458
14834
833
901
1327
700
Total 45411
Chronic musculoskeletal pain
Van Tulder et al. 1998
This study assessed treatments of 524 patients with chronic low back pain in general practice. 72.8% received 
no treatment. Forty two percent of total population visited their GP during 12 months follow up because of 
their low back pain and of these, 36% received no treatment. In the total population medication was the most 
frequent reported therapeutic modality (21.6%), and NSAIDs were used most often. With regard to non-drug 
treatments, postural advice was given to 6.1% of the patients and (bed)rest was advised to 5.7%. Table X 
below present results in more detail. 
Borghouts et al. 1998 (Scand J Prim Health Care)
This study assessed the treatment of 487 patients with chronic neck pain in general practice. 44% visited the 
GP for neck pain in the previous year. Of the patients who visited their GP, 31% did not receive treatment. 
Medication, specifically paracetamol / aspirin / NSAIDs, was the most frequent applied treatment; 58% of the 
patients who visited their GP received this. With regard to non-drug treatment, the application of heat was 
used in 20% of patients and postural advice in 18%. Other treatments were used less frequent. See table 15 
below for details.
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Table 15. Therapeutic modalities of chronic low back or neck pain in general practice during 12 months
Treatment
Chronic low back 
pain (n=524)
Chronic neck pain
Patients with 
GP consultation 
(n=212)
Total population 
n=487)
%*
95% 
confidence 
interval
n %* n %*
No therapy 72.8  68.8 to 76.8 65 31 310 67
Medication
   Paracetamol/aspirin
   NSAID
   Paracetamol/aspirin/NSAID
   Benzodiazepine
   Antidepressants
   Other medication
21.6
3.9
16.3
-
3.3
-
0.7
 17.9 to 25.3
 2.3 to 6.2
 12.8 to 19.8
 -
 1.8 to 5.5
 -
 0.1 to 2.0
-
-
-
120
23
7
16
-
-
-
58
10
3
8
-
-
-
120
23
7
16
-
-
-
26
5
2
3
Heat application
(Bed)rest
Injection
Postural advice
Work advice
Collar
Other treatment
4.0
5.7
0.4
6.1
1.3
-
3.0
 2.4 to 6.2
 3.8 to 8.2
 0.05 to 1.5
 4.1 to 8.7
 0.5 to 2.7
 -
 1.6 to 4.9
39
22
-
35
-
7
6
20
11
-
18
-
3
3
39
22
-
35
-
7
6
8
5
-
8
-
2
1
* Percentage of patients who were treated at least once with a specific therapeutic modality during the 
12-months prospective follow-up. Several modalities could be applied to 1 participant so these percentages 
cannot be added up to form a total score
Neuropathic pain
Dieleman et al. 2008
This study reported only types of medication as treatment. It’s not clear whether other treatments were not 
given to this population or whether these were not assessed.
 53% of the patients with neuropathic pain were prescribed medication and 47% were not. NSAIDs were 
the most commonly used drug (34.7%) followed by benzodiazepines (11.9%), sedative/hypnotics (9.1%) 
and opioids (6.6%). Anticonvulsants and tricyclic antidepressants were used by 4.8% and 4.7% of patients, 
respectively. 
Q6. Summary
Two studies on treatments for general chronic pain were found. One study, including patients with moderate to 
severe chronic pain, reported that 14% had seen a pain management specialist and that 33% were prescribed 
medicines. Furthermore, 52% had tried physiotherapy, 21% acupuncture and 17% massage for their pain. 
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The other study reported on frequency of invasive procedures carried out in Dutch hospitals. 85% of the 
respondents performed such procedures and performed approximately 63,000 procedures in 1991-1992.
Two other studies reported on chronic musculoskeletal pain in general practice. Among patients who visited 
their GP for low back or neck pain, 36% and 31% did not receive any treatment, respectively. For both 
indications, medication was most frequently applied treatment (22% of patients with low back pain received 
medication and 58% of patients with neck pain received paracetamol/aspirin/ NSAIDs). The most frequent used 
non-drug treatments for low back pain were (bed)rest (6%) and postural advice (6%) and for neck pain heat 
application (20%) and postural advice (18%).
The last study on neuropathic pain reported only types of medication as treatment. 53% of the patients with 
neuropathic pain were prescribed medication and 47% were not. NSAIDs were the most commonly used drug; 
about 35% received this.
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Q7. What is the 
compliance of treated 
chronic pain patients 
in the Netherlands?
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No studies were found reporting on compliance of treated chronic pain patients in the Netherlands.
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Q8. What is the 
duration and severity of 
chronic pain conditions 
in the Netherlands?
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We located 16 studies relevant to this question and selected three for this project (Table 16). 
One was rated as high quality and two were rated medium quality. Breivik et al. (2006) performed a large 
telephone survey to explore the prevalence, impact on daily life and treatment of chronic pain in 15 European 
countries and Israel, among which the Netherlands. Persons received an initial screening questionnaire and 
those who suffered from long-lasting pain were subsequently interviewed in-depth using a second structured 
questionnaire. From the Netherlands, 300 persons suffering chronic pain were interviewed. 
Sluiter et al. (2008) was a medium quality postal questionnaire sent to all members of the national chronic 
repetitive strain injury (RSI) patient association (n=1121). The aim was to study differences between working 
and sick-listed RSI patients in the Netherlands with respect to indices of quality of life and illness perception. 
Quality of life and cognitive illness perception were assessed, as well as demographic, complaint-related and 
work activities characteristics.
Suurmeijer et al. (2001) was a high quality longitudinal cohort study that followed 573 patients with recently 
diagnosed Rheumatoid arthritis (RA), including 268 from the Netherlands, 216 from Norway, and 89 from 
France to examine the quality of life (QoL) profiles and to relate these to disease and impairment variables. 
Table 16. Characteristics of studies relevant to Question 8: pain duration and severity
Study details Population Outcomes and analysis
Breivik et al. 2006
Study design
Cross-sectional study
Study method
Telephone survey in two 
parts. First, persons were 
screened for chronic 
pain. Those who qualified 
were interviewed in-
depth
Type of chronic pain
Long-lasting pain: chronic pain for at least 6 months, 
and pain in last month, and pain at least 2 times/
week, and rating pain intensity at least 5 on 10-point 
NRS
Confirmation of diagnosis
Not reported
Sample size and demographics
Total sample: 4839; Netherlands: 300 persons with 
long-lasting pain
Demographics for all countries together: 52% female 
mean age 50 years
For the Netherlands: female 60%, mean age 51.3 
years
Patient selection
Subjects with long-lasting pain (see definition above)
Outcomes measured
Duration, location, intensity of pain. 
Tolerance, time course of pain, impact pain on 
activities daily life, employment status, emotional 
status
Visits to doctors, visits to pain management 
specialist, treatment (medication and non-
medication), effectiveness of treatment, satisfaction 
with doctors, respondents’ attitudes and beliefs 
about pain and pain treatment, respondents’ 
perception of the attitude of others to their pain
Pain severity
18% reported severe pain
Analyses
Descriptive analysis only. No subgroups were 
reported (for the Netherlands)
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Study details Population Outcomes and analysis
Sluiter et al. 2008
Study design
Cross-sectional postal 
survey 
Study method
Postal questionnaire was 
sent to all members of 
the national RSI patient 
association
Type of chronic pain
Chronic repetitive strain injury (RSI) patients.
Confirmation of diagnosis
Not reported
Sample size and demographics
n=1121 assessable returned questionnaires; 
Working group (n=745); sick-listed group (n=376)
Mean age: 40.8 (SD 8.7); Women: 67%; High 
education: 67%
Patient selection
Members of the national RSI patient association in 
march 2005.
Outcomes measured
Quality of life and cognitive illness perception. Pain 
scale of SF-36; pain intensity using VAS (0-100)
Analyses
Multivariate ANOVA controlling for age, gender,
and education level or nonparametric tests (Mann–
Whitney) were performed to test differences 
between the two groups of RSI patients
Suurmeijer et al. 2001
Study design
Longitudinal study 
Study method
Part of the European 
Research on 
Incapacitating Disease 
and Social Support 
data. A series of clinical 
and psychosocial data 
collected on 4 (the 
Netherlands, France) and 
3 (Norway) occasions, 
with 1-year intervals 
separating the waves of 
data collection
Type of chronic pain
Patients with recently diagnosed Rheumatoid arthritis 
(RA)
Confirmation of diagnosis
RA according to the 1987 American College of 
Rheumatology (formerly the American Rheumatism 
Association) criteria
Sample size and demographics
573 patients (268 from the Netherlands, 216 from 
Norway, and 89 from France)
n=268; Mean age (SD): 54.4 (11.8); Women: 64%
Mean disease duration since RA diagnosis, months: 
21.9 (SD: 13.9)
Patient selection
Residence in the sampling areas, age between 20 
and 70 years, diagnosis of RA and a disease duration 
of 4 years or less
Outcomes measured
Disease: ESR; Impairment: Ritchie Articular Index; 
fatigue and pain (NHP);
Disability: GARS and HAQ;
Handicap: Leisure and ILRA
Rosenberg Self-Esteem scale and psychological 
distress (GHQ28); Satisfaction (SSQS)
Analyses
Descriptive data (mean, SD) for pain
Q8. Study quality
The quality of Breivik et al. (2006) was rated as moderate. The methods were clearly stated in this study, with 
clear eligibility criteria and an adequate description of study participants. However, it was not clear if the 
population participating in the study was representative of target population. Outcomes and their measurement 
were adequately described; but there was no description of statistical methods used and results were not 
reported as unadjusted and confounder-adjusted including precision.
Sluiter et al. was also rated moderate quality. The authors did not describe the eligibility criteria adequately, 
results were not sufficiently reported and the representativeness of the study population was unclear. The study 
by Suurmeijer et al. was rated as high quality. It was not clear that the population was representative, but all 
other quality items were fulfilled. 
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Q8. Results
Pain severity
Suurmeijer et al. 2001
Mean pain scores among the 268 Dutch patients with recently diagnosed Rheumatoid arthritis were 13.4 (SD: 
2.1), while scores ranged from 8 to 16. Forty-three percent of Dutch RA patients had low pain scores (≤13)
Sluiter et al. 2008
Pain intensity as measured on a 100mm VAS scale was 41.3 (SD: 25.4) for the total group of 1121 chronic 
repetitive strain injury (RSI) patients. The working group (N=745) scored 36.2 (SD: 24.7), while the sick-listed 
group (N=376) scored 51.6 (SD: 23.9).
Pain Duration
Breivik et al. 2006
From the Netherlands, 300 participants with moderate to severe chronic pain were included. Both screening 
questionnaire and in-depth interview contained questions about pain duration. The results for participating 
countries were presented on graphs and included means without standard deviations. The mean duration of 
chronic pain for Dutch participants was 6.5 years. 
Suurmeijer et al. 2001
Pain duration was not reported, but duration of disease was reported. Mean disease duration since RA 
diagnosis in months was 21.9 (SD: 13.9) for the Dutch RA patients. However, disease duration of 4 years or less 
was one of the inclusion criteria.
Q8. Summary
Pain severity and duration
General chronic pain:
Breivik et al. (2006) measured the mean duration of general chronic pain for Dutch participants at 6.5 years. 
Breivik et al. (2006) was rated medium quality and, as the authors compared their sample favourably to the 
general population of the Netherlands, we considered their results to be representative.
Patients with recently diagnosed Rheumatoid Arthritis (RA)
Mean pain scores among the 268 Dutch patients with recently diagnosed Rheumatoid arthritis were 13.4 (SD: 
2.1); while scores ranged from 8 to 16.
Patients with chronic repetitive strain injury (RSI) 
Pain intensity as measured on a 100mm VAS scale was 41.3 (SD: 25.4).
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Q9. What are the 
demographics of 
chronic pain sufferers 
in the Netherlands?
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We located 28 studies that were relevant to this question and selected three for this project (Table 17). 
The first was a medium quality study (Breivik et al. 2006) using a large telephone survey to explore the 
prevalence, impact on daily life and treatment of chronic pain in 15 European countries and Israel, among 
which the Netherlands. Persons received an initial screening questionnaire and those who suffered from 
long-lasting pain were subsequently interviewed in-depth using a second structured questionnaire. From the 
Netherlands, 300 persons suffering chronic pain were interviewed. 
The second study (Huisstede et al. 2008) was a moderate quality study based on DMC3 population survey data 
including 3664 respondents. Huisstede et al. 2008 aimed to study the prevalence of upper extremity disorders 
(UEDs) and neck as a total and complaints of the arm, neck and/or shoulder (CANS) not caused by acute trauma 
or any systemic disease as defined in the CANS model in the open population and to assess socio-demographic 
and health characteristics of chronic symptoms.
The third study (Opstelten et al. 2005) was a moderate quality study aimed to determine the incidence of 
Herpes Zoster (HZ) and Postherpetic Neuralgia (PHN) in a primary care population and to identify risk factors for 
the occurrence of PHN. This study used data from the database of the “Huisartsen Netwerk Utrecht” a general 
practice research database, from 1994 to 1999. Cases were identified by searching the database using an ICPC 
code and free text and medical records were reviewed for confirmation.
Table 17. Characteristics of the studies relevant to Question 9
Study details Population Outcomes and analysis
Breivik et al. 2006
Study design
Cross-sectional study
Study method
Telephone survey in two 
parts. First, persons were 
screened for chronic 
pain. Those who qualified 
were interviewed in-
depth
Type of chronic pain
Long-lasting pain: chronic pain for at least 6 months, 
and pain in last month, and pain at least 2 times/
week, and rating pain intensity at least 5 on 10-point 
NRS
Confirmation of diagnosis
Not reported
Sample size and demographics
Total sample: 4839; Netherlands: 300 persons with 
long-lasting pain
Demographics for all countries together: 52% female 
mean age 50 years
For the Netherlands: female 60%, mean age 51.3 
years
Patient selection
Subjects with long-lasting pain (see definition above)
Outcomes measured
Duration, location, intensity of pain
Tolerance, time course of pain, impact pain on 
activities daily life, employment status, emotional 
status
Visits to doctors, visits to pain management 
specialist, treatment (medication and non-
medication), effectiveness of treatment, satisfaction 
with doctors, respondents’ attitudes and beliefs 
about pain and pain treatment, respondents’ 
perception of the attitude of others to their pain
Pain severity
18% reported severe pain
Analyses
Descriptive analysis only. No subgroups were 
reported (for the Netherlands)
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Study details Population Outcomes and analysis
Huisstede et al. 2008
Study design
Cross-sectional/ survey
Study method
DMC3 study - national 
health survey of 
musculoskeletal 
conditions; postal 
questionnaire – with 
general questions and 
health questions. After 
screening question for 
each of 5 anatomical 
areas
Additional questions 
regarding pain in 
this area and its 
consequences; general 
health was measured 
using the Short 
Form(SF)-36
Type of chronic pain
Upper extremity disorders (UED) and neck pain; 
complaints of the arm, neck
and/or shoulder (CANS; excluding UED caused by an 
acute trauma or a systemic disease) 
Confirmation of diagnosis
NR; only screening question: ‘‘did you have pain in 
‘anatomic area’ during the past 12 months?’’ 
Sample size and demographics
3664 respondents 
25–44 years 47.0%, 
45–64 years 34.6%, 
65+ years 18.4% 
Female 50.9%
chronic UED 996
chronic UED due to systemic disease or acute trauma 
299
chronic CANS 697
Patient selection
DMC3 - Dutch population aged 25 years and above; 
this study - persons with musculoskeletal upper 
extremity and neck disorders in 4 anatomic sites: 
neck, shoulder, elbow, and wrist/hand
Outcomes measured
12-month prevalence, point prevalence, and 
prevalence of chronic pain (pain at baseline and 
lasting more than 3 months in the last 12 months)
course of pain, consequences of pain (contact 
with general practitioner, medical specialist or 
physiotherapist, work leave, limitations in daily life), 
general health
Pain severity
self-reported - severe or mild chronic total UED 
Continuous severe pain 5.4% 
Recurrent severe pain 12.7% 
Chronic CANS
Continuous severe pain 3.9% 
Recurrent severe pain 12.8% 
Analyses
Descriptive analysis only 
Opstelten et al 2005
Study design
Cross-sectional / survey
Study method
A search conducted in 
the Huisartsen Netwerk 
Utrecht” database, a 
general practice research 
database over a 5-year 
period
Type of chronic pain
Herpes zoster (HZ) and post herpetic neuralgia (PHN). 
PHN was defined as any pain that persisted at least 1 
month after HZ diagnosis
Confirmation of diagnosis
GP diagnosis (ICPC code 32 S70 (HZ) or GP 
confirmation of HZ)
Sample size and demographics
N=837
58% female
Patient selection
All HZ patients diagnosed between 1 August 1994 
and 31 July 1999 were identified by searching the 
database for ICPC code 32 S70 (HZ) and for free 
text (‘zoster’). Medical records were reviewed for 
confirmation
Outcomes measured
Incidence of HZ (in different age groups); Risk of PHN 
1 and 3 months after HZ diagnosis
Pain severity
Severity not reported.
Persistent pain 3 months after HZ diagnosis was 
reported in the medical records of 2.6% (95% CI: 
1.7, 4.0) of the HZ patients
Analyses
Multivariate logistic regression model
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Q9. Study quality
Breivik et al. 2006
The quality of Breivik et al. (2006) was rated as moderate. The methods were clearly stated in this study, 
with clear eligibility criteria and an adequate description of study participants. However, it was not clear if the 
population participating in the study was representative of target population. Outcomes and their measurement 
were adequately described; but there was no description of statistical methods used and results were not 
reported as unadjusted and confounder-adjusted including precision.
Huisstede et al. 2008
The quality of the Huisstede et al. 2008 study was rated as moderate, as it was unclear that the population 
was representative of the target sample, the statistical methods were not clearly described and the results were 
not reported as unadjusted and confounder-adjusted including precision. There was no adequate description of 
the eligibility criteria. 
Opstelten et al. 2002
This study was rated as moderate quality. It was unclear whether the study sample was representative of the 
target sample and the description of participants was inadequate. However, study design, eligibility criteria, 
statistical methods and outcomes were adequately described. Also results were clearly reported as adjusted or 
unadjusted with precision.
Q9. Results
Moderate to severe general chronic pain
Breivik et al. 2006
Of the 300 chronic pain participants interviewed, 82% reported moderate pain and 18% reported severe pain. 
The mean age of chronic pain sufferers in the Netherlands was 51.3 years and 60% were female.
Herpes zoster (HZ) and post herpetic neuralgia (PHN)
Opstelten et al. 2002
A total of 47% of all HZ patients were at least 55 years old and 58% were female. Age was found to be an 
independent risk indicator for the occurrence of PHN (adjusted OR for 55-74 years: 4.2 (95% CI: 1.8, 9.7); 
adjusted OR for >75 years: 10.7 (95% CI: 4.6, 25.1)).
Chronic musculoskeletal pain
Huisstede et al. 2008 
Nine hundred and ninety-six (996) persons With Chronic Complaints of the Upper Extremity and Neck (UEDs) 
were included in the study. Sixty-three percent (63%) of these were female and 29% were 65 years or older. 
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Q9. Summary
General Chronic Pain
Breivik et al. (2006) reported the mean age of moderate to severe chronic pain sufferers in the Netherlands 
was 51.3 years and 60% were female. 
Herpes zoster (HZ) and post herpetic neuralgia (PHN)
Opstelten et al. (2002) found that 47% of all HZ patients were at least 55 years old and 58% were female. 
Chronic musculoskeletal pain 
Huisstede et al. (2008) found that 63% of persons with UEDs were female and 29% were 65 years or older.
We considered all three studies (Breivik et al. 2006, Opstelten et al. 2002, Huisstede et al. 2008) to be of 
moderate quality and judge the Breivik et al. results to be representative of the target population (moderate 
to severe chronic pain suffers in the Netherlands). In the study by Opstelten et al. it was unclear whether the 
study sample was representative of the target sample.
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Q10. What are the  
co-morbidities of 
chronic pain sufferers 
in the Netherlands?
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We located 18 relevant studies and selected three for this question (Breivik et al. 2006, Demyttenaere et al. 
2007 and Picavet and Schouten 2003).
Breivik et al. (2006) performed a large telephone survey to explore the prevalence, impact on daily life and 
treatment of chronic pain in 15 European countries and Israel, among which the Netherlands. Persons received 
an initial screening questionnaire and those who suffered from long-lasting pain were subsequently interviewed 
in-depth using a second structured questionnaire. From the Netherlands, 300 persons suffering chronic pain 
were interviewed. 
Demyttenaere et al. 2007 aimed to estimate the prevalence of 12-month chronic back or neck pain in the 
general population of 85 088 participants in 17 countries in Europe, the Americas, the Middle East, Africa, Asia, 
and the South Pacific and to estimate the occurrence of specific 12-month mood, anxiety disorders, and alcohol 
abuse/dependence among persons with chronic back or neck pain as well as to investigate which mental 
disorders were most strongly associated with chronic back or neck pain and to assess the consistency of the 
associations between chronic back or neck pain and mental disorders. 
Picavet and Schouten 2003 was based on DMC3 population survey data with 3664 respondents. It aimed 
to present estimates on the prevalence of musculoskeletal pain of five different anatomical areas and ten 
anatomical sites, and their consequences and risk groups in the general Dutch population.
Table 18. Characteristics of the study selected for question 10
Study details Population Outcomes and analysis
Breivik et al. 2006
Study design
Cross-sectional study
Study method
Telephone survey in two 
parts. First, persons were 
screened for chronic 
pain. Those who qualified 
were interviewed in-
depth
Type of chronic pain
Long-lasting pain: chronic pain for at least 6 months, 
and pain in last month, and pain at least 2 times/
week, and rating pain intensity at least 5 on 10-point 
NRS
Confirmation of diagnosis
Not reported
Sample size and demographics
Total sample: 4839; Netherlands: 300 persons with 
long-lasting pain
Demographics for all countries together: 52% female 
mean age 50 years.
For the Netherlands: female 60%, mean age 51.3 
years
Patient selection
Subjects with long-lasting pain (see definition above)
Outcomes measured
Duration, location, intensity of pain
Tolerance, time course of pain, impact pain on 
activities daily life, employment status, emotional 
status
Visits to doctors, visits to pain management 
specialist, treatment (medication and non-
medication), effectiveness of treatment, satisfaction 
with doctors, respondents’ attitudes and beliefs 
about pain and pain treatment, respondents’ 
perception of the attitude of others to their pain
Pain severity
18% reported severe pain
Analyses
Descriptive analysis only. No subgroups were 
reported (for the Netherlands)
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Study details Population Outcomes and analysis
Demyttenaere et al. 
2007
Study design
Population surveys of 
community-dwelling 
adults in 17 countries in 
Europe, the Americas, 
the Middle East, Africa, 
Asia, and the South 
Pacific (N = 85,088).
Study method
Face-to-face survey with 
questions about chronic 
conditions adapted from 
the US Health Interview 
Survey (National Center 
for Health Statistics, 
1994)
Type of chronic pain
Back or neck pain
Confirmation of diagnosis
Not reported
Sample size and demographics
Netherlands sample n=1094
Mean age 45.0
Female 50.9%
Selection
All respondents who met criteria for any mental 
disorder and a probability sample of other 
respondents were administered part-2 (assessment 
of chronic physical conditions)
Outcomes measured
The 12-month prevalence of either back or neck pain
The prevalence of mental disorders among people 
with chronic back/neck pain
Analyses
Odds ratios (OR) for the association of each mental 
disorder with the pain condition were estimated for 
each survey. Adjusted ORs were estimated to assess 
the association of any mood disorder, any anxiety, 
and any alcohol abuse/ dependence with back or 
neck pain
Pain severity
Not reported
Picavet and Schouten 
2003
Study design
Cross-sectional study
Study method
DMC3 study - national 
health survey of 
musculoskeletal 
conditions; postal 
questionnaire – with 
general questions and 
health questions. After 
screening question for 
each of 5 anatomical 
areas
Additional questions 
regarding pain in 
this area and its 
consequences; 
socio-demographic 
characteristics 
Type of chronic pain
Neck, shoulder, higher back 44.5%
Elbow, wrist/hand 23.2%
Lower back 43.9% 
Hip, knee 28%
Ankle, foot 14.9%
Confirmation of diagnosis
NR; only screening question: ‘‘did you have pain in 
‘anatomic area’ during the past 12 months?’’ 
Sample size and demographics
Total sample: 3664 respondents 
weighted to present a distribution of sex, age, 
marital status and region of living equal to that of 
the Netherlands in 1998:
Sex
men 49.1%
women 50.9%
Age group
25-44 47.0%
45-64 34.6%
65+ 18.4%
Patient selection
Dutch inhabitants of 25 years and older 
Outcomes measured
Musculoskeletal pain period prevalence, point 
prevalence, prevalence of chronic pain, course of 
pain, consequences of pain (contact with general 
practitioner, medical specialist or physiotherapist, use 
of medicines, work leave, limitations in daily life, and 
work disability)
Pain severity
self-reported - severe or mild 
roughly 15% severe pain
Neck, shoulder or higher back
Continuous severe pain 3.1%
recurrent severe pain 8.3%
Elbow or wrist/hand
Continuous severe pain 4.0%
recurrent severe pain 11.0%
Lower back
Continuous severe pain 3.5%
recurrent severe pain 15.4%
Hip or knee
Continuous severe pain 5.2%
recurrent severe pain 10.1%
Ankle or foot
Continuous severe pain 6.1%
recurrent severe pain 12.4%
Analyses
descriptive, frequencies, multivariate logistic 
regression
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Q10. Study quality
The quality of the Breivik et al. 2006 study and Demyttenaere et al. 2007 study was rated as moderate; In both 
studies it was unclear that the population was representative, in the Breivik study the statistical methods were 
not clearly described, in Demyttenaere study the eligibility criteria were not clearly described. 
Picavet and Schouten 2003 study was rated as high quality; only one item was missing – the authors did not 
provide adequate description of eligibility criteria.
Q10. Results
Comorbidities in general pain conditions
Breivik et al. 2006
Among 251 of Dutch respondents 12% reported traumatic injury, 13% herniated/deteriorating disc and 19% 
arthritis or osteoarthritis as causes of their pain. These were also the most commonly reported causes for the 
whole Europe.
Among 294 of Dutch respondents 19% reported being diagnosed with depression by a medical doctor as a 
results of their pain, while the European average was 21%. 
Comorbidities in musculoskeletal pain – several pain locations
Picavet and Schouten 2003
The authors described coexistence of pain in several locations among 3664 respondents. 12 month period 
prevalence of musculoskeletal pain in 2–3 sites was about 30%, while in 4 or more sites about 20%. The 12 
month period prevalence of musculoskeletal pain in combinations of upper and lower extremities, back or neck 
and in left and right was over 10% (Figure 13).
Point prevalence of musculoskeletal pain in 2–3 sites was about 20%, while in 4 or more sites – about 10%. 
The point prevalence of musculoskeletal pain in combinations of upper and lower extremities, back or neck and 
in left and right was 5–9% (Figure 13)
Prevalence of chronic musculoskeletal pain in 2–3 sites was about 5%, while in 4 or more sites – about 7%. The 
prevalence of chronic musculoskeletal pain in combinations of upper and lower extremities, back or neck and in 
left and right 4–6% (Figure 13).
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Figure 13. Prevalence of musculoskeletal pain (12 month period prevalence, point prevalence, prevalence of 
chronic pain) in 2 or more sites and combinations of locations (UEx – upper extremity, LEx – lower extremity, 
L – left, R – right) 
When prevalence of current musculoskeletal pain (point prevalence) was analysed in age groups (25–44, 45–64 
and 65+) the lowest values for 2–3 sites, 4 or more sites and combinations (upper extremities, neck, back, left, 
right) for men and for women were noted in the youngest age group (Figure 14). The prevalence increased 
with age in women, while in men the values were higher for the age group 45–64 and then for men they 
decreased for the oldest age group in most of the cases. For 2–3 sites, 4 or more sites and combinations (upper 
extremities, neck, back, left, right) the prevalence was higher for women than for men (Figure 14). 
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Figure 14. Prevalence of current musculoskeletal pain in 2 or more sites and combinations of locations by 
gender and age group (UEx – upper extremity, LEx – lower extremity, L – left, R – right) 
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Co-morbid mental health conditions in patients with back/neck pain
Demyttenaere et al. 2007
Prevalence of mood disorders among persons with versus without back/neck pain:
Major depressive episode: 4.4% no back or neck pain; 9.4% back or neck pain; OR 2.3 (1.5, 3.6)
Dysthymia: 1.2% no back or neck pain; 4.5% back or neck pain; OR 4.2 (1.8, 9.7)
Prevalence (%) of anxiety disorders among persons with versus without back/neck pain: 
Generalized anxiety disorder: 0.8% no back or neck pain; 2.1% back or neck pain; OR 2.8 (1.0, 7.7)
Agoraphobia or Panic disorder: 1.7% no back or neck pain; 1.7% back or neck pain; OR 1.0 (0.4, 2.6)
Social Phobia: 1.0% no back or neck pain; 2.4% back or neck pain; OR 2.5 (0.8, 7.7)
Posttraumatic stress disorder: 1.4% no back or neck pain; 7.4% back or neck pain; OR 4.4 (1.5, 13.3)
Prevalence (%) of alcohol abuse/dependence disorders among persons with versus without back/neck pain: 
1.7% no back or neck pain; 1.7% back or neck pain; OR 1.3 (0.5, 3.2)
0 2 4 6 8 10
back or neck pain
no back or neck
pain
major depressive disorder
dysthymia
GAD
agoraphobia or panic
disorder
social phobia
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Figure 15. Percentage of patients with back or neck pain with co-morbid mental conditions 
Q10. Summary
The three included studies reported comorbidities in several pain conditions. In general pain condition 
depression was reported in 19% of respondents, in patients with back or neck pain mood disorders were 
reported by 4.5–9.4% (major depressive disorder was reported by the highest percentage of respondents) 
of pain sufferers, anxiety disorders by 1.7–7.4% of respondents and alcohol abuse by 1.7%. In patients with 
musculoskeletal pain coexistence of pain in several locations was reported by 5–7% and more widespread pain 
including combinations of upper and lower extremities, back or neck and in left and right was reported by 
4–6% of respondents. 
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Q11. How many 
sufferers in the 
Netherlands have 
inadequate pain 
control? 
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We located one study that was relevant to this question (Breivik et al. 2006).
Breivik et al. (2006) performed a large telephone survey to explore the prevalence, impact on daily life and 
treatment of chronic pain in 15 European countries and Israel, among which the Netherlands. Persons received 
an initial screening questionnaire and those who suffered from long-lasting pain were subsequently interviewed 
in-depth using a second structured questionnaire. From the Netherlands, 300 persons suffering chronic pain 
were interviewed. 
Table 19. Characteristics of the study selected for question 11
Study details Population Outcomes and analysis
Breivik et al. 2006
Study design
Cross-sectional study
Study method
Telephone survey in two 
parts. First, persons were 
screened for chronic 
pain. Those who qualified 
were interviewed in-
depth
Type of chronic pain
Long-lasting pain: chronic pain for at least 6 months, 
and pain in last month, and pain at least 2 times/
week, and rating pain intensity at least 5 on 10-point 
NRS
Confirmation of diagnosis
Not reported
Sample size and demographics
Total sample: 4839; Netherlands: 300 persons with 
long-lasting pain
Demographics for all countries together: 52% female 
mean age 50 years.
For the Netherlands: female 60%, mean age 51.3 
years
Patient selection
Subjects with long-lasting pain (see definition above)
Outcomes measured
Duration, location, intensity of pain
Tolerance, time course of pain, impact pain on 
activities daily life, employment status, emotional 
status
Visits to doctors, visits to pain management 
specialist, treatment (medication and non-
medication), effectiveness of treatment, satisfaction 
with doctors, respondents’ attitudes and beliefs 
about pain and pain treatment, respondents’ 
perception of the attitude of others to their pain
Pain severity
18% reported severe pain
Analyses
Descriptive analysis only. No subgroups were 
reported (for the Netherlands)
Q11. Study quality
The quality of the Breivik et al. study was rated as moderate; in this study it was not clear that the population 
was representative and the statistical methods were not clearly described. 
Q11. Results
The authors reported that out of 119 respondents 79% reported inadequate pain control from medication 
(affirmative answer to the question: ‘‘Are there ever times when your pain
medicines are not adequate to control your pain?) while a European average was 64%. Out of 274 respondents 
56% reported inadequate overall pain control (affirmative answer to the question: ‘‘Would you say your pain is 
being adequately controlled?’’) while a European average was 40%.
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Q11. Summary
Breivik et al. 2006 reported inadequate pain control from medication according to patients assessment in 79% 
and inadequate overall pain control in 56%. 
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Q12a. In the 
Netherlands what is the 
impact of chronic pain 
on quality of life?
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We located three studies that were relevant to this question (Alonso et al. 2004, Lame et al. 2005 and Picavet 
and Hoeymans 2004).
Alonso et al. 2004 aimed to assess the impact of common chronic conditions on HRQL among the general 
populations of eight countries: Denmark, France, Germany, Italy, Japan, the Netherlands, Norway and the 
United States. 
Lame et al. 2005 aimed to investigate pain cognitions and quality of life of chronic pain patients referred to a 
multi-disciplinary university pain management clinic and to search for predictors of quality of life.
Picavet and Hoeymans 2004 was based on DMC3 population survey data with 3664 respondents. It aimed to 
examine the health related quality of life of persons with one or more self reported musculoskeletal diseases, as 
measured by the short form 36 item health status survey (SF-36) and the Euroqol questionnaire (EQ-5D).
 
Table 20. Characteristics of the study selected for question 12a
Study details Population Outcomes and analysis
Alonso et al. 2004
Study Design
Cross-sectional survey
Study Method
Cross-sectional mail and 
interview surveys 
Type of chronic pain
Arthritis (defined as “arthritis or a type of rheumatic 
disease”)
Confirmation of diagnosis
Self-reported
Sample Size and Demographics
Total: 24936
Netherlands N = 4059
Mean age = 43.4 (SD 17.9)
46.1% males
Patient selection 
General population normative data. The International 
Quality of Life Assessment (IQOLA) project protocol 
established that the sample should represent the age 
and gender characteristics of the population and 
should be representative of the various regions in a 
country. For the Netherlands: representative of the 
general Amsterdam population (using age, gender, 
marital status and residential district)
Outcomes measured
Prevalence of chronic conditions
Heath-related quality of life (HRQL) measures (SF-36 
Health Survey)
Pain Severity
Not reported
Analyses
Adjusted, multivariate linear regression analysis
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Study details Population Outcomes and analysis
Lame et al. 2005
Study design
Cross-sectional/ survey
Study method
Patients completed a set 
of mailed questionnaires
Type of chronic pain
Neck pain and/or brachialgia (23.3%); back pain and/
or sciatica (27.9%); other pain, such as CRPS I en II, 
neuropathic pain
syndrome, trigeminus neuralgia, fibromyalgia and RA 
(15.7%); multiple pain localisations (30.1%)
Confirmation of diagnosis
NR
Sample size and demographics
N=1208
mean 49.9 years SD 14.7
female 62%
Patient selection
a population of the outpatient’s clinic for Pain 
and Pain management of the University Hospital 
Maastricht. Each new non-malignant pain patient 
between February 2000 and March 2002 was mailed 
the questionnaire which had to be completed before 
first appointment with the physician
Outcomes measured
demographic information, pain cause, localisation 
and duration
Qol (Rand-36*), pain coping and cognition list 
(PCCL), pain catastrophising scale (PCS) and the 
McGill pain questionnaire (MPQ).
* is same as SF-36
Pain severity
NR
Analyses
Student’s t test, Levene’s test for equality of variance, 
ANOVA, hierarchical stepwise regression analyses
Picavet and Hoeymans 
2004
Study design
Cross-sectional/ survey
Study method
DMC3 study - national 
health survey of 
musculoskeletal 
conditions; postal 
Type of chronic pain
Musculoskeletal pain: herniated disc (spine), gout, 
RSI, epicondylitis, OA knee, OA hip, osteoporosis, 
whiplash, RA, other chronic arthritis, fibromyalgia, 
tendinitis and capsulitis 
Confirmation of diagnosis
Self-reported
Sample size and demographics
Total 3664 respondents 
Patient selection
DMC3 – a random sample of Dutch inhabitants 
aged 25 years and above, who completed the 
questionnaires
Outcomes measured
Quality of life (SF 36, EQ5D)
Pain severity
NR
Analyses
Descriptive analysis weighted for age, sex, region, 
and marital status of the Netherlands’ population in 
1998
Q12a. Study quality 
The study of Alonso et al 2004 was rated as moderate quality. The study population was representative of 
the target population and study outcomes, statistical methods were adequately described. Also, it was clear 
whether results were presented with or without adjustment and precision was given. However there was no 
description of the eligibility criteria of participants and the relevant dates for recruitment and data collection 
were not reported. 
Lame et al. 2005 study was rated as low quality. The study design, outcomes and the study participants were 
adequately described, but there was no adequate description of eligibility criteria, it was unclear that the 
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population was representative, the statistical methods were not clearly described and it was unclear if the 
results were not reported as unadjusted or confounder-adjusted.
The quality of the study of Picavet and Hoeymans 2004 was rated as moderate. The study population was 
representative of the target population and study design, outcomes, statistical methods were adequately 
described. Also, it was clear whether results were presented with or without adjustment and precision was 
given. However, there was no adequate description of the eligibility criteria and study participants. 
Q12a. Results
Several pain populations
Lame et al. 2005
The included pain population reported low quality of life on each domain. Differences between the pain groups 
were found on all domains with the exception of role limitations emotional. Patients with back pain, other pain 
and multiple pain locations experienced more functional limitations (physical functioning and role limitations 
physical) than the other pain groups. In addition, patients with multiple pain localizations scored significantly 
lower on mental health, vitality and general health. Patients with other pain showed significantly lower scores on 
bodily pain than the other pain groups. Gender differences were found for physical functioning, role limitations 
physical, vitality, bodily pain and general health, whereby women reported lower scores than men (Table 2 1). 
When the values of quality of life were compared with other chronic pain populations in the Netherlands and 
a healthy reference population the chronic pain patient from the multi-disciplinary university pain clinic scored 
significant lower on all domains than each of the other groups.
Table 21. Quality of life mean scores for total pain population, according to age and in pain groups 
Dimensions of Rand-36 questionnaire, mean (SD)
PF SF RF RE MH VT BP GH
Total 41.3
(26.3)
39.9
(27.0) 
9.7
(24.3) 
46.6
(46.1) 
56.7
(22.6) 
39.8
(20.4) 
24.6
(17.9) 
44.7
(21.4) 
Men 44.0
(26.2)*
41.4
(27.0) 
12.3
(26.7)*
47.2
(45.6) 
57.7
(21.8) 
42.5
(20.4)* 
27.0
(18.4)*
46.4
(21.0)*
Women 39.6
(26.2)
39.0
(27.0)
8.2
(22.5)
46.3
(46.5)
56.1
(23.0)
38.1
(20.2)
23.1
(17.3)
43.6
(21.7)
Neck pain (1) 55.1
(23.1)#2,4 
43.7
(27.7)#4 
9.9
(25.0) 
47.0
(46.4) 
57.7
(22.9) 
43.5
(21.1)#4
24.9
(18.3)#3 
48.8
(20.8)#4 
Back pain (2) 31.0
(21.1)#1,3
38.3
(27.2) 
8.6
(22.5)#3 
47.8
(45.9) 
60.1
(22.2)#4
41.4
(19.2)#4
22.7
(17.3)#3 
47.3
(21.7)#4 
Other pain (3) 49.8
(31.0)#2,4
43.7
(26.8) 
16.7
(31.3)#2,4 
49.4
(47.0) 
57.6
(21.4) 
40.6
(21.2) 
30.2
(19.5)#1,2,4
46.8
(21.9)#4 
Multiple pain localisations 
(incl. headache) (4)
34.0
(23.0)#1,3
36.4
(25.8)#1
7.4
(20.8)#3
42.5
(45.5)
52.4
(23.0)#2
35.2
(19.8)#1,2
23.2
(16.5)#3
37.4
(19.7) #1,2,3
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*Significant difference between men and women; # Significant difference (p < 0:05) with pain group corresponding 
to the numbers in superscript; PF, physical functioning; SF, social functioning; RP, role limitation physical; RE, role 
limitation emotional; MH, mental health; VT, vitality; BP, bodily pain; GH, general health
Musculoskeletal pain
Arthritis
Alonso et al. 2004
Participants who reported that they had arthritis scored 4.1 points lower on the Physical Summary Component 
of the SF-36 than respondents who did not report any chronic conditions, who scored a mean score of 53.4. 
Participants with arthritis also scored 1.0 points higher than those without chronic conditions on the Mental 
Summary Component for the SF-36, who had a mean score of 55.2. 
 
Musculoskeletal diseases
Picavet and Hoeymans 2004 
For all musculoskeletal diseases and all quality of life dimensions it was found that having the disease was 
associated with a worse health related quality of life (Table 22). Subjects with any of the 12 musculoskeletal 
diseases had significantly lower scores on all SF-36 dimensions than those without musculoskeletal disease, 
especially for physical functioning (SF-36 score 75.2 (SE 0.5) vs 87.8 (SE0.5)), role limitations from physical 
problems (67.1 (SE 0.9) vs 85.8 (SE 0.8)), and bodily pain (68.5 (SE 0.6) vs 84.1 (SE0.5)). Those reporting a 
musculoskeletal disease also reported more health problems on the EQ-5D dimensions than those without a 
musculoskeletal disease, for example, for mobility (29.9% vs 10.5%), pain/discomfort (62.5% v 31.2%), and 
usual activities (34.5% v 12.4%).
With an increasing number of musculoskeletal conditions the health related quality of life deteriorated. In 
general, the health related quality of life scores for subjects with coexistent musculoskeletal disorders were 
worse than those with only one specific disease. 
The dimensions typically affected by musculoskeletal diseases were physical functioning and pain on the SF36, 
and the dimensions ‘‘mobility’’ and ‘‘pain’’ on the EQ-5D. The diseases with the worst health related quality of 
life for those dimensions were: osteoarthritis of the knee or hip,
rheumatoid arthritis, other types of chronic arthritis, osteoporosis, and fibromyalgia. The diseases with the least 
severe scores on these dimensions were epicondylitis, whiplash injury, repetitive strain injury, and tendinitis and 
capsulitis.
For the health related quality of life dimensions involving mental health problems, most musculoskeletal 
diseases did not score lower than the general population. These dimensions included vitality, role limitation 
due to emotional problems, and mental health on the SF36, and the dimension anxiety/depression on the EQ-
5D. Two exceptions were fibromyalgia (for all these dimensions) and rheumatoid arthritis (only a low score on 
vitality) (see Table 22 on next page).
Epidemiology of chronic pain in the Netherlands - Q12a
110
Q12a. Summary
The three included studies reported on quality of life in several pain populations. Quality of life scores were 
low for patients with pain or musculoskeletal diseases. Patients with back pain, other pain and multiple pain 
locations experienced more functional limitations (physical functioning and role limitations physical) than the 
other pain groups. In addition, patients with multiple pain localizations scored significantly lower on mental 
health, vitality and general health. 
Patients with arthritis had lower scores on physical summary component than patients not reporting any 
chronic conditions. 
For all musculoskeletal diseases and all quality of life dimensions it was found that having the disease was 
associated with a worse health related quality of life. The dimensions typically affected by musculoskeletal 
diseases were physical functioning and pain on the SF36, and the dimensions ‘‘mobility’’ and ‘‘pain’’ on the 
EQ-5D. 
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Table 22. Percentage of respondents reporting any problem on EQ5D dimension and mean score of SF-36 
questionnaire in patients with musculoskeletal diseases 
N
Any problem (moderate 
and severe) on EQ-5D 
dimension, % (SE)
Dimensions of SF-36 questionnaire, 
mean (SE)
M SC UA P/D A/D PF RP BP GH VT SF RE MH
Herniated disc 
(spine) 
368 29.9 
(1.9) 
8.1 
(1.1)
36.6 
(2.2)
65.3 
(2.7)
27.7 
(2.1)
73.2 
(1.1)
65.8 
(2.0)
67.3 
(1.3)
62.9 
(1.1)
61.4 
(1.1)
77.7 
(1.2)
82.6 
(1.7)
73.2 
(0.9)
Gout   138 31.9 
(3.5) 
3.6 
(1.9)
32.8 
(4.0)
59.2 
(4.7)
22.8 
(3.8)
75.6 
(2.0)
68.1 
(3.6)
70.2 
(2.2)
64.7 
(1.9)
60.8 
(1.9)
79.1 
(2.2)
78.7 
(3.0)
73.2 
(1.7)
RSI 63 27.7 
(4.3) 
7.4 
(2.3)
44.4 
(4.9)
78.7 
(5.8)
23.3 
(4.7)
73.5 
(2.5)
65.1 
(4.4)
64.5 
(2.7)
64.9 
(2.3)
60.2 
(2.4)
79.2 
(2.7)
82.7 
(3.7)
72.8 
(2.0)
Epicondylitis  418 21.5 
(1.8) 
3.7 
(1.0) 
32.0 
(2.1) 
54.0 
(2.5) 
21.3 
(2.0)
80.5 
(1.1)
68.1 
(1.9)
71.0 
(1.2)
67.8 
(1.0)
63.1 
(1.0)
82.4 
(1.1)
82.8 
(1.6)
75.1 
(0.9)
Osteoarthritis of 
knee 
547 44.1 
(1.7) 
10.0 
(1.0) 
40.9 
(2.0) 
71.1 
(2.4) 
28.3 
(1.9)
67.6 
(1.0)
61.0 
(1.9)
62.7 
(1.1)
60.1 
(1.0)
58.8 
(1.0)
75.7 
(1.1)
80.4 
(1.6)
72.0 
(0.9)
Osteoarthritis 
of hip 
354 56.3 
(2.3) 
14.8 
(1.3) 
51.9 
(2.7) 
76.6 
(3.2) 
26.8 
(2.6)
62.4 
(1.4)
52.8 
(2.5)
59.1 
(1.5)
60.0 
(1.3)
56.8 
(1.3)
73.2 
(1.5)
80.5 
(2.1)
73.5 
(1.2)
Osteoporosis 280 41.3 
(2.5) 
16.1 
(1.4) 
49.3 
(2.9) 
72.3 
(3.4) 
30.3 
(2.7)
64.3 
(1.4)
55.9 
(2.6)
60.9 
(1.6)
58.6 
(1.3)
56.7 
(1.4)
69.8 
(1.6)
77.2 
(2.2)
68.9 
(1.2)
Whiplash 79 20.1 
(4.1) 
6.1 
(2.2) 
41.0 
(4.6) 
71.3 
(5.5) 
24.2 
(4.4)
72.3 
(2.3)
57.6 
(4.2)
62.7 
(2.6)
63.0 
(2.2)
58.3 
(2.3)
77.3 
(2.5)
78.0 
(3.5)
72.3 
(1.9)
Rheumatoid 
arthritis 
156 52.1 
(3.3) 
15.6 
(1.9) 
54.3 
(3.8) 
80.6 
(4.6) 
28.5 
(3.7)
62.3 
(2.0)
49.0 
(3.5)
58.0 
(2.2)
52.1 
(1.8)
52.2 
(1.9)
70.3 
(2.1)
72.3 
(3.0)
69.2 
(1.6)
Other chronic 
arthritis 
155 42.5 
(3.3) 
16.3 
(1.8) 
49.8 
(3.8) 
78.1 
(4.4) 
33.1 
(3.6)
65.0 
(1.9)
54.7 
(3.4)
57.3 
(2.1)
53.3 
(1.8)
54.5 
(1.8)
69.9 
(2.0)
74.1 
(2.8)
70.7 
(1.6)
Fibromyalgia 43 66.7 
(5.5) 
12.3 
(3.0) 
73.8 
(6.3) 
93.1 
(7.6) 
4.17 
(6.1)
55.0 
(3.2)
41.4 
(5.8)
48.2 
(3.6)
50.1 
(3.0)
39.9 
(3.1)
60.3 
(3.4)
81.5 
(4.8)
64.1 
(2.6)
Tendinitis and
capsulitis 
587 29.5 
(1.5) 
6.6 
(0.8) 
37.7 
(1.7) 
65.1 
(2.0) 
22.7 
(1.6)
75.3 
(0.8)
62.9 
(1.5)
66.2 
(0.9)
63.1 
(0.8)
60.5 
(0.8)
79.4 
(0.9)
83.4 
(1.3)
73.8 
(0.7)
One MSD 957 22.7 
(1.1) 
4.5 
(0.6) 
26.3 
(1.3) 
53.3 
(1.5) 
20.4 
(1.3)
80.0 
(0.6)
74.3 
(1.2)
73.8 
(0.7)
67.7 
(0.6)
64.6 
(0.6)
83.2 
(0.7)
86.7 
(1.0)
76.0 
(0.6)
Two MSD 478 33.1 
(1.7) 
6.5 
(1.0) 
39.8 
(1.9) 
71.1 
(2.3) 
23.6 
(1.9)
72.7 
(1.0)
63.0 
(1.8)
65.5 
(1.0)
64.0 
(0.9)
60.2 
(1.0)
79.6 
(1.1)
84.0 
(1.5)
73.8 
(0.8)
Three MSD 193 49.0 
(2.8) 
12.3 
(1.6) 
52.2 
(3.2) 
82.2 
(3.8) 
30.3 
(3.2)
63.4 
(1.6)
53.2 
(3.0)
57.0 
(1.8)
55.8 
(1.6)
56.0 
(1.6)
69.1 
(1.8)
76.0 
(2.6)
69.9 
(1.4)
Four or more 
MSD 
148 57.2 
(3.2) 
19.7 
(1.9) 
66.7 
(3.7) 
85.8 
(4.4) 
39.1 
(3.7)
56.2 
(1.8)
34.9 
(3.3)
47.1 
(2.0)
50.2 
(1.8)
47.8 
(1.8)
63.9 
(2.1)
66.0 
(2.9)
65.8 
(1.6)
Any MSD 1776 29.9 
(0.9) 
6.6 
(0.5) 
34.5 
(1.0) 
62.5 
(1.2) 
23.3 
(1.0)
75.2 
(0.5)
67.1 
(0.9)
68.5 
(0.6)
64.6 
(0.5)
61.6 
(0.5)
79.8 
(0.6)
83.7 
(0.8)
74.3 
(0.4)
No MSD 1888 10.5 
(0.8) 
2.3 
(0.4) 
12.4 
(0.9) 
31.2 
(1.1) 
14.8 
(0.9)
87.8 
(0.5)
85.8 
(0.8)
84.1 
(0.5)
72.8 
(0.4)
69.3 
(0.5)
87.6 
(0.5)
89.8 
(0.8)
79.7 
(0.4)
M, mobility; SC, self care; UA, usual activities; P/D, pain/discomfort; A/D, anxiety/depression; PF, physical functioning; 
RP, role function physical aspect; BP, bodily pain; GH, general; health; VT, vitality; SF, social functioning; RE, role 
function emotional aspect; MH, mental health; MSD, musculoskeletal disease, RSI, repetitive strain injury
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Q12b. In the 
Netherlands what is the 
impact of chronic pain 
on activities of daily 
living?
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We located four studies that were relevant to this question (Huisstede et al. 2008, Picavet and Schouten 2003, 
Rupp et al. 2006 ScanJRheumatol, Rupp et al. 2006 J Rheumatol).
Huisstede et al. 2008 and Picavet and Schouten 2003 were based on DMC3 population survey data with 3664 
respondents. Huisstede et al. 2008 aimed to study the prevalence of upper extremity disorders(UEDs) and neck 
as a total and complaints of the arm, neck and/or shoulder (CANS) not caused by acute trauma or any systemic 
disease as defined in the CANS model in the open population and to assess sociodemographic and health 
characteristics of chronic symptoms. The aim of Picavet and Schouten 2003 study was to present estimates on 
the prevalence of musculoskeletal pain of five different anatomical areas and ten anatomical sites, and their 
consequences and risk groups in the general Dutch population.
Rupp et al. 2006 ScanJRheumatol and Rupp et al. 2006 J Rheumatol were based on a longitudinal study in 
patients with rheumatoid arthritis (RA). Rupp et al. 2006 ScanJRheumatol aimed to study the associations 
between disability and health-related quality of life, and radiographic joint damage, disease activity, pain, and 
depressive symptoms among 307 patients with RA while Rupp et al. 2006 J Rheumatol aimed to assess the 
predictive value of selected socio-demographic characteristics, RA-specific clinical factors, and comorbidity with 
respect to patient-reported health outcomes, i.e., pain, disability, and health-related quality of life, among 882 
patients with RA.
Table 23. Characteristics of the study selected for question 12b
Study details Population Outcomes and analysis
Huisstede et al. 2008
Study design
Cross-sectional/ survey
Study method
DMC3 study - national 
health survey of 
musculoskeletal 
conditions; postal 
questionnaire – with 
general questions and 
health questions. After 
screening question for 
each of 5 anatomical 
areas
Additional questions 
regarding pain in 
this area and its 
consequences; general 
health was measured 
using the Short 
Form(SF)-36
Type of chronic pain
Upper extremity disorders (UED) and neck pain; 
complaints of the arm, neck and/or shoulder (CANS; 
excluding UED caused by an acute trauma or a 
systemic disease) 
Confirmation of diagnosis
NR; only screening question: ‘‘did you have pain in 
‘anatomic area’ during the past 12 months?’’ 
Sample size and demographics
3664 respondents 
25–44 years 47.0%, 
45–64 years 34.6%, 
65+ years 18.4% 
Female 50.9%
chronic UED 996
chronic UED due to systemic disease or acute  
trauma 299
chronic CANS 697
Patient selection
DMC3 - Dutch population aged 25 years and above; 
this study - persons with musculoskeletal upper 
extremity and neck disorders in 4 anatomic sites: 
neck, shoulder, elbow, and wrist/hand
Outcomes measured
12-month prevalence, point prevalence, and 
prevalence of chronic pain (pain at baseline and 
lasting more than 3months in the last 12 months)
course of pain, consequences of pain (contact 
with general practitioner, medical specialist or 
physiotherapist, work leave, limitations in daily life), 
general health
Pain severity
self-reported - severe or mild 
chronic total UED 
Continuous severe pain 5.4% 
Recurrent severe pain 12.7% 
Chronic CANS
Continuous severe pain 3.9% 
Recurrent severe pain 12.8% 
Analyses
Descriptive analysis only
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Study details Population Outcomes and analysis
Picavet and Schouten 
2003
Study design
Cross-sectional study
Study method
DMC3 study - national 
health survey of 
musculoskeletal 
conditions; postal 
questionnaire – with 
general questions and 
health questions. After 
screening question for 
each of 5 anatomical 
areas
Additional questions 
regarding pain in 
this area and its 
consequences; 
socio-demographic 
characteristics 
Type of chronic pain
Neck, shoulder, higher back 44.5%
Elbow, wrist/hand 23.2%
Lower back 43.9% 
Hip, knee 28%
Ankle, foot 14.9%
Confirmation of diagnosis
NR; only screening question: ‘‘did you have pain in 
‘anatomic area’ during the past 12 months?’’ 
Sample size and demographics
Total sample: 3664 respondents 
weighted to present a distribution of sex, age, 
marital status and region of living equal to that of 
the Netherlands in 1998:
Sex
men 49.1%
women 50.9%
Age group
25-44 47.0%
45-64 34.6%
65+ 18.4%
Patient selection
Dutch inhabitants of 25 years and older 
Outcomes measured
Musculoskeletal pain period prevalence, point 
prevalence, prevalence of chronic pain, course of 
pain, consequences of pain (contact with general 
practitioner, medical specialist or physiotherapist, use 
of medicines, work leave, limitations in daily life, and 
work disability)
Pain severity
self-reported - severe or mild 
roughly 15% severe pain
Neck, shoulder or higher back
Continuous severe pain 3.1%
recurrent severe pain 8.3%
Elbow or wrist/hand
Continuous severe pain 4.0%
recurrent severe pain 11.0%
Lower back
Continuous severe pain 3.5%
recurrent severe pain 15.4%
Hip or knee
Continuous severe pain 5.2%
recurrent severe pain 10.1%
Ankle or foot
Continuous severe pain 6.1%
recurrent severe pain 12.4%
Analyses
descriptive, frequencies, multivariate logistic 
regression
Rupp et al. 2006 
ScanJRheumatol
Study design
longitudinal / cohort 
study
Study method
a self-administered postal 
questionnaire and a 
short clinical assessment 
(Disease Activity Score 
DAS28), the erythrocyte 
sedimentation rate (ESR), 
radiographic progression, 
RA related pain, 
depressive symptoms, 
disability, comorbidity, 
HRQoL; Information 
on disease duration 
abstracted from the 
patients’ files
Type of chronic pain
Rheumatoid arthritis
Confirmation of diagnosis
RA according to the 1987 revised American College 
of Rheumatology (ACR) criteria 
Sample size and demographics
Baseline n = 330, follow up: n = 307
Mean age 58.1 yrs [SD13.4]; Median age 59.6 yrs 
[IQR 49.1; 68.9] 
Female 71%
Patient selection
patients registered at an outpatient centre for 
rheumatology and rehabilitation in Amsterdam or 
at one of its affiliated outpatient clinics, randomly 
selected based on disease duration. Inclusion
criteria: RA according to the 1987 revised American 
College of Rheumatology (ACR) criteria, age >16 
years, sufficient command of the Dutch language 
and valid radiographs and 28-joint-count available 
for baseline and follow up
Outcomes measured
RA related pain on VAS, depressive symptoms (a 
Dutch version of the Centre for Epidemiological 
Study–Depression Scale (CES-D)), disease impact 
- disability (the validated Dutch questionnaire 
capacities of daily life (VDF)), comorbidity, HRQoL 
(a validated Dutch version of the RAND-36), 
radiographic damage (modified Sharp/ van der 
Heijde method), disease activity (DAS 28)
Pain severity
VAS 0–100 mm
Pain (VAS; 0–100)
baseline mean 36.8 [SD 26.1], median 32.0 
[IQR15.0; 56.0] follow up mean 34.5 [SDS 26.4], 
median 28.5 [IQR 11.0; 56.0]
Analyses
Multivariate linear regression analyses (cross-
sectional approach and longitudinal approach)
Epidemiology of chronic pain in the Netherlands - Q12b
116
Study details Population Outcomes and analysis
Rupp et al. 2006 
JRheumatol
Study design
longitudinal / cohort 
study
Study method
a self-administered 
postal questionnaire and 
twice a short clinical 
assessment (Disease 
Activity Score DAS28) 
and the erythrocyte 
sedimentation rate (ESR); 
RA related pain, somatic 
and psychological 
comorbidity (depressive 
symptoms), disability, 
HRQoL; Information on 
disease duration and RF 
positivity abstracted from 
the patients’ files
Type of chronic pain
Rheumatoid arthritis
Confirmation of diagnosis
RA according to the 1987 revised American College 
of Rheumatology (ACR) criteria 
Sample size and demographics
Baseline n = 882, follow up: n = 529
Mean age 59.8 (SD 14.8) 
Female 71.9%
Patient selection
patients registered at an outpatient centre for 
rheumatology and rehabilitation in Amsterdam or 
at one of its affiliated outpatient clinics, randomly 
selected based on disease duration. Inclusion
criteria: RA according to the 1987 revised American 
College of Rheumatology (ACR) criteria, age >16 
years, sufficient command of the Dutch language to 
complete the questionnaire
Outcomes measured
RA related pain on VAS, disability (the validated 
Dutch questionnaire capacities of daily life (VDF)), 
somatic comorbidity (a self-report list, adapted from 
the Health Interview Survey of Statistics Netherlands), 
HRQoL (a validated Dutch version of the RAND-36), 
disease activity (DAS 28), psychological comorbidity 
(depressive symptoms (a Dutch version of the Centre 
for Epidemiological Study–Depression Scale (CES-D))
Pain severity
VAS 0–100 mm
mean 40.6 (SD 28.1)
Analyses
mixed-effect modeling procedure ProcMixed of SAS 
using random intercept linear regression models; 
univariate analyses (Student t tests and chi-square 
tests), multivariate logistic regression analyses; 
odds ratios (OR) of the logistic regression model, 
with 95% confidence intervals (95% CI). OR were 
adjusted for all other variables in the model
Q12b. Study quality
The quality of Huisstede et al. 2008 study was rated as moderate, it was unclear that the population was 
representative and the statistical methods were not clearly described and the results were not reported as 
unadjusted and confounder-adjusted including precision and there was no adequate description of the 
eligibility criteria. 
Picavet and Schouten 2003 study was rated as high quality; only one item was missing – the authors did not 
provide adequate description of eligibility criteria.
The quality of Rupp et al. 2006 ScanJRheumatol study was rated as moderate. it was unclear that the 
population was representative and the statistical methods were not clearly described. 
Rupp et al. 2006 JRheumatol study quality was rated as moderate. Loss to follow up was more than 25% for 5 
years of follow up and as compared with those who did no respond the participants had higher HRQol values, 
less disability,, they were younger and had overall a more favorable socioeconomic status, but they did not 
differ with respect to gender. 
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Q12b. Results
Musculoskeletal pain
Huisstede et al. 2008
Among people with chronic upper extremity and neck complaints (UED) 38.3% reported limitation in daily life 
due to their pain complaints in the last year. In the subgroup of people with chronic upper extremity and neck 
complaints due to systemic disease or acute trauma more than half (52.9%) reported limitation in daily life due 
to their complaints in the last year. 
Among people with complaints of the arm, neck and/or shoulder (CANS) not caused by acute trauma or any 
systemic disease about one third (32.1%) reported limitation in daily life due to their complaints in the last 
year. In the subgroup of patients with CANS who were using healthcare the percentage was 48.9 and in those 
not using healthcare it was 8.5. The figure below presents percentage with limitation in daily life to patients in 
complaints in the subgroups and according to its length. 
limitation in daily life
0 10 20 30 40 50
limitation in
daily life
total  chronic UED
chronic CANS due to acute
trauma or systemic disease
chronic CANS
chronic CANS HC users
chronic CANS nonHC users
Figure 16. Limitation in daily life in the last year due to their complaints among participants with upper 
extremity and neck complaints and subgroups (CANS – complaints of the arm, neck and/or shoulder not 
caused by acute trauma or any systemic disease, HC – healthcare, UED – chronic upper extremity and neck 
complaints)
Picavet and Schouten 2003
Roughly 30% reported limitation in daily life in the last year due to their musculoskeletal pain. Figure presents 
the results according to different locations. 
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Figure 17. Limitation in daily life in the last year among participants with musculoskeletal pain complaints by 
location 
Rheumatoid arthritis
Rupp et al. 2006 ScanJRheumatol
Disability was measured with the validated Dutch questionnaire capacities of daily life (VDF) which consists of 
20 items measuring the degree of difficulty a patient has in performing activities of daily living (ADL) in eight 
areas (dressing and grooming, arising, eating, walking, hygiene, gripping, reaching, and other activities). Scores 
0–3, with higher scores indicating more disability.
Mean values at baseline were 0.46 (SD 0.48) and at follow up 0.56 (SD 0.56) and median values were at 
baseline 0.3 (IQR 0.05, 0.7) and at follow up 0.4 (IQR 0.1, 0.9).
In cross-sectional approach pain was the most important predictor for disability (regression coefficient B 0.007 
[95% CI 0.005; 0.009]; standardized b = 0.359; p<0.001). For depressive symptoms (regression coefficient 
B 0.013 [95% CI 0.008; 0.019]; p<0.001) and radiographic damage (regression coefficient B 0.002 [95% CI 
0.001; 0.003]; p<0.001) and disease activity (regression coefficient B 0.081 [95% CI 0.046; 0.116]; p<0.001) 
statistically significant associations were found. Depressive symptoms were slightly more important than 
radiographic damage (standardized b 0.232 vs 0.216) and disease activity showed a stronger association 
than radiographic damage with disability (standardized b 0.236 vs 0.216). Age, gender, disease duration, 
comorbidity, were not significantly related to disability. 
In longitudinal approach change in pain was the most important predictor for changes in disability (regression 
coefficient B –0.005 [95% CI –0.006; –0.003]; standardized b = –0.330;p<0.001). Progression in radiographic 
joint damage (regression coefficient B –0.003 [95% CI –0.005; –0.000]; p <0.05) and change in disease activity 
(regression coefficient B –0.060 [95% CI –0.093; –0.026]; p<0.001) were also significantly associated with 
change in disability. Change in disease activity had a stronger association than radiographic progression with 
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changes in disability (standardized b –0.195 vs –0.135). Age, gender, disease duration, comorbidity and change 
in depressive symptoms were not statistically significantly associated with change in disability.
Rupp et al. 2006 JRheumatol
Disability was measured with the validated Dutch questionnaire capacities of daily life (VDF) which consists of 
20 items measuring the degree of difficulty a patient has in performing activities of daily living (ADL) in eight 
areas (dressing and grooming, arising, eating, walking, hygiene, gripping, reaching, and other activities). Scores 
0–3, with higher scores indicating more disability.
Mean values at baseline were 0.66 (SD 0.62).
The authors divided patients into showing much poorer health outcomes (10% poorest) and much better 
outcomes (10% best). With respect to disability “poorest outcomes patients” were, in comparison to “best 
outcomes patients,” more often women (85.2% vs 56.8%), they were older (67.7 years vs 61.6 years), had low 
SES (47.1% vs 21.%), had paid work less often (1.2% vs 23.9%), and were more often divorced or widowed 
(40.7% vs 15.9%). Further, they were positive for RF (73.9% vs 58.6%), had a higher disease activity assessment 
(4.6 vs 2.9), they reported more somatic (1.9 vs 0.8) and psychological comorbidity (20.6 vs 7.7).
Risk factors for poor outcome with respect to disability were : female sex (OR 2.2 [95% CI 1.1–4.5]; p<0.05) 
and older age (OR 1.3 [95% CI 1.1–1.6]; p<0.05), RF positivity (OR 2.0 [95% CI 1.1–3.5]; p<0.05) and 
disease activity (OR 1.7 [95% CI 1.3–2.3]; p<0.001) as well as somatic (OR 1.2 [95% CI 1.0–1.5]; p<0.05) and 
psychological comorbidity (OR 1.1 [95% CI 1.1–1.1]; p<0.001).
Disease activity (OR 0.7 [95% CI 0.6–0.8]; p<0.01) and psychological comorbidity (OR 0.9 [95% CI 0.9–1.0]; 
p<0.001) hampered good outcomes with respect to disability.
Q12b. Summary
The four included studies reported on prevalence of limitation in daily life due to pain or associations between 
socio-demographic characteristics or disease characteristics and disability in rheumatoid arthritis. In patients 
with musculoskeletal pain limitation in daily life were reported by 8.5–53% of patients. In patients with 
rheumatoid arthritis pain was the most important predictor for disability, significant associations were also 
found for depressive symptoms, radiographic damage and disease activity. Female sex, older age, RF positivity, 
disease activity and somatic and psychological co-morbidties were found to be risk factors for poor outcome 
with respect to disability. 
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Q12c. In the 
Netherlands what is 
the impact of chronic 
pain on depression and 
other mental illnesses?
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We located four studies that were relevant to this question (Breivik et al. 2006, Demyttenaere et al. 2007 and 
Rupp et al. 2006 ScanJRheumatol, Rupp et al. 2006 J Rheumatol).
Breivik et al. (2006) performed a large telephone survey to explore the prevalence, impact on daily life and 
treatment of chronic pain in 15 European countries and Israel, among which the Netherlands. Persons received 
an initial screening questionnaire and those who suffered from long-lasting pain were subsequently interviewed 
in-depth using a second structured questionnaire. From the Netherlands, 300 persons suffering chronic pain 
were interviewed. 
Demyttenaere et al. 2007 aimed to estimate the prevalence of 12-month chronic back or neck pain in the 
general population of 85 088 participants in 17 countries in Europe, the Americas, the Middle East, Africa, Asia, 
and the South Pacific and to estimate the occurrence of specific 12-month mood, anxiety disorders, and alcohol 
abuse/dependence among persons with chronic back or neck pain as well as to investigate which mental 
disorders were most strongly associated with chronic back or neck pain and to assess the consistency of the 
associations between chronic back or neck pain and mental disorders. 
Rupp et al. 2006 ScanJRheumatol and Rupp et al. 2006 J Rheumatol are based on a longitudinal study in 
patients with rheumatoid arthritis (RA). Rupp et al. 2006 ScanJRheumatol aimed to study the associations 
between disability and health-related quality of life, and radiographic joint damage, disease activity, pain, and 
depressive symptoms among 307 patients with RA while Rupp et al. 2006 J Rheumatol aimed to assess the 
predictive value of selected socio-demographic characteristics, RA-specific clinical factors, and comorbidity with 
respect to patient-reported health outcomes, i.e., pain, disability, and health-related quality of life, among 882 
patients with RA.
Q12c - Epidemiology of chronic pain in the Netherlands
123
Table 24. Characteristics of the study selected for question 12c
Study details Population Outcomes and analysis
Breivik et al. 2006
Study design
Cross-sectional study
Study method
Telephone survey in two 
parts. First, persons were 
screened for chronic 
pain. Those who qualified 
were interviewed in-
depth
Type of chronic pain
Long-lasting pain: chronic pain for at least 6 months, 
and pain in last month, and pain at least 2 times/
week, and rating pain intensity at least 5 on 10-point 
NRS
Confirmation of diagnosis
Not reported
Sample size and demographics
Total sample: 4839; Netherlands: 300 persons with 
long-lasting pain
Demographics for all countries together: 52% female 
mean age 50 years
For the Netherlands: female 60%, mean age 51.3 
years
Patient selection
Subjects with long-lasting pain (see definition above).
Outcomes measured
Duration, location, intensity of pain
Tolerance, time course of pain, impact pain on 
activities daily life, employment status, emotional 
status
Visits to doctors, visits to pain management 
specialist, treatment (medication and non-
medication), effectiveness of treatment, satisfaction 
with doctors, respondents’ attitudes and beliefs 
about pain and pain treatment, respondents’ 
perception of the attitude of others to their pain
Pain severity
18% reported severe pain
Analyses
Descriptive analysis only. No subgroups were 
reported (for the Netherlands)
Demyttenaere et al. 
2007
Study design
Population surveys of 
community-dwelling 
adults in 17 countries in 
Europe, the Americas, 
the Middle East, Africa, 
Asia, and the South 
Pacific (N = 85,088)
Study method
Face-to-face survey with 
questions about chronic 
conditions adapted from 
the US Health Interview 
Survey (National Center 
for Health Statistics, 
1994)
Type of chronic pain
Back or neck pain
Confirmation of diagnosis
Not reported
Sample size and demographics
Netherlands sample n=1094
Mean age 45.0
Female 50.9%
Selection
All respondents who met criteria for any mental 
disorder and a probability sample of other 
respondents were administered part-2 (assessment 
of chronic physical conditions)
Outcomes measured
The 12-month prevalence of either back or neck pain
The prevalence of mental disorders among people 
with chronic back/neck pain
Analyses
Odds ratios (OR) for the association of each mental 
disorder with the pain condition were estimated for 
each survey. Adjusted ORs were estimated to assess 
the association of any mood disorder, any anxiety, 
and any alcohol abuse/ dependence with back or 
neck pain
Pain severity
Not reported
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Study details Population Outcomes and analysis
Rupp et al. 2006 
ScanJRheumatol
Study design
longitudinal / cohort 
study
Study method
a self-administered postal 
questionnaire and a 
short clinical assessment 
(Disease Activity Score 
DAS28), the erythrocyte 
sedimentation rate (ESR), 
radiographic progression, 
RA related pain, 
depressive symptoms, 
disability, comorbidity, 
HRQoL; Information 
on disease duration 
abstracted from the 
patients’ files
Type of chronic pain
Rheumatoid arthritis
Confirmation of diagnosis
RA according to the 1987 revised American College 
of Rheumatology (ACR) criteria 
Sample size and demographics
Baseline n = 330, follow up: n = 307
Mean age 58.1 yrs [SD13.4]; Median age 59.6 yrs 
[IQR 49.1; 68.9] 
Female 71%
Patient selection
patients registered at an outpatient centre for 
rheumatology and rehabilitation in Amsterdam or 
at one of its affiliated outpatient clinics, randomly 
selected based on disease duration. Inclusion
criteria: RA according to the 1987 revised American 
College of Rheumatology (ACR) criteria, age >16 
years, sufficient command of the Dutch language 
and valid radiographs and 28-joint-count available 
for baseline and follow up
Outcomes measured
RA related pain on VAS, depressive symptoms (a 
Dutch version of the Centre for Epidemiological 
Study–Depression Scale (CES-D)), disease impact 
- disability (the validated Dutch questionnaire 
capacities of daily life (VDF)), comorbidity, HRQoL 
(a validated Dutch version of the RAND-36), 
radiographic damage (modified Sharp/ van der 
Heijde method), disease activity (DAS 28)
Pain severity
VAS 0–100 mm
Pain (VAS; 0–100)
baseline mean 36.8 [SD 26.1], median 32.0 
[IQR15.0; 56.0] follow up mean 34.5 [SDS 26.4], 
median 28.5 [IQR 11.0; 56.0]
Analyses
Multivariate linear regression analyses (cross-
sectional approach and longitudinal approach)
Rupp et al. 2006 
JRheumatol
Study design
longitudinal / cohort 
study
Study method
a self-administered 
postal questionnaire and 
twice a short clinical 
assessment (Disease 
Activity Score DAS28) 
and the erythrocyte 
sedimentation rate (ESR); 
RA related pain, somatic 
and psychological 
comorbidity (depressive 
symptoms), disability, 
HRQoL; Information on 
disease duration and RF 
positivity abstracted from 
the patients’ files
Type of chronic pain
Rheumatoid arthritis
Confirmation of diagnosis
RA according to the 1987 revised American College 
of Rheumatology (ACR) criteria 
Sample size and demographics
Baseline n = 882, follow up: n = 529
Mean age 59.8 (SD 14.8) 
Female 71.9%
Patient selection
patients registered at an outpatient centre for 
rheumatology and rehabilitation in Amsterdam or 
at one of its affiliated outpatient clinics, randomly 
selected based on disease duration. Inclusion
criteria: RA according to the 1987 revised American 
College of Rheumatology (ACR) criteria, age >16 
years, sufficient command of the Dutch language to 
complete the questionnaire
Outcomes measured
RA related pain on VAS, disability (the validated 
Dutch questionnaire capacities of daily life (VDF)), 
somatic comorbidity (a self-report list, adapted from 
the Health Interview Survey of Statistics Netherlands), 
HRQoL (a validated Dutch version of the RAND-36), 
disease activity (DAS 28), psychological comorbidity 
(depressive symptoms (a Dutch version of the Centre 
for Epidemiological Study–Depression Scale (CES-D))
Pain severity
VAS 0–100 mm
mean 40.6 (SD 28.1)
Analyses
mixed-effect modeling procedure ProcMixed of SAS 
using random intercept linear regression models; 
univariate analyses (Student t tests and chi-square 
tests), multivariate logistic regression analyses; 
odds ratios (OR) of the logistic regression model, 
with 95% confidence intervals (95% CI). OR were 
adjusted for all other variables in the model
Q12c - Epidemiology of chronic pain in the Netherlands
125
Q12c. Study quality
The quality of the Breivik et al. 2006 study, Demyttenaere et al. 2007 study and Rupp et al. 2006 
ScanJRheumatol study was rated as moderate. In all studies it was unclear that the population was 
representative, in the Breivik and Rupp study the statistical methods were not clearly described, in 
Demyttenaere study the eligibility criteria were not clearly described. 
Rupp et al. 2006 JRheumatol study quality was rated as moderate. Loss to follow up was more than 25% for  
5 years of follow up and as compared with those who did not respond the participants had higher HRQol 
values, less disability, they were younger and had overall a more favorable socioeconomic status, but they did 
not differ with respect to gender. 
Q12c. Results
General chronic pain
Breivik et al. 2006
Among 294 of Dutch respondents 19% reported being diagnosed with depression by a medical doctor as a 
results of their pain, while the European average was 21%. 
Back/neck pain
Demyttenaere et al. 2007
Prevalence of mood disorders among persons with versus without back/neck pain:
Major depressive episode: 4.4% no back or neck pain; 9.4% back or neck pain; OR 2.3 (1.5, 3.6)
Dysthymia: 1.2% no back or neck pain; 4.5% back or neck pain; OR 4.2 (1.8, 9.7).
Prevalence (%) of anxiety disorders among persons with versus without back/neck pain: 
Generalized anxiety disorder: 0.8% no back or neck pain; 2.1% back or neck pain; OR 2.8 (1.0, 7.7)
Agoraphobia or Panic disorder: 1.7% no back or neck pain; 1.7% back or neck pain; OR 1.0 (0.4, 2.6)
Social Phobia: 1.0% no back or neck pain; 2.4% back or neck pain; OR 2.5 (0.8, 7.7)
Posttraumatic stress disorder: 1.4% no back or neck pain; 7.4% back or neck pain; OR 4.4 (1.5, 13.3).
Prevalence (%) of alcohol abuse/dependence disorders among persons with versus without back/neck pain: 
1.7% no back or neck pain; 1.7% back or neck pain; OR 1.3 (0.5, 3.2).
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Figure 18. Prevalence of mental illnesses in patients with back or neck pain (GAD – generalised anxiety 
disorder, PTSD – posttraumatic stress disorder) 
Rheumatoid arthritis
Rupp et al. 2006 ScanJRheumatol
Depressive symptoms were assessed by Centre for Epidemiological Study-Depression Scale (CES-D; Scores  
0 to 60, with higher scores indicating more depressive symptomatology). Mean values at baseline were 10.3 
(SD 8.2) and at follow up 10.5 (SD 7.9) and median values were at baseline 9.0 (IQR 4, 14) and at follow up 
10.0 (IQR 4, 14.4).
Mental component of quality of life was assessed with the use of mental component summary (MCS) scale 
from RAND-36 (Higher scores indicate better health status). Mean values at baseline were 50.9 (SD 10.6) and 
at follow up 50.0 (SD 10.1). Median values were at baseline 54.2 (IQR 44.8, 58.6) and at follow up 53.0 (IQR 
43.2, 57.7).
In cross sectional approach depressive symptoms appeared to be the most important predictor for mental 
health (MCS) (regression coefficient B –0.895 [ 95% CI –1.006; –0.784]; p<0.001). Depressive symptoms 
were also significantly related to disability (regression coefficient B 0.013 [95% CI 0.008; 0.019]; p<0.001) 
and slightly more important than radiographic damage. Depressive symptoms were not significantly related to 
physical component summary scale of RAND-36. A statistically significant association between radiographic 
damage and MCS was found (regression coefficient B 0.034 [95% CI 0.015; 0.053]; p<0.001). Age, gender, 
disease duration, comorbidity, disease activity and pain were not significantly related to MCS. 
In longitudinal approach change in depressive symptoms was the most important predictor for change 
in mental health (MCS) (regression coefficient B –0.781 [95% CI –0.964; –0.599]; p<0.001), but was not 
statistically significantly associated with change in disability and physical component summary scale of  
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RAND-36. Age, gender, disease duration, comorbidity, disease activity, pain and progression in radiographic 
joint damage were not significantly associated with change in MCS.
Rupp et al. 2006 JRheumatol
Psychological comorbidity (depressive symptoms) was assessed by Centre for Epidemiological Study-Depression 
Scale (CES-D; Scores 0 to 60, with higher scores indicating more depressive symptomatology). Mean values 
at baseline were 12.3 (SD 9.2). Mental component of quality of life was assessed with the use of mental 
component summary (MCS) scale from RAND-36 (Higher scores indicate better health status). Mean values at 
baseline were 49.2 (SD 11.4).
The authors divided patients into showing much poorer health outcomes (10% poorest) and much better 
outcomes (10% best). “Poorest outcomes patients” reported more psychological comorbidity than “best 
outcomes patients” (19–27 vs 4–8; all p <0.001). With respect to MCS “poorest outcomes patients, in 
comparison to “best outcomes patients” had low SES (31% vs 20.5%), less often had paid work (5.7% vs 
21.6%), more often were divorced or widowed (32.2% vs 15.9%), reported more somatic (1. vs 0.9) and 
psychological comorbidity (27.4 vs 4.4). 
Disease activity seemed to decrease the risk of poor mental health as measured by MCS (OR 0.6 [95%  
CI 0.4–0.8]; p < 0.001). Psychological comorbidity consistently increased the risk for poor outcomes with 
respect to pain (OR 1.1 [95% CI 1.1–1.1]; p < 0.001), disability (OR 1.1 [95% CI 1.1–1.1]; p < 0.001), physical 
component summary scale (OR 1.1 [95% CI 1.0–1.1]; p < 0.001) and MCS (OR 1.3 [95% CI 1.2–1.4];  
p < 0.001).
Medium SES hampered good mental health as measured by MCS (OR 0.5 [95% CI 0.2–0.9]; p < 0.05). 
Somatic appeared to be associated with good outcome of MCS (OR 1.3 [95% CI 1.0–1.7]; p < 0.05). 
Psychological comorbidity hampered good outcomes with respect to pain (OR 0.9 [95% CI 0.8–0.9];  
p < 0.001), disability(OR 0.9 [95% CI 0.9–1.0]; p < 0.001 ), PCS (OR 0.9 [95% CI 0.8–0.9]; p < 0.001),  
and MCS (OR 0.7 [95% CI 0.7–0.9]; p < 0.001 ).
Q12c. Summary
The three included studies reported on prevalence of depressive symptoms or associations between 
disability and health-related quality of life rheumatoid arthritis radiographic joint damage, disease activity, 
pain, and depressive symptoms. In general pain condition depression was reported in 19% of respondents, 
in patients with back or neck pain mood disorders were reported by 4.5–9.4% (major depressive disorder 
was reported by the highest percentage of respondents) of pain sufferers, anxiety disorders by 1.7–7.4% of 
respondents and alcohol abuse by 1.7%. In patients with rheumatoid arthritis depressive symptoms appeared 
to be the most important predictor for mental health and were significantly related to disability. Psychological 
comorbidity (depressive symptoms) was also a risk factor for poor outcomes and to hamper good outcomes 
with respect to all health outcomes (pain, disability, physical component summary scale and mental component 
summary scale).
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Q12d. In the 
Netherlands what is 
the impact of chronic 
pain on isolation and 
helplessness?
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We found two studies that were relevant to this question: EURIDISS (Suurmeijer et al 2001, Strating 2006) on 
social support and Samwell et al (2006) on helplessness.
European Research on Incapacitating Disease and Social Support (EURIDISS) is a multicenter, multidisciplinary 
longitudinal European study set up to explore the relationships between “disease variables,” “social support,” 
and a number of quality of life (QoL) measures among patients with early rheumatoid arthritis (RA). Suurmeijer 
et al (2001) examined the QoL profiles of these patients and related these to disease and impairment variables 
as indicated, respectively, by erythrocyte sedimentation rate (ESR) and by tender joint count (Ritchie Articular 
Index), fatigue, and pain. Strating et al (2006) examined the strength and stability of the relationships between 
disease-related factors (joint tenderness, pain, and functional disability), social support, and distress over time.
Samwel et al. (2006) performed a cross-section study to examine the relative contribution of helplessness, fear 
of pain, and passive pain-coping to pain level, disability, and depression in chronic pain patients attending an 
interdisciplinary pain center. 
Table 25. Characteristics of the studies selected for question 12d
Study details Population Outcomes and analysis
EURIDISS
Study design
longitudinal / cohort 
study
Study method
The present study uses 
part of the EURIDISS 
data of 573 patients 
with recently diagnosed 
RA (268 from the 
Netherlands, 216 from 
Norway, and 89 from 
France). A series of 
clinical and psychosocial 
data were collected 
on 4 (the Netherlands, 
France) and 3 (Norway) 
occasions, with 1-year 
intervals separating the 
waves of data collection
Type of chronic pain
Rheumatoid arthritis pain
Confirmation of diagnosis
RA according to the 1987 American College of 
Rheumatology (formerly the American Rheumatism 
Association) criteria
Sample size and demographics
Sample from the Netherlands
N=268, 64% female
Mean age 54.4 years (SD 11.8) 
Patient selection
Inclusion criteria are residence in the sampling 
areas, age between 20 and 70 years, diagnosis 
of RA according to the 1987 American College of 
Rheumatology criteria, and disease duration of 4 
years or less
Outcomes measured
Disease: Erythrocyte sedimentation rate (ESR).
Impairment: Ritchie Articular Index (RAI); Subscales 
“fatigue” and “pain” of the
Nottingham Health Profile (NHP)
Disability: Groningen Activity Restriction Scale 
(GARS); Health Assessment Questionnaire (HAQ).
Handicap: Leisure; Independent Living With RA (ILRA)
The “mental domain” of QoL: Rosenberg Self-
Esteem scale (RSE) and the 28-item version of the 
General Health Questionnaire (GHQ28) measuring 
psychological distress
Satisfaction: Social Support Questionnaire: 
Satisfaction With Supportive Transactions (SSQS)
Pain severity
Sample from the Netherlands
Mean 13.4 (SD: 2.1); 
43% had low pain scores (<=13.00)
Analyses
Descriptive data (mean, SD) for pain
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Study details Population Outcomes and analysis
Samwel et al. 2006
Study design
Cross-sectional / survey
Study method
Patients completed 
questionnaires and diary 
for 7 days
Type of chronic pain
Unexplained chronic pain for which no biomedical 
cause could be identified
Confirmation of diagnosis
Not reported
Sample size and demographics
N=169, 63.9% females 
mean age 47.1 years (SD 13.9)
Patient selection
Recruited from patients accepted for interdisciplinary 
pain treatment between November 1999 and 
January 2001: patients had to be at least 18 years 
with their pain problem present for more than 3 
months
Outcomes measured
pain intensity (10 cm VAS), disability (Pain Disability 
Index), Depression (depression scale of Symptom 
Checklist-90), fear of pain (Tampa scale of 
Kinesophobia), Passive Pain coping (Pain Coping 
Inventory), helplessness (Helplessness scale of the 
Illness Cognition Questionnaire)
Pain severity
mean (SD): 54.3 (19.9)
Analyses
Pearson correlation coefficients, regression analyses 
with pain level, disability, and depression as 
dependent variables
Q12d. Study quality
The study of Suurmeijer was rated as a high-quality study. Study design, eligibility criteria, outcomes, statistical 
methods and study participants were adequately reported. Loss to follow-up was just 8% over 4 years and 
results were clearly reported as adjusted or unadjusted with precision. However, it was unclear whether the 
population was representative of the target population.
The study of Samwel et al. (2006) was rated moderate quality. Eligibility criteria were unclear and it was unclear 
whether the study sample was representative of the target sample. Also the outcomes were poorly reported 
as the ranges per scale and the direction were not clear. However, study design and statistical methods were 
adequately described. Also results were clearly reported as adjusted or unadjusted with precision.
12d. Results
Isolation
EURIDISS
No results on isolation were found but EURIDISS reported data on satisfaction of patients with RA on social 
support using the satisfaction with supportive transactions questionnaire (a scale from 23 to 69), consisting of 
the subscale ESS (emotional support satisfaction, from 11 to 33) and the subscale SCS (Social companionship 
satisfaction, from 5-15). Higher score indicate more satisfaction.
Overall SSQS (Social support questionnaire for satisfaction with supportive transactions) is 64.9 (SD 4.6), for 
ESS (emotional support satisfaction) 31.1 (SD 2.7) and for SCS (Social companionship satisfaction) 13.8 (1.5) 
(Suurmeijer et al 2001). No differences were found during the follow-up period of 4 years for ESS and SCS 
(Strating et al. 2006). (see Table 26 below).
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Table 26. Mean and SD for SSDQ, ESS and SCS during follow-up
Mean 
over all 
years
T1 T2 T3 T4 T5
SSDQ* (23-69)
ESS* (11-33)
SCS* (5-15)
64.9 (4.6)
31.1 (2.7)
13.8 (1.5)
-
30.6 (3.6)
13.6 (1.9)
-
30.9 (3.3)
13.8 (1.9)
-
31.1 (3.1)
13.8 (1.6)
-
31.2 (3.4)
13.7 (2.0)
-
28.0 (3.1)
13.7 (1.9)
* higher score indicates better functioning.
ESS: emotional support satisfaction; SCS: social companionship satisfaction
Helplessness
Samwel et al (2006)
Helplessness was measured using the Helplessness scale of the Illness Cognition Questionnaire, with a range 
from 6 to 24 and a higher score representing more helplessness. Passive coping was measured using the Pain 
Coping Inventory. The PCI is rated on a 4-point Likert scale (1=rarely or never to 4, very frequent). 
The mean (SD) score for helplessness the total group was 14.6 (4.7). The means for passive coping were as 
follows: Worrying: 2.0 (0.5): Retreating: 1.5 (0.5), Resting: 2.5 (0.6). There were no significant differences 
between pain subgroups (see table 27)
Table 27. Mean (SD) of helplessness and passive coping for the total sample and subgroups based on 
location of pain
Total 
sample
(n=169)
Back pain 
(n=48)
Leg pain 
(n=41)
Neck/
Shoulder 
pain 
(n=26)
Other 
pain 
location 
(n=36)
More 
than 
1 pain 
location 
(n=18)
Helplessness
Passive coping
Worrying
Retreating
Resting
14.6 (4.7)
2.0 (0.5)
1.5 (0.5)
2.5 (0.6)
15.6 (4.2)
2.2 (0.5)
1.5 (0.4)
2.6 (0.6)
14.1 (4.0)
2.0 (0.5)
1.5 (0.5)
2.5 (0.8)
16.2 (5.1)
2.2 (0.5)
1.8 (0.5)
2.7 (0.6)
14.5 (3.7)
2.2 (0.5)
1.6 (0.5)
2.6 (0.7)
16.3 (3.7)
2.1 (0.5)
1.5 (0.4)
2.6 (0.6)
Q12d. Summary
Only two studies were found that reported on isolation or helplessness. One study was on patients with early 
RA and the other on patients with unexplained chronic pain attending an interdisciplinary treatment centre. 
Patients with early RA seem to be satisfied with their social support and patients with unexplained pain seem to 
experience at most moderate helplessness. Resting, however, a passive pain coping strategy seems to be used 
sometimes to frequent. For both studies it’s unclear whether the populations are representative of the target 
population. Together with the difficulties interpreting the data, we should conclude that the current data gives 
only a limited view on the impact of chronic pain on isolation and helplessness.
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Q12e. In the 
Netherlands what is the 
impact of chronic pain 
on days off work?
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We located four studies that were relevant to this question (Borghouts et al. 1999, Breivik et al. 2006, Huisstede 
et al. 2008 and Picavet and Schouten 2003).
Borghouts et al (1999) investigated the costs of neck pain in the Netherlands in 1996 to assess the financial 
burden to society. The study was based on prevalence data and data sources included national registries, 
reports of research institutes and health care authorities.
Breivik et al. (2006) performed a large telephone survey to explore the prevalence, impact on daily life and 
treatment of chronic pain in 15 European countries and Israel, among which the Netherlands. Persons received 
an initial screening questionnaire and those who suffered from long-lasting pain were subsequently interviewed 
in-depth using a second structured questionnaire. From the Netherlands, 300 persons suffering chronic pain 
were interviewed. 
Huisstede et al. 2008 and Picavet and Schouten 2003 were based on DMC3 population survey data with 3664 
respondents. Huisstede et al. 2008 aimed to study the prevalence of upper extremity disorders(UEDs) and neck 
as a total and complaints of the arm, neck and/or shoulder (CANS) not caused by acute trauma or any systemic 
disease as defined in the CANS model in the open population and to assess socio-demographic and health 
characteristics of chronic symptoms. The aim of Picavet and Schouten 2003 study was to present estimates on 
the prevalence of musculoskeletal pain of five different anatomical areas and ten anatomical sites, and their 
consequences and risk groups in the general Dutch population.
Table 28. Characteristics of the study selected for question 12e
Study details Population Outcomes and analysis
Borghouts et al. 1999
Study design
Cost-of-illness study
Study method
Study is based on 
prevalent cases of neck 
pain. Direct medical costs 
and indirect costs were 
estimated using national 
registries, reports of 
research institutes and 
health care authorities
Type of chronic pain
Neck pain
Confirmation of diagnosis
Not reported
Sample size and demographics
Not reported
Patient selection
All prevalent cases in 1996 were included
Outcomes measured
direct medical costs (hospital care, medical 
procedures, medical specialists fees, ambulatory 
hospital care, general practice care and paramedical 
care), indirect costs (absenteeism, disability)
Pain severity
Not reported
Analyses
Human capital Method; Friction Cost Method
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Study details Population Outcomes and analysis
Breivik et al. 2006
Study design
Cross-sectional study
Study method
Telephone survey in two 
parts. First, persons were 
screened for chronic 
pain. Those who qualified 
were interviewed in-
depth
Type of chronic pain
Long-lasting pain: chronic pain for at least 6 months, 
and pain in last month, and pain at least 2 times/
week, and rating pain intensity at least 5 on 10-point 
NRS
Confirmation of diagnosis
Not reported
Sample size and demographics
Total sample: 4839; Netherlands: 300 persons with 
long-lasting pain
Demographics for all countries together: 52% female 
mean age 50 years
For the Netherlands: female 60%, mean age 51.3 
years
Patient selection
Subjects with long-lasting pain (see definition above)
Outcomes measured
Duration, location, intensity of pain. 
Tolerance, time course of pain, impact pain on 
activities daily life, employment status, emotional 
status
Visits to doctors, visits to pain management 
specialist, treatment (medication and non-
medication), effectiveness of treatment, satisfaction 
with doctors, respondents’ attitudes and beliefs 
about pain and pain treatment, respondents’ 
perception of the attitude of others to their pain
Pain severity
18% reported severe pain
Analyses
Descriptive analysis only. No subgroups were 
reported (for the Netherlands)
Huisstede et al. 2008
Study design
Cross-sectional/ survey
Study method
DMC3 study - national 
health survey of 
musculoskeletal 
conditions; postal 
questionnaire – with 
general questions and 
health questions. After 
screening question for 
each of 5 anatomical 
areas
Additional questions 
regarding pain in 
this area and its 
consequences; general 
health was measured 
using the Short 
Form(SF)-36
Type of chronic pain
Upper extremity disorders (UED) and neck pain; 
complaints of the arm, neck
and/or shoulder (CANS; excluding UED caused by an 
acute trauma or a systemic disease) 
Confirmation of diagnosis
NR; only screening question: ‘‘did you have pain in 
‘anatomic area’ during the past 12 months?’’ 
Sample size and demographics
3664 respondents 
25–44 years 47.0%, 
45–64 years 34.6%, 
65+ years 18.4% 
Female 50.9%
chronic UED 996
chronic UED due to systemic disease or acute trauma 
299
chronic CANS 697
Patient selection
DMC3 - Dutch population aged 25 years and above; 
this study - persons with musculoskeletal upper 
extremity and neck disorders in 4 anatomic sites: 
neck, shoulder, elbow, and wrist/hand
Outcomes measured
12-month prevalence, point prevalence, and 
prevalence of chronic pain (pain at baseline and 
lasting more than 3months in the last 12 months)
course of pain, consequences of pain (contact 
with general practitioner, medical specialist or 
physiotherapist, work leave, limitations in daily life), 
general health
Pain severity
self-reported - severe or mild 
chronic total UED 
Continuous severe pain 5.4% 
Recurrent severe pain 12.7% 
Chronic CANS
Continuous severe pain 3.9% 
Recurrent severe pain 12.8% 
Analyses
Descriptive analysis only. 
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Study details Population Outcomes and analysis
Picavet and Schouten 
2003
Study design
Cross-sectional study
Study method
DMC3 study - national 
health survey of 
musculoskeletal 
conditions; postal 
questionnaire – with 
general questions and 
health questions. After 
screening question for 
each of 5 anatomical 
areas
Additional questions 
regarding pain in 
this area and its 
consequences; 
socio-demographic 
characteristics 
Type of chronic pain
Neck, shoulder, higher back 44.5%
Elbow, wrist/hand 23.2%
Lower back 43.9% 
Hip, knee 28%
Ankle, foot 14.9%
Confirmation of diagnosis
NR; only screening question: ‘‘did you have pain in 
‘anatomic area’ during the past 12 months?’’ 
Sample size and demographics
Total sample: 3664 respondents 
weighted to present a distribution of sex, age, 
marital status and region of living equal to that of 
the Netherlands in 1998:
Sex
men 49.1%
women 50.9%
Age group
25-44 47.0%
45-64 34.6%
65+ 18.4%
Patient selection
Dutch inhabitants of 25 years and older 
Outcomes measured
Musculoskeletal pain period prevalence, point 
prevalence, prevalence of chronic pain, course of 
pain, consequences of pain (contact with general 
practitioner, medical specialist or physiotherapist, use 
of medicines, work leave, limitations in daily life, and 
work disability)
Pain severity
self-reported - severe or mild 
roughly 15% severe pain
Neck, shoulder or higher back
Continuous severe pain 3.1%
recurrent severe pain 8.3%
Elbow or wrist/hand
Continuous severe pain 4.0%
recurrent severe pain 11.0%
Lower back
Continuous severe pain 3.5%
recurrent severe pain 15.4%
Hip or knee
Continuous severe pain 5.2%
recurrent severe pain 10.1%
Ankle or foot
Continuous severe pain 6.1%
recurrent severe pain 12.4%
Analyses
descriptive, frequencies, multivariate logistic 
regression
Q12e. Study quality
Borghouts et al (1999) was rated as a study of moderate quality. The study was representative for the target 
population. However the eligibility criteria were not clearly described and the sample includes a proportion of 
non-chronic neck pain. Furthermore a description of the included population was lacking and it was unclear if 
the results were presented as adjusted or unadjusted. 
The quality of the Breivik et al. 2006 study was rated as moderate; it was unclear that the population was 
representative, and the statistical methods were not clearly described. 
The quality of Huisstede et al. 2008 study was rated as moderate, it was unclear that the population was 
representative and the statistical methods were not clearly described and the results were not reported as 
unadjusted and confounder-adjusted including precision and there was no adequate description of the 
eligibility criteria. 
Picavet and Schouten 2003 study was rated as high quality; only one item was missing – the authors did not 
provide adequate description of eligibility criteria.
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Q12e. Results
General chronic pain
Breivik et al. 2006
Among the whole European group of respondents who were working mean time lost from work due to pain in 
the past 6 months was 7.8 days. Fifty-five percent had lost no days at all, 11% had lost one to three days, 12% 
had lost four to nine days, 9% had lost 10 to 15 days, and 13% had lost at least 16 days.
Among 86 of Dutch respondents mean time lost from work (full or part time) due to pain in the past 6 months 
was 6.8 days. 
Musculoskeletal pain
Borghouts et al. 1999
The authors calculated the total number of sick days due to musculoskeletal diseases and neck disorders in 
1996. They reported two methods of the calculations. 
Using human capital method the number of sick days regarding diseases of musculoskeletal system was 19 
367 744 and the number of sick days related to neck disorders was 1 435 044. 
Using friction cost method the number of sick days regarding neck pain for less than 90 days was estimated 
to be 487 915 days. The total number of patients who had sick leave for neck pain for more than 90 days was 
estimated to be 4935. The number of sick days for patients with sick leave for more than 90 days regarding 
their neck was estimated to be 444 150. 
Huisstede et al. 2008
The authors reported the percentage of patients who left work due to their complaints in the last year among 
patients with paid work and age 25–64 years.
For patients who had paid work the majority did not report work leave because of their pain complaint. 
Among people with chronic upper extremity and neck complaints (UED) 23% left their work in the last year. 
Among people with complaints of the arm, neck and/or shoulder (CANS) not caused by acute trauma or any 
systemic disease about 19% left their work due to their complaints in the last year. In the subgroup of patients 
with CANS who were using healthcare the percentage was 32 and in those not using healthcare it was 3.9. The 
figure below presents work leave due to patients in complaints in the subgroups and according to its length. 
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Figure 19. Work leave in the last year among participants with upper extremity and neck complaints and 
subgroups by its length (CANS – complaints of the arm, neck and/or shoulder not caused by acute trauma or 
any systemic disease, HC – healthcare, UED – chronic upper extremity and neck complaints)
Picavet and Schouten 2003
For patients who had paid work the majority did not report work leave because of their pain complaint. The 
highest percentage with work leave during the last year was found for low back pain: almost a quarter (24.4%) 
of those with low back pain reported sick leave in the past year. For pain of ankle or foot (22.4%) and neck, 
shoulder or higher back (21%) work leave was also relatively common but for pain of elbow or wrist/hand 
(16%) and pain of hip or knee (13%) sick leave was less frequent. The figure below presents work leave due to 
patients in complaints in the subgroups and according to its length.
0 5 10 15 20 25
total
>4wks
1-4 wks
<wk
neck, shoulder, higher back
elbow, wrist/hand
lower back
hip or knee
ankle or foot
Figure 20. Work leave in the last year among participants with musculoskeletal pain complaints by location 
and work leave length 
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Q12e. Summary
The four included studies reported either the number of days off work or the percentage of patients leaving 
work due to pain for a certain length of time. Mean time lost from work due to general chronic pain in the past 
6 months was 6.8 days. One cost-of-illness study reported total number of sick days related to neck disorders as 
1 435 044 days. Two studies based on DMC3 data reported the percentages of patients with work leave due to 
musculoskeletal pain during last year between 4 and 32% depending on the subgroup.
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Q12f. In the 
Netherlands what is the 
impact of chronic pain 
on incapacity benefits?
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We located three studies that were relevant to this question (Borghouts et al. 1999, Chorus et al. 2001, van 
Doorn et al. 1995).
Borghouts et al (1999) investigated the costs of neck pain in the Netherlands in 1996 to assess the financial 
burden to society. The study was based on prevalence data and data sources included national registries, 
reports of research institutes and health care authorities.
Chorus et al. 2001 study aimed to assess separate and combined effects of work factors and behavioural 
coping in relation to withdrawal from the labour force among 720 patients with rheumatoid arthritis (RA).
Van Doorn (1995) investigated low back disability among self-employed dentists, veterinarians, physicians and 
physical therapists in the Netherlands from 1977 to 1989. For this purpose a retrospective study was performed 
based on data from a private non-profit mutual insurance company.
Table 29. Characteristics of the study selected for question 12f
Study details Population Outcomes and analysis
Borghouts et al. 1999
Study design
Cost-of-illness study
Study method
Study is based on 
prevalent cases of neck 
pain. Direct medical costs 
and indirect costs were 
estimated using national 
registries, reports of 
research institutes and 
health care authorities
Type of chronic pain
Neck pain
Confirmation of diagnosis
Not reported
Sample size and demographics
Not reported
Patient selection
All prevalent cases in 1996 were included
Outcomes measured
direct medical costs (hospital care, medical 
procedures, medical specialists fees, ambulatory 
hospital care, general practice care and paramedical 
care), indirect costs (absenteeism, disability)
Pain severity
Not reported
Analyses
Human capital Method; Friction Cost Method
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Study details Population Outcomes and analysis
Chorus et al. 2001
Study design
cross-sectional / survey
Study method
a self-administered 
questionnaire containing 
several standardised 
instruments. Data on 
socio-demographic 
factors, disease 
characteristics, functional 
abilities, health related 
quality of life, present 
and past working 
conditions, and coping 
with the disease
Type of chronic pain
RA
Confirmation of diagnosis
Not reported
Sample size and demographics
Total n = 720
withdrawn from the labour force after diagnosis 
n=343
age at the time of study 
20–29 1.8%
30–39 10.2%
40–49 27.5%
50–59 60.2%
male 29.9%
in paid employment at time of study n=377
age at the time of the study
20–29 6.2%
30–39 14.9%
40–49 42.7%
50–59 36.2%
male 43.9%
Patient selection
Eligible patients identified from the national 
Standardised Diagnosis Register of Rheumatic 
Diseases (SDR); a random sample of patients 
with RA aged 16–59 years was selected from 
a geographically representative sample of 35 
rheumatologists in 17 practices in the Netherlands. 
Patients contacted by mail by their own 
rheumatologist. For the present analysis only those 
patients with paid employment at the time of 
diagnosis or at any time after being diagnosed with 
RA were included
Outcomes measured
Socio-demographic characteristics, disease activity 
(RADAI), functional abilities in daily life (HAQ), work 
factors (a Dutch generic structured instrument, 
the Vocational Handicap Questionnaire (VHQ)), 
behavioural coping styles (validated Coping with 
Rheumatic Stressors (CORS))
Pain severity
Not reported
Analyses
chi square, t tests; unconditional logistic regression 
analysis, logistic regression analysis, multivariate 
regression analysis
Van Doorn, 1995
Study design
Retrospective cohort 
study
Study method
Data came from private 
non-profit mutual 
insurance company 
insuring
self-employed dentists, 
veterinarians, physicians 
and physical therapists
Type of chronic pain
Low back pain
Confirmation of diagnosis
By medical advisor of insurance company
Sample size and demographics
1,119 claims filled by 39 persons; 38% referred to 
absence of > 3 months
Patient selection
All claims for low back pain disability between  
1977-1989
Outcomes measured
Total costs for compensation of disability, starting 
age, claims per months, chronic LBP disability, 
incidence rate, duration, long-term LBP disability, 
recurrence 
Pain severity
Not reported
Analyses
Descriptive analyses; Chi square, Wilcoxon Rank Sum 
Test, BMDP’ stepwise logistic regression, Kaplan-
Meier method, Mantel-Cox test, multivariate analysis 
– Cox regression model
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Q12f. Study quality
Borghouts et al (1999) was rated as a study of moderate quality. The study was representative for the target 
population. However the eligibility criteria were not clearly described and the sample includes a proportion of 
non-chronic neck pain. Furthermore a description of the included population was lacking and it was unclear if 
the results were presented as adjusted or unadjusted. 
Chorus et al. 2001 study was rated as moderate quality. There was no adequate description of 
study design and setting and no adequate description of eligibility criteria. It was also unclear if the study was 
representative for target population.
Van Doorn (1995) also has been rated low as the eligibility criteria, the representativeness of the population and 
the statistical methods and the way the results have been reported were not clear. Also, the study participants 
have not been well described.
Q12f. Results
Musculoskeletal pain
Borghouts et al. 1999
The proportion of patients receiving a disability pension in relation to the neck pain (based on ICD-codes) in the 
Netherlands in 1996 appeared to be 2.5%. 
Van Doorn et al. 1995
Low back disability claims from self-employed medical professionals were analysed. Between 1977 to 1989 
the number of low back disability claims increased every year. The average number of recurrences per person 
(claiming low back disability more than once) was 0.55 (0–13). 
The starting age of the first claim was higher for specific causes of low back pain when compared with 
nonspecific causes. There was seasonal variation in the number of disability claims – in December there were 
more claims than expected. Fifty nine percent of all claims were due to nonspecific low back pain and 34% due 
to specific low back pain, for 7.1% no classification could be made. Chronic low back disability developed in 
23% of all claims, in 12% of the claims for nonspecific low back pain and in 45% of the claims for specific low 
back pain. 
Claims of six months duration or more accounted for 19% of nonspecific low back pain form subjects treated 
conservatively, 40% of the claims from subject who had surgery and 1.4% from subjects for whom no 
treatment was reported. 
Claims of six months duration or more accounted for 46% of specific low pain from subjects treated 
conservatively, 49% from subject who had surgery and 8.6% from subjects for whom no treatment was 
reported.
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For 261 claims made by 247 persons the disability was chronic. Some of the chronically disabled were 
permanently disabled and they will receive the compensation until the insurance policy expires. The median 
duration until expiration of insurance policy was 10 (1.5–36) years. The permanently chronically disabled group 
contained more claimants who were >50% disabled (p<0.001), in the age group over 54 years (p<0.001).
The annual incidence rate of low back disability increased from 3.5 per 1000 persons at risk in 1977 to 7.4 in 
1989 (adjusted for profession, age and deferred period). When analysed by professional subgroups, physical 
therapist and veterinarians compared to dentists had significantly greater risk of claiming low back disability (RR 
2.67 [95% CI 2.23–3.19] and 2.04 [95% CI 1.72–2.43]), while physicians had no significantly different risk (RR 
0.7 [95% CI 0.72–1.06]). 
Age groups over 35 years had significantly greater risk than the age group under 35 years (RR 2.15 [95% CI 
1.2–2.52] for 35–44 years, RR 2.22 [95% CI 1.81–2.71] for 45–54 years and RR 2.26 [95% CI 1.8–2.4] for 
55–65 years).
The risk of chronic low back disability for physical therapists and veterinarians compared to dentists was 
significantly higher (RR 3.17 [95% CI 2.22–4.55] and RR 3.23 [95% CI 2.31–4.5]) and for physicians it was 
lower (RR 0.4 [95% CI 0.25–0.66]). The risk also increased with age, when compared to those under 35 years 
(RR 3.34 [95% CI 2.28–4.9] for 35–44 years, RR 4.83 [95% CI 3.06–7.63] for 45–55 years and RR 11.24 [95% 
CI 7.14–17.7] for 55–65 years).
Incidence of low back disability exceeding one year adjusted for differences in distribution according to age 
and gender was 0.85 per 1000 person-years among self-employed medical professionals versus 2.56 per 1000 
person-years among general working population. The general working population had three times greater risk 
of claiming low back disability lasting longer than one year than self-employed medical professionals (RR 2.99 
[95% CI 2.35–3.82]).
The median duration of all the claims was 51 days [95% CI 41–58]. The chance of returning to work decreased 
with increasing duration. Among first claimants the chance to return to work within 2 years after the start of 
the disability decreased from 89% at the start to 71 percent after 90 days and 50% after 10 days. After 1 year 
the chance of returning to work within 2 years after the start of disability was 22%.
Rheumatoid arthritis
Chorus et al. 2001
Most of the patients (94.4%) who had withdrawn from the labour force were officially recognised as being fully 
(≥80% disabled; 68.9% of patients) or partially disabled (<80% disabled; 25.5% of patients) for work purposes 
since they received a government work disability pension. Partial work disability was recognized in 14.4% of the 
patients who still had paid employment (significant difference when compared with those withdrawn). 
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Q12f. Summary
The three included studies reported the proportion of patients receiving disability pension or recognized 
as being fully or partially disabled for work purposes or incidence of disability claims. In 1996 2.5% of the 
Netherlands population on disability pension were receiving disability pension in relation to the neck pain. Over 
ninety percent of analysed patients with rheumatoid arthritis who had withdrawn from the labour force were 
officially recognised as being fully or partially disabled for work purposes. The annual incidence rate of low back 
disability in self-employed medical professionals increased between 1977 and 1989 and the incidence. When 
incidence of low back disability exceeding one year was compared with general working population the risk for 
the latter was three times higher. 
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Q13. In the 
Netherlands, what are 
the costs of chronic 
pain from societal, 
health care system and 
patient perspective?
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Four studies reported data on cost of chronic pain in the Netherlands (Borghouts et al. 1999, Boonen et al 
2005; Kemler and Furnée, 2002; Van Doorn, 1995). Of these, three reported on costs for society (Borghouts, 
Boonen and Van Doorn), two on costs for the health care system (Borghouts and Boonen) and one on costs for 
the patient (Kemler and Furnée, 2002).
Borghouts et al (1999) investigated the costs of neck pain in the Netherlands in 1996 to assess the financial 
burden to society. The study was based on prevalence data and data sources included national registries, 
reports of research institutes and health care authorities.
Boonen et al (2005) compared the cost-of-illness of three musculoskeletal conditions. Patients with fibromyalgia 
(FM), chronic low back pain (CLBP), and ankylosing spondylitis (AS) who were referred to a specialist and 
participated in three randomised trials completed a cost diary for the duration of the study, comprising direct 
medical and non-medical resource utilisation and inability to perform paid and unpaid work. The RCTs were 
performed during 1993-1995 for FM and CLBP and in 1999 for AS.
Kemler and Furnée (2002) studied what happens in a family when one member suffers from chronic pain. They 
assessed the effect on employment status, time allocation, additional domestic help and out-of-the-pocket 
expenses of Dutch patients with complex regional pain syndrome (CRPS) and their spouses.
Van Doorn (1995) investigated low back disability among self-employed dentists, veterinarians, physicians and 
physical therapists in the Netherlands from 1977 to 1989. For this purpose a retrospective study was performed 
based on data from a private non-profit mutual insurance company. See Table 30 for study characteristics. 
Table 30. Characteristics of the studies selected for question 13
Study details Population
Outcomes and 
analysis
Cost data
Borghouts et al. 1999
Study design
Cost-of-illness study
Study method
Study is based on 
prevalent cases of neck 
pain. Direct medical costs 
and indirect costs were 
estimated using national 
registries, reports of 
research institutes and 
health care authorities
Type of chronic pain
Neck pain
Confirmation of diagnosis
Not reported
Sample size and 
demographics
Not reported
Patient selection
All prevalent cases in 1996 were 
included
Outcomes measured
direct medical costs (hospital 
care, medical procedures, medical 
specialists fees, ambulatory 
hospital care, general practice 
care and paramedical care), 
indirect costs (absenteeism, 
disability)
Pain severity
Not reported
Analyses
Human capital Method; Friction 
Cost Method
Cost for society:
Total cost (direct and indirect)
Total indirect costs (absenteeism 
and disability)
Costs for health care:
Total direct medical costs (costs 
for hospital care, medical 
procedures, medical specialists 
fee, ambulatory hospital care, 
general practice, and paramedical 
care)
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Study details Population
Outcomes and 
analysis
Cost data
Boonen et al. 2005
Study design
Cost-of-illness study
Study method
Patients who participated 
in three randomised trials 
completed a cost diary 
for the duration of the 
study
Type of chronic pain
Fibromyalgia (FM), chronic low 
back pain (CLBP), and ankylosing 
spondylitis (AS)
Confirmation of diagnosis
FM: College of Rheumatology 
(ACR) classification criteria for 
fibromyalgia, 
CLBP: low back pain for more 
than six months without evidence 
of a specific spinal disease
AS: modified New York criteria
Sample size and 
demographics
FM: n=69, mean age 44.9 (SD 
9.4) 13% males
CLBP: n=110, mean age 40.9 (SD 
8.7) 40% males
AS: n=111, mean age 47.8 (SD 
10.1), 71% males
Patient selection
Patients participated in 3 RCTs; 
patients with FM or CLBB were 
referred by physicians and 
patients with AS were recruited 
through the patient association
Outcomes measured
Direct medical costs, direct non-
medical costs, productivity loss 
costs
Pain severity
Not reported
Analyses
Friction Costs Method for 
productivity loss, univariate 
analysis for differences in costs, 
multivariate regression analyses
Cost for society:
Total cost (direct and productivity 
loss costs)
Costs for health care:
Total direct medical costs (costs 
general practitioner, specialist 
physician, physiotherapist, 
complementary medicine, 
psychotherapist, hospital 
admissions, prescription drugs, 
OTC drugs)
Kemler and Furnée, 
2002
Study design
Cross sectional/survey
Study method
Patient completed a 
7-day diary
Type of chronic pain
Chronic refractory complex 
regional pain syndrome (CRPS)
Confirmation of diagnosis
Diagnostic criteria of the 
International Association for the 
Study of Pain (IASP)
Sample size and 
demographics
N=50
Mean age (SD)=39 (11) years
30% males, 70% females 
Patient selection
Consecutively sampled
Outcomes measured
Employment status, household 
income, time allocation, domestic 
help and out-of-pocket expenses
Pain severity
All had a mean pain intensity of at 
least 5 (on a 10-p VAS)
Analyses
Fisher’s exact tests: to compare 
proportions of employment 
status, independent samples 
t-test: to compare time allocation 
results and out-of-pocket 
expenses. Bonferroni correction 
was used to account for multiple 
significance testing
Costs for patient:
Out-of-pocket expenses, 
household income before and 
after diagnosis
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Study details Population
Outcomes and 
analysis
Cost data
Van Doorn, 1995
Study design
Retrospective cohort 
study
Study method
Data came from private 
non-profit mutual 
insurance company 
insuring
self-employed dentists, 
veterinarians, physicians 
and physical therapists
Type of chronic pain
Low back pain
Confirmation of diagnosis
By medical advisor of insurance 
company
Sample size and 
demographics
1,119 claims filled by 839 
persons; 38% referred to absence 
of > 3 months
Patient selection
All claims for low back pain 
disability between 1977-1989
Outcomes measured
Total costs for compensation of 
disability
Pain severity
Not reported
Analyses
Descriptive analyses; Chi square, 
Wilcoxon Rank Sum Test, BMDP’ 
stepwise logistic regression, 
Kaplan-Meier method, Mantel-
Cox test, multivariate analysis – 
Cox regression model
Costs for society
Total costs for compensation of 
disability
Q13. Study quality
Borghouts et al (1999) was rated as a study of moderate quality. The study was representative for the target 
population. However the eligibility criteria were not clearly described and the sample includes a proportion of 
non-chronic neck pain. Furthermore a description of the included population was lacking and it was unclear if 
the results were presented as adjusted or unadjusted. 
Boonen et al (2005) was also rated as moderate quality study. This study was based on data of RCTs. 
In addition, there is a difference between the number of patients randomized and the number of patients 
included in the analysis, as only the patients who completed cost diaries during the study were included in this 
cost-of-illness study and it’s unclear whether the population is representative of the overall population. And 
except for paid work and work disability it is unclear if the results presented were unadjusted or adjusted for 
confounders.
Kemler and Furnée (2002) has been rated low because it was not clear when the study took place (unclear 
design) and it’s unclear whether the population is representative. Also the statistical methods are poorly 
described and for the reported results it’s unclear whether or not these have been adjusted. 
Van Doorn (1995) also has been rated low as the eligibility criteria, the representativeness of the population and 
the statistical methods and the way the results have been reported were not clear. Also, the study participants 
have not been well described.
Q13. Results
In this section all relevant results will be described per study. The summary combines results of papers and 
presents results for a. Society, b. Health care and c. Patient.
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Results per study
Borghouts et al (1999)
The total costs for neck pain in 1996 were estimated at $686.2 million. Of this, 23% was related to direct 
medical costs and 77% to indirect medical costs (see table 31). Total costs for indirect non-medical costs 
depend on the method of calculation used (table 32).
Table 31. Annual costs of neck pain in The Netherlands in 1996 (Borghouts et al. 1999) 
Component Costs (in US $) % of total costs
Hospital care
Medical procedures
Medical specialists fee
Ambulatory hospital care
General practice
Paramedical care
Total direct medical costs
17 336 397
2 170 648
1 586 790
726 259
4 360 448
133 443 333
159 623 875
3
0.3
0.2
0.1
0.6
19
23
Absenteeism
Disability
Total indirect non-medical costs
185 422 035
341 108 500
526 530 535
27
50
77
Total 686 154 410 100
Table 32. Indirect non-medical costs of neck pain in 1996 (in US $): HCM vs FCM
Method Absenteeism (US $) Disability Total costs
Human Capital Method
Friction Cost method
185 422 035
96 345 695
341 108 500
-
526 530 535
96 345 695
Boonen et al. 2005
Below, costs for three types of musculoskeletal disorders are presented: fibromyalgia, chronic low back pain and 
ankylosing spondylitis. Total annual costs per patient for fibromyalgia are 7814, for chronic low back pain 8533 
and for ankylosing spondylitis 3205 euro’s. Direct medical costs accounted for are 32% for AS, 17% for FM and 
13% for CLBP. Tables 33 and 34 specify annual costs for different health care resources and sources of non-
medical costs directly related to the disease.
Table 33a. Annual direct, indirect and total costs per patient for fibromyalgia
Costs Mean (E/pt/year) Median (E/pt/year) %
Direct medical costs
Direct non-medical costs
Total direct costs
Productivity (friction) costs
1311 
3930
5241
2573
673
2362
3166
0
17%
50%
67%
33%
Total costs 7814 5145 100%
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Table 33b. Annual direct, indirect and total costs per patient for chronic low back pain
Costs Mean (E/pt/year) Median (E/pt/year) %
Direct medical costs
Direct non-medical costs
Total direct costs
Productivity (friction) costs
1104
4491
5594
2939
594
2502
3770
0
13%
53%
66%
34%
Total costs 8533 5068 100%
Table 33c. Annual direct, indirect and total costs per patient for ankylosing spondylitis
Costs Mean (E/pt/year) Median (E/pt/year) %
Direct medical costs
Direct non-medical costs
Total direct costs
Productivity (friction) costs
1043
1330
2373
834 
691
1330
2373
0
32%
41%
74%
26%
Total costs 3205 1793 100%
Table 34a. Annual costs for different health care resources for patients with fibromyalgia
Costs Mean (E/pt) Median (E/pt) %
General practitioner
Specialist physician
Physiotherapist
Complementary medicine
Psychotherapist
Hospital admissions
Prescription drugs
Non-prescription drugs
Direct medical costs
Unpaid household help
Paid household help
Paid and unpaid help
Inactivity
Aids/appliances/adaptations
Direct non-medical costs
81
296
297
180
-
226
183
50
1311
829
1505
2334
1454
142
3930
35
155
0
0
0
87
133
673
93
0
964
336
0
2362
1.5%
5.6%
5.7%
3.4%
4.3%
3.5%
0.9%
25%
15.8%
28.7%
44.5%
27.7%
2.7%
75%
Total direct costs 5241 3166 100%
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Table 34b. Annual costs for different health care resources for patients with chronic low back pain
Costs Mean (E/pt) Median (E/pt) %
General practitioner
Specialist physician
Physiotherapist
Complementary medicine
Psychotherapist
Hospital admissions
Prescription drugs
Non-prescription drugs
Direct medical costs
Unpaid household help
Paid household help
Paid and unpaid help
Inactivity
Aids/appliances/adaptations
Direct non-medical costs
85
243
185
97
124
167
186
24
1104
782.5
1410
2193
1925
372
4491
53
78
0
0
0
0
41
0
594
0
0
840
0
0
2502
1.5%
4.3%
3.3%
1.7%
2.2%
3.0%
3.3%
0.4%
20%
14.0%
25.2%
39.2%
34.4%
6.6%
80%
Total direct costs 5594 3770 100%
Table 34c. Annual costs for different health care resources for patients with ankylosing spondylitis
Costs Mean (E/pt) Median (E/pt) %
General practitioner
Specialist physician
Physiotherapist
Complementary medicine
Psychotherapist
Hospital admissions
Prescription drugs
Non-prescription drugs
Direct medical costs
Unpaid household help
Paid household help
Paid and unpaid help
Inactivity
Aids/appliances/adaptations
Direct non-medical costs
37
215
449
41
-
48
249
4
1043
261
454
715
584
31
1330
23
202
226
0
0
148
0
691
0
0
0
0
0
0
1.5%
9.1%
18.9%
1.7%
2.0%
10.5%
0.2%
44%
11%
19.1%
30%
24.6%
1.3%
56%
Total direct costs 2373 1305 100%
Van Doorn, 1995
Total costs for compensation of low back pain disability among self-employed dentists, veterinarians, physicians 
and physical therapists was 7.5 million NLG in 1987 and 8.0 million in 1989. Over the period 1977-1989, 1,119 
claims were made for low back pain disability by 839 claimants. 23% of the claims accounted for 90% of the 
compensation paid and for 89% of disability days.
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Kemler and Furnée (2002)
CRPS had a negative effect on income of patients or their families. For single people, the mean net yearly 
income decreased from $8,500 to $5,500. For male patients, the mean net family income decreased from 
$26,000 to $22,000 and for females. For female patients, the mean net family income decreased from $24,500 
to $22,500 per year.
Mean out-of-pocket expenses related to CRPS were $ 1,350 per patient per year. This amount was 1,600 for 
families with a male patient and 1250 for families with a female patient (difference was not significant).
Q13. Summary
Costs for society due to neck pain in 1996 were estimated to be $686.2 million. It’s not clear what proportion 
of it refers to chronic neck pain. Cost for three chronic musculoskeletal diseases ranged between 3205 and 
8533 euro’s per patient per year. Cost for compensation of low back pain disability was 8.0 million in 1989 for 
a group of self-employed health care professionals.
Direct medical costs accounted for 23% for neck pain and between 13 and 32% for the chronic 
musculoskeletal diseases, depending on the type. For neck pain, paramedical care accounted for the majority of 
costs (19 of 23%). For the chronic musculoskeletal diseases, large proportions of costs were used for specialist 
physicians, physiotherapists and prescription drugs.
Only one study reported costs for patients; patients with CRPS have a decreased income and the mean out-of-
pocket expenses were reported to be $1350 euro per patient per year.
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Q14. What are the 
issues/determinants 
of patients’ awareness 
of chronic pain in the 
Netherlands?
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Only three studies reported results that were relevant to this question (Sluiter and Frings-Dresen, 2008, Verbunt 
et al, 2003, Satink et al, 2004).
Sluiter and Frings-Dresen (2008) studied differences between working and sick-listed patients with chronic 
repetitive strain injury (RSI) with respect to quality of life and illness perception. For this purpose, they performed 
a cross-sectional study, sending a questionnaire to all 3250 members of the national RSI patient association.
Verbunt et al (2003) performed a survey in patients with non-specific chronic low back pain, referred to a 
rehabilitation center for a pain program. The authors tested the assumption that fear of injury leads to disability 
and physical deconditioning in these patients and evaluated the relation between disability and physical 
deconditioning.
Satink et al (2004) performed a qualitative study and examined the influence of chronic low back pain on 
the motives for activities in the patients’ daily lives (occupational performance). They assessed what activities 
patients carried out, what motives they had for those activities and how pain affected that. See Table 35 for 
study characteristics. 
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Table 35 Characteristics of the studies selected for question 14
Study details Population Outcomes and analysis
Sluiter and Frings-
Dresen, 2008
Study design
Cross-sectional study
Study method
A postal questionnaire 
was sent to all members 
of the national RSI 
patient association
Type of chronic pain
Repetitive Strain Injury (RSI)
Confirmation of diagnosis
Not reported
Sample size and demographics
3250 were invited, the response was 36%
Mean age 40.8 (SD 8.7) years
67% female
67% had high education
Patient selection
Self-selection (those who returned the questionnaire) 
Outcomes measured
Pain (VAS 0-100);
Quality of life using 7 subscales of SF-36 (physical 
role functioning, emotional role functioning, social 
functioning, pain, mental health, vitality, and physical 
functioning
VAS to rate present general quality of life with 
respect to health and quality of life with respect 
to health before the RSI complaints started (higher 
score is better quality of life)
Brief illness perception questionnaire (IPQ-B) for 
cognitive illness perception.
Demographic, complaint-related and work activities 
characteristics
Pain severity
Mean (SD) VAS 0-100- higher score more pain): 41.3 
(25.4)
Mean (SD) SF-36 subscale 0-100 - higher score less 
pain): 54.7 (21.6)
Analyses
Descriptive analysis (means and SDs); multivariate 
analysis or nonparametric tests (Mann–Whitney) 
were performed to test differences between working 
and sick-listed patients
Verbunt et al, 2003
Study design
Cross-sectional study
Study method
Patients completed 
questionnaires
Type of chronic pain
Non-specific low back pain for at least 3 months
Confirmation of diagnosis
Not reported
Sample size and demographics
N=37; 11 women, 26 men
Mean age 45.2 (SD 7.8) years
70% has paid job
Patient selection
Patients with non-specific low back pain, aged 
between 18 and 65 years, referred to rehabilitation 
center
Outcomes measured
Perceived disability (Roland Disability Questionnaire), 
fear of movement (Tampa Scale for kinesiophobia), 
depression (Beck Depression Inventory), 
catastrophizing (Pain catastrophizing Scale), physical 
factors (physical activities, aerobic fitness, body 
composition)
Pain severity
Not reported
Analyses
Descriptive analyses, Student t-test and Mann-
Whitney tests to compare two groups, Spearman 
rank correlation for bivariate correlations, multiple 
regression analysis
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Study details Population Outcomes and analysis
Satink et al 2004
Study design
Qualitative study
Study method
7 clients were 
interviewed
Type of chronic pain
Low back pain for more than 3 years
Confirmation of diagnosis
Not reported
Sample size and demographics
N=7; 4 women, 3 men
Age range 42-70
Patient selection
Purposive sampling via rehabilitation center that 
provides pain programs. Patients with a current paid 
job or with acute depression were excluded
Outcomes measured
Daily occupations, motives for performing these, 
impact of pain on these motives
Pain severity
Not reported
Analyses
Qualitative analysis (Constant comparative method)
Q14. Study quality
The quality of the study of Sluiter and Frings-Dresen (2008) was rated as moderate. The description of eligibility 
criteria was inadequate; this study included members of the RSI patient association but did not confirm the 
diagnosis. Furthermore, it was unclear whether the population was representative: the response was 36% and 
the recruitment method is likely to have resulted in a selective sample of patients. Furthermore, it was unclear 
whether reported results were adjusted or unadjusted.
The study quality of Verbunt et al (2003) was also rated as moderate because of unclear eligibility criteria of the 
study sample. Also, it was not clear whether the study sample was representative of the target population.
The quality of the Satink (2004) study was rated low. Because of the small sample size, this study is unlikely to 
be representative. Furthermore the date of study (design) and the eligibility criteria were unclear. Also outcomes 
and method of data summary were unclear. 
Q14. Results
RSI
Sluiter and Frings-Dresen 2008
Mean pain intensity (VAS) was 41.3 (SD 25.4) for the whole population; patients who were working reported 
less pain than those who were sick-listed (36.2 vs. 51.6, p<0.001). For the variables physical functioning 
and illness perception at least moderate correlations (coefficient >0.40) were found with pain intensity. The 
associations were as follows: patients that were able to work, those with a better physical role or a better 
physical functioning had less pain (correlations -0.48, -0.45 and -0.52, respectively). And, patients who 
experienced fewer consequences, those who experienced fewer symptoms and those who were less concerned 
about their illness had less pain (correlations 0.51, 0.64, 0.46, respectively). No p-values were reported for these 
associations.
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Low back pain
Verbunt et al. 2003
The mean score of perceived disability (RDQ) was 11.4 (SD 5.4). Women felt more disabled then men (14.9 vs 
9.9, p <0.05). Both fear of injury and catastrophizing correlated with disability (correlation coefficients 0.44, 
p<0.01) and 0.45, p<0.05, respectively). A multiple linear regression analyses to explain disability included 
gender, fear of injury and catastrophizing with an adjusted R2 of 28%.
Satink 2004
This qualitative study identified three phases in the process of living with chronic low back pain. In the first 
phase, patients had the wish to be normal and wanted to meet social and personal expectations. Participants 
fought against the pain to be active and did not want to accept the existence of pain or the experienced 
limitations, which led to ignoring the pain. However, patients experienced that they could not ignore the pain 
and that the pain had overpowered them.
In the second phase, the pain took control and the patients withdrew from social participation. Patients seemed 
to believe or hope that withdrawal from occupations would lead to control and thus a reduction of pain. 
However, the withdrawal caused negative emotions, and a kind of new pain (‘emotional pain’). Patients started 
to realize the impact of the pain and the consequences of withdrawal from occupations on their life. This led to 
a wish to prioritize and participate in occupations that patients really wanted to do.
In the third phase, patients became more conscious of the dynamics and dilemma’s between self, the pain, and 
the environment. Patients experienced that acceptance of and listening to the pain as a part of themselves led 
to better control of the pain. Patients had become aware that they could choose between occupations and 
social interactions ‘with or without pain’ sometimes they would choose to do nothing and decrease the pain 
and at other moments they chose engaging activities or social participation even when they knew that it would 
cause more pain.
Q14. Summary
Two quantitative studies reported determinants of awareness of chronic pain or disability. Patients who are 
able to work, who have a better physical role or better physical functioning have less pain. Also, those who 
experience fewer consequences and symptoms and are less concerned about their illness have less pain. Fear of 
injury and catastrophizing was associated with more disability.
A qualitative study showed 3 phases in the process of living with chronic pain: first patients aim to be normal, 
ignoring the pain and with unchanged activities. Then they aim to control and reduce the pain by withdrawing 
from activities. The pain is in control here. Last, they aim to collaborate with the pain. To do this they have to 
constantly face dilemmas of prioritizing activities in order to incorporate pain in everyday life. 
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Q15. What are the 
issues/determinants 
of health care 
professionals’ 
awareness of 
chronic pain in the 
Netherlands?
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We located one study that was relevant to this question (Zwakhalen et al. 2007). It used a cross-sectional 
survey design to develop a psychometrically sound questionnaire and to gather information about knowledge 
and beliefs of nursing staff regarding various aspects of pain in elderly patients with dementia. It also aimed 
to compare the results with respect to beliefs about pain between several categories of nurses (based on 
educational level and work experience). The results were based on the answer to a 17-item questionnaire. The 
items of the questionnaire were divided into four components: 1) contrasting aspects of pain in elderly with 
aspects of pain in younger people, 2) pain assessment and treatment in their workplace, 3) medication aspects, 
and 4) beliefs regarding pain and pain treatment in the elderly.
Table 36. Characteristics of the study selected for question 15
Study details Population Outcomes and analysis
Zwakhalen et al. 2007
Study design
Cross-sectional study
Study method
a questionnaire – 
demographic information 
and statements about 
pain to measure 
knowledge and attitudes 
about pain (five-point 
Likert scale from 1= 
completely disagree, 
5= completely agree)
Type of chronic pain
Pain in elderly with dementia
Confirmation of diagnosis
Not reported
Sample size and demographics
168 nurses: 123 nursing home staff,
25 PhD students in nursing science, 20
registered nurses in training to become pain nurse 
specialists
staff mean age 36.7 years SD 10.5, female 88.6%
PhD mean age 38.6 years SD 9.5, female 84%
trainee mean age 36.2 years SD 8, female 60%
Participant selection
All nursing staff from the psychogeriatric wards of 
the two nursing homes in the Netherlands, and two 
additional groups : a convenience sample of 25 
PhD students in nursing science and a group of 20 
registered nurses in training to become pain nurse 
specialists
Outcomes measured
Knowledge and beliefs about pain in elderly nursing 
home residents with dementia
Pain severity
Not reported
Analyses
Descriptive, a principal components analysis (PCA), 
internal consistency analyses, nonparametric Mann-
Whitney U tests
Q15. Study quality
The quality of Zwakhalen et al. 2007 study was rated as low mainly because there was no adequate description 
of study design and settings and no description of eligibility criteria, it was unclear if the study sample was 
representative for the target population, there was an inadequate description of statistical methods and it was 
unclear if the results reported were unadjusted or confounder-adjusted.
Q15. Results
The authors found that many nursing home staff showed knowledge gaps or negative beliefs
about pain in elderly people with dementia, which could contribute to inadequate assessment and treatment. 
They also demonstrated that educational level is an important factor. 
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The results of nursing home staff were as follows: 
1)  Most respondents reported that elderly patients do not experience less pain than younger people and that 
they do not experience pain less intensely than younger patients and disagreed with the statement that 
assessing pain in dementia patients was a matter of guessing.
2)  A large majority of nursing home staff were convinced that pain was being correctly assessed (83%) and 
treated (83%) at their ward, and that there was a great deal of attention paid to pain in dementia patients 
(80%).
3)  The question of whether pain medication should be administered when necessary, rather than according to a 
fixed schedule generated all possible answers (no unanimity). 
4)  No unanimity was noted for questions “pain is a part of the aging process”, “older people are more likely to 
be affected by pain than younger people” and “pain medication, if administered in large quantities, easily 
leads to addiction among the elderly”.  
Only 28% of the nursing home staff were aware of the fact that older people are affected more often by 
pain than younger people (ie, that incidence rates of chronic pain are known to be higher for the elderly than 
for younger people).
Results compared between groups of nurses:
1.  Nursing home staff vs trainee pain nurse specialists 
Significant differences were observed The trainee pain nurse specialists had more realistic beliefs and 
knowledge about pain in dementia patient group. Significant differences between the groups were most 
often related to issues of pain medication. All trainee pain nurse specialists disagreed with the statement 
“Pain medication should only be administered to patients suffering from severe pain”.  
While none of the trainee pain nurse specialists agreed that it is better to administer pain medication only 
‘when necessary’, rather than according to a fixed schedule, a large number of nursing home nurses agreed 
with this statement, not recognizing the value of fixed regular analgesia.  
Findings also indicated that the nursing home staff respondents were more anxious about the risk of 
addiction than the trainee pain nurse specialists. 
2.  Nursing home staff and PhD students 
Significant differences were also observed, mostly relating to the same issues as in the comparison above. 
Nursing home staff respondents had higher scores on all items belonging to the second component, 
referring to pain management at the ward.
3.  Nursing home staff groups according to their experience 
No significant differences in responses were found between nursing home staff who had less than five years 
vs five or more years. 
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Q15. Summary
Nursing home staff respondents showed knowledge deficits about several aspects of pain, even though they 
were satisfied about the way pain was assessed and treated at their wards. Specific knowledge deficits were 
found regarding pain treatment and medication in elderly nursing home residents. Staff educational level 
seemed to influence their beliefs and knowledge about pain in elderly nursing home patients.
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Q16. What are the 
main symptoms and 
complaints with 
which patients present 
themselves to health 
care professionals in 
the Netherlands?
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No studies were found reporting on symptoms and complaints with which patients present themselves to 
health care professionals in the Netherlands.
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Q17. What are 
the frequencies of 
drug, non-drug and 
combined treatments 
in the Netherlands?
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Of 11 relevant studies, we selected three studies that were most informative to this question (Breivik et al. 
2006, Van Herk et al. 2009 and Dieleman et al. 2008).
Breivik et al. (2006) performed a large telephone survey to explore the prevalence, impact on daily life and 
treatment of chronic pain in 15 European countries and Israel, among which the Netherlands. Persons received 
an initial screening questionnaire and those who suffered from long-lasting pain were subsequently interviewed 
in-depth using a second structured questionnaire. From the Netherlands, 300 persons suffering chronic pain 
were interviewed. 
Van Herk et al. (2009) performed a cross-sectional multicenter study of 233 residents of Dutch nursing homes. 
The study aimed to assess the prevalence and intensity of pain in older adults living in Dutch nursing homes and 
assess the characteristics of pain and the analgesics prescribed as well as impact of pain on daily functioning.
Dieleman et al. (2008) performed a population based cohort study to estimate the incidence and assessed 
treatment approaches of neuropathic pain conditions in the general population. The study population included 
persons registered for at least one year in the Integrated Primary Care Information (IPCI) database between 
1996 and 2003. See Table 37 for study characteristics. 
Table 37. Characteristics of the studies selected for question 17
Study details Population Outcomes and analysis
Breivik et al. 2006
Study design
Cross-sectional study
Study method
Telephone survey in two 
parts. First, persons were 
screened for chronic 
pain. Those who qualified 
were interviewed in-
depth
Type of chronic pain
Long-lasting pain: chronic pain for at least 6 months, 
and pain in last month, and pain at least 2 times/
week, and rating pain intensity at least 5 on 10-point 
NRS
Confirmation of diagnosis
Not reported
Sample size and demographics
Total sample: 4839; Netherlands: 300 persons with 
long-lasting pain
Demographics for all countries together: 52% female 
mean age 50 years
For the Netherlands: female 60%, mean age 51.3 
years
Patient selection
Subjects with long-lasting pain (see definition above)
Outcomes measured
Duration, location, intensity of pain
Tolerance, time course of pain, impact pain on 
activities daily life, employment status, emotional 
status
Visits to doctors, visits to pain management 
specialist, treatment (medication and non-
medication), effectiveness of treatment, satisfaction 
with doctors, respondents’ attitudes and beliefs 
about pain and pain treatment, respondents’ 
perception of the attitude of others to their pain
Pain severity
18% reported severe pain
Analyses
Descriptive analysis only. No subgroups were 
reported (for the Netherlands)
Q17 - Epidemiology of chronic pain in the Netherlands
169
Study details Population Outcomes and analysis
Van Herk et al. 2009
Study design
cross-sectional / survey
Study method
A standardized pain 
questionnaire was used 
based on the McGill Pain 
Questionnaire to measure 
aspects on pain. The 
use of analgesics was 
extracted from medical 
charts
Type of chronic pain
Self-reported pain in previous week. For 72% the 
pain was chronic (at least 3 months)
Confirmation of diagnosis
Not reported
Sample size and demographics
233 residents completed questionnaires
Median age 79 years (IQR 73-84)
70% were female
Patient selection
residents without cognitive impairment
Outcomes measured
Characteristics of pain, pain treatment, pain 
management index (how well is pain managed), 
impact pain on sleep and ADL, satisfaction pain 
treatment
Pain severity
Median pain intensity was 5 (IQR 2-7), 88 reported 
moderate or severe pain (>= 4 on NRS)
Analyses
Nonparametric data are given as median 
and interquartile range (IQR). Differences in 
demographics between the nursing homes are 
analysed by chi-squared tests and Kruskall-Wallis 
tests. The multiple linear regression method was 
used to identify interferences with sleep and 
ADL, with pain intensity for the previous week as 
dependent variable
Dieleman et al. 2008
Study design
longitudinal / cohort 
study
Study method
Study conducted in 
the IPCI database - a 
longitudinal general 
practice research 
database containing data 
of more than 500,000 
patients records
Type of chronic pain
Neuropathic pain
Confirmation of diagnosis
Case definition relied on GP and specialists symptoms 
and diagnosis recorded in the medical record with 
the GP. GP diagnoses were accepted if they recurred 
in the patient record and if typical neuropathic pain 
symptoms were present
Sample size and demographics
362,693 persons (1,116,215 person years)
Age and gender distribution similar to Dutch 
population
Patient selection
All individuals from the IPCI database with at least 
one year of follow-up
Outcomes measured
incidence rates of 13 subtypes of neuropathic pains, 
prescribed treatments
Pain severity
Not reported
Analyses
Age and gender specific incidence rates of different 
types of neuropathic pain, Cox-regression analysis 
for the relative risk and 95% confidence interval of 
neuropathic pain for women versus men
Q17. Study quality
The quality of the studies of Breivik et al. and Dieleman et al. were both rated as moderate; in the Breivik study 
it was not clear that the population was representative and the statistical methods were not clearly described. 
Dieleman et al. did not describe the study population adequately and loss to follow-up was not reported 
adequately.
The Van Herk et al. study was rated low mainly because it was not clear that the sample was representative of 
all nursing home residents, the eligibility criteria were not clearly described and nor were the statistical methods.
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Q17. Results
General chronic pain
Breivik et al. 2006
300 Dutch patients with chronic pain were interviewed. Of these, 33% (n=99) were currently prescribed 
medicines: 36% were using NSAIDs, 14% weak opioids, 5% strong opioids, 11% paracetamol and 16% a COX-
2 inhibitor. Of non-drug treatments it was reported that 21% of Dutch patients had tried acupuncture, 52% 
had tried physical therapy and 17% had tried massage. 
One third of the chronic pain patients in Europe (31%) were not treated for their pain. 69% had used non-drug 
treatments. Most respondents (53%) had not taken any non-prescription oral pain medicines in the last six 
months and 36% had taken one or two. 79% had ever taken prescription medicine. Most respondents (52%) 
were currently taking prescription pain medicine, 26% stopped taking prescription medicine. These figures were 
not presented separate for the Netherlands.
Van Herk et al. 2006
153 residents of nursing homes reported that they had experienced pain in the previous week. Of these, 38 
(24.8) were not prescribed analgesics, 65 (42.5%) were prescribed non-opioids, 13 (8.5%) weak opioids, 16 
(10.5%) strong opioids. The majority of the residents in pain (61%) received analgesics on a routine basis, 
and 38 (25%) did not receive analgesics at all. Of the 88 residents with an NRS 4 for present pain, and the 
41 residents with intolerable pain at present, 19 (22%) and 12 (29%), respectively, did not receive any pain 
medication.
Neuropathic pain
Dieleman et al. 2008
53% of the patients with neuropathic pain were prescribed medication and 47% were not treated. NSAIDs 
were the most commonly used drug (34.7%) followed by benzodiazepines (11.9%), sedative/hypnotics (9.1%) 
and opioids (6.6%). Anticonvulsants and tricyclic antidepressants were used by 4.8% and 4.7% of cases 
respectively. 
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Figure 21. Percentage of patients with and without prescribed drugs for chronic pain (NB Breivik 2006 refers 
to ‘patients ever taking prescription drugs’)
0 10 20 30 40 50
Dieleman
Van Herk
Breivik
NSAIDs
weak opiods
strong opioids
other drugs
Figure 22. Percentage of patients that were prescribed NSAIDs, weak opioids, strong opioids or other drugs 
for their pain. (NB Dieleman et al. do not differentiate between weak and strong opioids and the NSAIDs 
category also includes aspirin)
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Q17. Summary
In two out of three studies data for this question referred only to the frequency of drug treatment. The 
percentage of people that currently were prescribed medicines varied between 33 to 75% in the selected 
studies. Most of the patients were prescribed NSAIDs. 
One study reported that specific non-drug treatments had been tried by 21 to 52% of Dutch patients. No data, 
specifically for the Netherlands, was available on the frequency of overall non-drug or combined drug/nondrug 
treatments.
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Q18. What are the 
determinants of 
treatment choice 
between drug 
treatment and non-
drug treatment in the 
Netherlands?
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We located one study that was relevant to this question (Kroese et al. 2008).
Kroese et al. 2008 aimed to gather information from five types of professionals (GPs, rheumatologists, physical 
therapists, psychologists, rehabilitation specialists) on their usual management methods for fibromyalgia in 
order to assess whether treatment regimens have changed in the Netherlands during a period of 6 years and to 
gain insight into the therapeutic motives of the professionals.
Table 38. Characteristics of the studies selected for question 18
Study details Population Outcomes and analysis
Kroese et al. 2008
Study design
cross-sectional / survey
Study method
self administered 
questionnaire sent to 
general practitioners, 
rheumatologists, 
rehabilitation specialists, 
physical therapists and 
psychologists
Type of chronic pain
Fibromyalgia
Confirmation of diagnosis
Not reported
Sample size and demographics
1998: 320 respondents (out of 715): 59 GPs, 63 
rheumatologists, 71 physical therapist, 41 psychologists, 
86 rehabilitation specialists 
2005: 303 respondents (out of 750): 52 GPs, 89 
rheumatologists, 54 physical therapist, 39 psychologists, 
69 rehabilitation specialists 
Age and gender not reported
Patient selection
The samples of 150 practitioners selected from the 
Dutch Medical Directory or from their respective 
professional associations. For the disciplines in which less 
than 150 practitioners were working, all professionals 
were included
Outcomes measured
Management of fibromyalgia - common 
methods of treatment
Referrals to other specialists
2005 questionnaire – factors that 
influence the choice of a treatment for 
fibromyalgia by practitioners
Pain severity
Not reported
Analyses
descriptive, the non-parametric Kruskal–
Wallis test 
Q18. Study quality
The quality of the study of Kroese et al. 2008 was rated as low mainly because the description of eligibility 
criteria was unclear, it was unclear if the study sample was representative for the target population, there was 
no description of statistical methods and study participants and the results were not reported as unadjusted 
and confounder-adjusted including precision.
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Q18. Results
Fibromyalgia
Kroese et al. 2008
This study reported determinants of treatment choice in general rather than determinants of choice between 
drug and non-drug treatment.
Figure 23 presents factors that influence the choice of treatment for fibromyalgia by practitioners. From this 
figure, it can be seen that the practitioners’ treatment choices for fibromyalgia are led more by the ‘professional 
group’ (ie EBM, protocols, courses, own experience and experiences of colleagues) than by the ‘patient/
consumer’ (ie all patient factors). Concerning the professional group, it is notable that subjective factors, 
for instance own experiences, seem to be more important for rheumatologists and rehabilitation specialists 
than for GPs. The GP is mostly guided by objective factors, such as publications and research results, but 
not to the same extent as the other two medical disciplines. Regarding the patient/consumer as influencing 
factor, dynamic aspects, for instance, the expectations of the patient, are much more important than static 
characteristics, such as the social class of the patient. Especially for GPs, dynamic factors are very important 
motives for their treatment choices.
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Figure 23. Percentage of professionals reporting factors influencing their fibromyalgia treatment choice  
(GP = general practitioner, RMT = rheumatologists, Rehab = rehabilitation specialists; pt = patient)
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Q18. Summary
Factors influencing choice of treatment for fibromyalgia differ per discipline. The choice is mainly made on the 
basis of subjective, professional group-bound factors such as EBM, protocols, courses, own experience and 
experiences of colleagues. For GPs, dynamic patient factors are an important motive in the management of FM. 
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Q19. What are the 
determinants of 
treatment choice 
within drug treatments 
in the Netherlands?
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No studies were found reporting on the determinants of treatment choice within drug treatments in the 
Netherlands.
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Q20. What are the 
determinants of 
compliance/adherence 
to drug treatment in 
the Netherlands?
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No studies were found reporting on the determinants of compliance/adherence to drug treatment in the 
Netherlands.
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Q21. What is patients’ 
satisfaction about 
drug treatments in the 
Netherlands? 
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We found only one study that was relevant to this question (Van Herk et al. 2009).
Van Herk et al. (2009) performed a cross-sectional multi-centre study of 233 residents of Dutch nursing homes. 
The study aimed to assess the prevalence and intensity of pain in older adults living in Dutch nursing homes and 
assess the characteristics of pain and the analgesics prescribed.
See Table 39 for study characteristics. 
Table 39. Characteristics of the only study found for question 21
Study details Population Outcomes and analysis
Van Herk et al. 2009
Study design
cross-sectional / survey
Study method
A standardized pain 
questionnaire was used 
based on the McGill Pain 
Questionnaire to measure 
aspects on pain. The use of 
analgesics was extracted 
from medical charts
Type of chronic pain
Self-reported pain in previous week. For 72% the pain 
was chronic (at least 3 months)
Confirmation of diagnosis
Not reported
Sample size and demographics
233 residents completed questionnaires
Median age 79 years (IQR 73-84)
70% were female
Patient selection
residents without cognitive impairment
Outcomes measured
Characteristics of pain, pain treatment, 
pain management index (how well is 
pain managed), impact pain on sleep 
and ADL, satisfaction pain treatment
Pain severity
Median pain intensity was 5 (IQR 2-7), 
88 reported moderate or severe pain 
(>= 4 on NRS)
Analyses
Nonparametric data are given as 
median and interquartile range (IQR). 
Differences in demographics between 
the nursing homes are analyzed by chi-
squared tests and Kruskall-Wallis tests. 
The multiple lineair regression method 
was used to indentify interferences 
with sleep and ADL, with pain intensity 
for the previous week as dependent 
variable
Q21. Study quality
The Van Herk et al. study was rated low mainly because it was not clear that the sample was representative of 
all nursing home residents, the eligibility criteria were not clearly described and nor were the statistical methods 
and it was unclear if the presented results were unadjusted or adjusted for confounders.
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Q21. Results
General chronic pain
Van Herk et al. 2006
146 residents of nursing homes reported that they had experienced pain in the previous week and answered 
the questions on pain treatment. Of these, 88 (60.3%) agreed with the statement ‘I am satisfied about the pain 
treatment’, 31 (21.2%) did not agree and 27 (18.5) did neither.
0 10 20 30 40 50 60 70
Not agree
Neither
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Figure 24. Opinion of patients on the statement ‘I am satisfied about the pain treatment’ 
Q21. Summary
Only one low quality study, performed in a Dutch nursing home population was found reporting on satisfaction 
about drug treatment. 60% were satisfied and 21% were not.
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Question
Number of 
studies and 
quality (low, 
med, high)
Results
Conclusion
Chronic pain Moderate or severe chronic pain
2 
prevalence of 
chronic pain
61 studies relevant
Three studies 
selected
Breivik  
2006-med
Kerssens  
2002-med
DCM3 study 
(Picavet  
2003 Pain - high / 
Picavet  
2003 Ann Rheum 
Dis - med)
Chronic musculoskeletal pain > 3 
months: 
44.4% (Picavet 2003 Pain)
Chronic diseases (self-reported) with 
>10% prevalence (males vs females)
Tendinitis / capsulitis 15.4 vs 17.2%
Herniated disc or back: 10.3 vs 8.3%
Epicondylitis: 10.4 vs 11.6%
Osteoarthritis of knee: 10.1 vs 13.6%
(Picavet 2003 Ann Rheum Dis)
Moderate to severe 
pain> 6months
18% of Dutch population 
suffered from moderate to 
severe chronic pain in 2003 
(Breivik 2006)
Unexplained severe 
chronic pain in general 
practice: 
7.91 per 1000 enlisted 
patients in general practice 
(Kerssens 2002)
The DCM3 study 
and Kerssens used 
a representative 
population
The DCM3 study is 
rated high quality 
and Breivik and 
Kerssens medium
3 
incidence of 
chronic pain
Five studies relevant
Four studies 
selected
De Mos  
2007-med
Dieleman  
2008-med
Opstelten  
2005-med
Steenstra  
2006-med
The overall incidence rates 
-  neuropathic pain 8.2/1000 PY (95%CI 8.0 to 
8.4) (Dieleman 2008)
-  Complex Regional Pain Syndrome 26.2/ 
100,000 PY (95%CI 23.0 to 29.7) (De Mos 
2007)
-  Herpes zoster (HZ) 3.4/1000 PY (95%CI 2.9 
to 3.9) (Opstelten 2005)
-  Persistent pain 3 months after HZ diagnosis 
reported in medical records of 2.6% (95%CI 
1.7 to 4.0)
-  incidence of occupational disability as a 
result of back disorders: 2.02 and 2.14 per 
1000 workers per year for men and women, 
resp. (Steenstra 2006)
De Mos 2007, 
Dieleman 2008 
and Steenstra 
2006 used a 
representative 
population
All studies were 
rated medium 
quality
4 
% untreated
Five studies 
located
Borghouts  
1999-med
Breivik et al.  
2006-med
Smalbrugge  
2007-med 
Van Herk  
2009-low
Van Tulder  
1998-med
Percentage untreated:
-  between 25 and 36% (patients in nursing 
homes who do not receive medication) (Van 
herk 2009, Smallbrugge 2007)
-  between 31 and 36% (patients with neck or 
low back pain who visit their GP)(Borghouts 
1999; Van Tulder 1998)
Percentages inadequately treated:
-  up to 69% of nursing home residents 
(patients with inadequate analgesics dosing) 
(Smalbrugge 2007)
-  34% of nursing home residents (inadequate 
treatment as indicated by Pain Management 
Index) (Van Herk 2009)
Percentages 
inadequately treated:
-  79% of general chronic 
pain population 
inadequate pain control 
from medication 
(affirmative answer to 
the question: ‘‘Are there 
ever times when your 
pain medicines are not 
adequate to control your 
pain?) 
-  56% of general chronic 
pain population 
inadequate pain control 
(affirmative answer to the 
question: ‘‘Would you 
say your pain is being 
adequately controlled?’’) 
(Breivik 2006)
Van Tulder 1998 
was the only study 
that included a 
representative 
population
Four studies were 
rated medium 
quality and Van 
Herk 2009 was 
rated low quality
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Question
Number of 
studies and 
quality (low, 
med, high)
Results
Conclusion
Chronic pain Moderate or severe chronic pain
5 
% who 
present 
for pain 
treatment
Thirteen studies 
located
Five studies 
selected
De Mos  
2009-med
Huisstede  
2008-med
Picavet  
1999-high
Picavet and 
Schouten  
2003-high 
Picavet  
2008-low
Complex regional pain syndrome
-  61% CRPS patients visited the GP as the 
first physician; >80% of the patients visited 
a medical specialist at any time (on average 
2.4 different specialties) anesthetist was the 
most commonly consulted (55%) (deMos 
2009)
Musculoskeletal pain
-  50% of the patients with chronic upper 
extremity disorders and neck pain (UED) 
reported contact with the GP, 40% – contact 
with medical specialist and 37% –contact 
with physiotherapist in the last 12 months 
due to their symptoms (Huisstede 2008)
-  around 50% of patients with 
musculoskeletal pain in any of the 5 
examined locations (neck, shoulder, higher 
back; elbow, wrist/hand; lower back; hip, 
knee; ankle, foot) reported contact with any 
health professional because of their specific 
musculoskeletal pain during the last year; 
30–40% – GP, 20–30% – medical specialist 
and 20–30% – physiotherapist (Picavet and 
Schouten 2003)
-  9–13% of population had contact with GP 
due to low back pain during last year; 39% 
people with chronic low back pain reported 
GP contact, 26% – medical specialist and 
36% – physiotherapist (Picavet 2008)
-  19% of working and 24% of non-working 
men and women reported use of healthcare 
services due to low back pain (Picavet 1999)
Picavet 1999 
and Picavet 
and Schouten 
2003 used a 
representative 
population
These studies were 
also rated high-
quality. De Mos 
2009 and Huisstede 
were rated medium 
and Picavet 2000 
low quality
6 
% who get 
treated, 
broken down 
by treatment
Fourteen studies 
relevant
Five studies 
selected:
Breivik  
2006-med
Van Dasselaar 
2002-low
Van Tulder  
1998-med
Borghouts  
1999 -med
Dieleman  
2008-med
Chronic non-cancer pain: 
-  In 1991/1992 approx. 63,000 invasive 
procedures were performed in Dutch 
hospitals (Van Dasselaar 2002)
Chronic musculoskeletal pain in general 
practice (patients who visited GP) :
-  36 and 31% no treatment for low back or 
neck pain, respectively
-  medication most frequently applied 
treatment (22% of patients with low 
back pain received medication and 58% 
of patients with neck pain received 
paracetamol/aspirin/ NSAIDs). 
-  The most frequent used non-drug treatments 
for low back pain were (bed)rest (6%) and 
postural advice (6%) and for neck pain heat 
application (20%) and postural advice (18%).
(Van Tulder 1998/Borghouts 1999)
Neuropathic pain
-  53% were prescribed medication  
(Dieleman 2008)
General chronic pain: 
-  14% saw pain specialist
-  33% prescribed 
medicines
- 52% tried physiotherapy
-  21% tried acupuncture
-  17% tried massage  
(Breivik 2006)
Only the studies of 
Van Tulder 1998 
and Dieleman 2008 
used representative 
populations
Four studies were 
rated medium 
quality and Van 
Dasselaar 2002 was 
rated low quality
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Question
Number of 
studies and 
quality (low, 
med, high)
Results
Conclusion
Chronic pain Moderate or severe chronic pain
7
% who 
comply 
with their 
treatment
No studies were 
found
8
disease 
duration of 
chronic pain 
conditions
16 studies relevant
Three studies 
selected:
Breivik  
2006-med
Sluiter  
2008-med
Suurmeijer  
2001-high
Severity
Rheumatoid Arthritis (RA):
Mean pain (range 8-16): 13.4 (SD: 2.1)
(Suurmeijer 2001)
Chronic repetitive strain injury (RSI):
Mean pain (100 p VAS): 41.3 (SD: 25.4)
(Sluiter 2008)
Duration
General chronic pain:
Mean of 6.5 years  
(Breivik 2006) 
None of the studies 
clearly used a 
representative 
population
Suurmeijer 2001 
was rated high-
quality and Breivik 
2006 and Sluiter 
2001 medium 
quality
9
demographics 
of chronic 
pain sufferers
28 studies relevant
Three studies 
selected:
Breivik  
2006-med
Huisstede  
2008-med
Opstelten  
2002-mod
Herpes zoster (HZ) and post herpetic 
neuralgia (PHN)
-  47% of all HZ patients ≥ 55 years
-  58% females
(Opstelten 2002)
Chronic musculoskeletal pain (upper 
extremity and neck pain):
-  63% females
-  29% ≥65 years 
(Huisstede 2008)
General chronic pain:
-  mean age 51.3 years
-  60% females 
(Breivik 2006)
None of the studies 
clearly used a 
representative 
sample
All studies were 
rated medium 
quality
10 
co-morbidities 
of chronic 
pain sufferers
18 studies relevant
Three studies 
selected:
Breivik  
2006-med
Demyttenaere 
2007-med
Picavet  
2003-high
Musculoskeletal pain
-  30% coexistence of pain in several locations 
(Picavet 2003)
Chronic back/neck pain:
-  9.4% major depressive episode
-  4.5% dysthymia
-  2.1% generalized anxiety disorder
-  1.7% agoraphobia / panic disorder
-  2.4% social phobia
-  7.4% posttraumatic stress disorder
-  1.7% alcohol abuse/dependence disorders 
(Demyttenaere 2007)
General chronic pain:
-  19% depression  
(Breivik 2006)
Picavet 2003 
was rated as 
high quality 
study that used 
a representative 
population
The other two 
studies were 
unclear about 
representativeness 
of the population 
and were rated 
medium quality
11
% with 
inadequate 
pain control
One study found:
Breivik  
2006-med
General chronic pain:
-  79% inadequate pain 
control from medication 
-  56% inadequate overall 
pain control 
(Breivik 2006)
It was unclear 
whether the 
population of 
Breivik was 
representative, the 
study was rated 
medium quality
Summary Table - Epidemiology of chronic pain in the Netherlands
193
Question
Number of 
studies and 
quality (low, 
med, high)
Results
Conclusion
Chronic pain Moderate or severe chronic pain
12a
impact QoL
Three studies 
selected:
Alonso  
2004-med
Lame  
2005-low 
Picavet  
2004-med
Several pain populations
-  low Qol on each domain in patients with 
pain; patients with back pain, other pain and 
multiple pain locations experienced more 
functional limitations (physical functioning 
and role limitations physical) than the other 
pain groups; patients with multiple pain 
localizations scored lower on mental health, 
vitality and general health. Patients with 
other pain had lower scores on bodily pain 
than the other pain groups; women had 
lower scores than men (Lame 2005)
Musculoskeletal pain
-  participants with arthritis scored 4.1 points 
lower on the Physical Summary Component 
of the SF-36 than respondents who did 
not report any chronic conditions (a mean 
score of 53.4); participants with arthritis also 
scored 1.0 points higher than those without 
chronic conditions on the Mental Summary 
Component for the SF-36 (a mean score of 
55.2) (Alonso 2004)
-  subjects with any of the 12 musculoskeletal 
diseases (MSD) had lower scores on all SF-
36 dimensions than those without MSD, 
especially for physical functioning (75.2 (SE 
0.5) vs 87.8 (SE0.5)), role limitations from 
physical problems (67.1 (SE 0.9) vs 85.8 (SE 
0.8)), and bodily pain (68.5 (SE 0.6) vs 84.1 
(SE0.5)); Those with MSD had more health 
problems on the EQ-5D dimensions than 
those without MSD (mobility (29.9% vs 
10.5%), pain/discomfort (62.5% v 31.2%), 
and usual activities (34.5% v 12.4%)); with 
an increasing number of MSD the health 
related quality of life deteriorated (Picavet 
2004)
The populations of 
Alonso 2004 and 
Picavet 2004 were 
representative, 
and these studies 
were rated medium 
quality
Lame 2005 was 
rated low quality
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Question
Number of 
studies and 
quality (low, 
med, high)
Results
Conclusion
Chronic pain Moderate or severe chronic pain
12b 
impact ADL
Four studies 
selected:
Huisstede  
2008-med
Picavet and Schouten  
2003-high
Rupp  
2006 
ScanJRheumatol-med
Rupp  
2006  
J Rheumatol-med
Musculoskeletal pain
-  38.3% of people with UED reported 
limitation in daily life due to their pain 
complaints in the last year (Huisstede 2008)
-  roughly 30% reported limitation in daily life 
in the last year due to their musculoskeletal 
pain (neck, shoulder or higher back, elbow 
or wrist/hand, lower back, hip or knee) 
(Picavet and Schouten 2003)
Rheumatoid arthritis
-  disability in VDF (higher scores – more 
disability) mean values at baseline 0.46 
(SD 0.48) and at follow up 0.56 (SD 0.56); 
pain was the most important predictor for 
disability, significant associations were also 
found for depressive symptoms, radiographic 
damage and disease activity (Rupp 2006 
ScanJRheumatol)
-  disability in VDF mean values at baseline 
were 0.66 (SD 0.62); female sex, older age, 
RF positivity, disease activity and somatic and 
psychological comorbidties were found to be 
risk factors for poor outcome with respect to 
disability (Rupp 2006 JRheumatol)
Only the population 
of the high-quality 
study Picavet 
2003 was rated 
representative
Other studies were 
rated medium 
quality
12c 
impact 
depression
Four studies 
selected:
Breivik  
2006-med
Demyttenaere  
2007-med 
Rupp  
2006 
ScanJRheumatol-med
Rupp  
2006  
J Rheumatol-med
Back/neck pain
-  prevalence of: major depressive episode 
9.4%, dysthymia 4.5%; generalized 
anxiety disorder 2.1%; agoraphobia or 
panic disorder 1.7%; social phobia 2.4%; 
posttraumatic stress disorder 7.4%; alcohol 
abuse/ dependence disorders 1.7% 
Rheumatoid arthritis
-  depressive symptoms mean values at 
baseline 10.3 (SD 8.2) and at follow up 
10.5 (SD 7.9) in CES-D (Scores 0 to 60, with 
higher scores – more symptoms); MCS of 
RAND-36 (Higher scores indicate better 
health status) mean values at baseline 50.9 
(SD 10.6) and at follow up 50.0 (SD 10.1); 
depressive symptoms the most important 
predictor for mental health and were 
significantly related to disability (Rupp 2006 
ScanJRheumatol)
-  depressive symptoms in CES-D mean values 
at baseline 12.3 (SD 9.2); MCS of RAND-36 
mean values at baseline were 49.2 (SD 11.4); 
depressive symptoms were a risk factor 
for poor outcomes and hampered good 
outcomes with respect to pain, disability, Qol 
(Rupp 2006 JRheumatol)
In none of 
the studies a 
representative 
population was 
used
All studies were 
rated medium 
quality
Summary Table - Epidemiology of chronic pain in the Netherlands
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Epidemiology of chronic pain in the Netherlands - Summary Table
Question
Number of 
studies and 
quality (low, 
med, high)
Results
Conclusion
Chronic pain Moderate or severe chronic pain
12d 
impact 
isolation
Two studies 
found:
EURIDISS 
(Suurmeijer  
2001-high;  
Strating  
2006) 
Samwel  
2006-med
Rheumatoid arthritis:
-  Overall SSQS (Social support questionnaire 
for satisfaction with supportive transactions: 
range 23-69, higher is better) mean 64.9 
(SD 4.6)
-  ESS (emotional support satisfaction, range 
11-33) mean 31.1 (SD 2.7) 
-  SCS (Social companionship satisfaction, 
range 5-15) mean 13.8 (1.5)  
(Suurmeijer et al 2001)
Unexplained chronic 
pain
-  mean (SD) for 
helplessness (range 6-24, 
higher is worse) 14.6 
(4.7) 
(Samwel 2006)
For both studies 
it was unclear 
whether the 
population was 
representative
Suurmeijer 2001 
was a high-quality 
study and Samwel 
2006 medium-
quality
12e 
impact days 
off work
Four studies 
selected:
Borghouts  
1999-med
Breivik  
2006-med
Huisstede  
2008-med
Picavet and 
Schouten  
2003-high
Musculoskeletal pain
-  1 435 044 sick days related to neck disorders 
and 19 367 744 sick days regarding diseases 
of musculoskeletal system in 1996 in the 
Netherlands (human capital method); 487 
915 sick days because of neck pain when 
leave for <90 days and 444 150 sick days 
due to neck pain when leave for >90 days 
(friction cost method) (Borghouts 1999)
-  23% of patients with UED and paid work 
and age 25–64 years had work absence in 
the last year (Huisstede 2008)
-  24% of people with low back pain reported 
sick leave in the past year; 22% of people 
with pain of ankle or foot, 21% of people 
with neck, shoulder or higher back pain 
16% with pain of elbow or wrist/hand and 
13% with pain of hip or knee (Picavet and 
Schouten 2003)
General chronic pain
-  mean time lost from work 
(full or part time) due to 
pain in the past 6 months 
was 6.8 days  
(Breivik 2006)
Picavet 2003 
and Borghouts 
1999 used a 
representative 
population
Qaulity of Picavet 
2003 was rated 
high and the 
other three studies 
medium
12f 
impact 
incapacity 
benefits
Three studies 
found:
Borghouts  
1999-med
Chorus  
2001-med
van Doorn  
1995-low
Musculoskeletal pain
-  2.5% of patients receiving a disability 
pension received it in relation to the 
neck pain (based on ICD-codes) in the 
Netherlands in 1996 (Borghouts 1999)
-  the annual incidence rate of low back 
disability increased from 3.5 per 1000 
persons at risk in 1977 to 7.4 in 1989; 
incidence of low back disability >1year was 
0.85 per 1000 person-years among self-
employed medical professionals vs 2.56 per 
1000 person-years among general working 
population (RR 2.99 [95% CI 2.35–3.82]) 
(Van Doorn 1995)
Rheumatoid arthritis
-  94% of patients withdrawn from the labour 
force officially recognised as being fully 
(³80% disabled; 69% of patients) or partially 
disabled (<80% disabled; 25% of patients) 
for work purposes; partial work disability 
recognized in 14% of the patients in paid 
employment (Chorus 2001)
Only Borghouts 
1999 used a 
representative 
population
Study quality of 
Borghouts 1999 
and Chorus 2001 
were rated medium 
and Van Doorn low
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Question
Number of 
studies and 
quality (low, 
med, high)
Results
Conclusion
Chronic pain Moderate or severe chronic pain
13 
economic 
costs
Four studies 
found:
Borghouts  
1999-med
Boonen  
2005-med
Kemler and Furnée  
2002-low
Van Doorn  
1995-low
Costs for society 
-  neck pain in 1996 $686.2 million (Borghouts 
1999)
-  three chronic musculoskeletal diseases: 
between 3205 and 8533 E/pt/year (Boonen 
2005)
-  compensation of low back pain disability in 
1989: 8.0 million (self-employed health care 
professionals)(Van Doorn 1995)
Direct medical costs 
-  neck pain 23%: paramedical care accounted 
for the majority of costs (19 of 23%) 
(Borghouts 1999)
-  chronic musculoskeletal diseases between 
13 and 32%: large proportions of costs 
were used for specialist physicians, 
physiotherapists and prescription drugs 
(Boonen 2005)
Cost for patients:
-  patients with CRPS have a decreased income 
-  mean out-of-pocket expenses $1350 euro 
per patient per year 
(Kemler 2002)
Only Borghouts 
1999 used a 
representative 
population
Study quality of 
Borghouts 1999 
and Boonen 2005 
was rated medium 
and of Kemler 2002 
and Van Doorn low
14 
determinants 
of patient 
awareness of 
chronic pain
Three studies 
found:
Sluiter  
2008-med
Verbunt  
2003-med
Satink  
2004-low
Determinants awareness RSI chronic 
pain:
-  Patients who are able to work, who have 
a better physical role or better physical 
functioning have less pain
-  Patients who experience fewer 
consequences and symptoms and are less 
concerned about their illness have less pain  
(Sluiter 2008)
Determinants awareness of LBP 
disability
-  Fear of injury and catastrophizing was 
associated with more disability  
(Verbunt 2003)
Three phases in the process of living 
with chronic pain: 
-  1. pts aim to be normal, ignoring the pain 
and with unchanged activities
-  2. pts aim to control and reduce the pain by 
withdrawing from activities. The pain is in 
control here
-  3. pts aim to collaborate with the pain. To do 
this they have to constantly face dilemmas of 
prioritizing activities in order to incorporate 
pain in everyday life 
(Satink 2004)
None of the 
studies used a 
representative 
sample
Sluiter 2008 and 
Verbunt 2003 were 
rated medium-
quality and Satink 
2004 low quality
Summary Table - Epidemiology of chronic pain in the Netherlands
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Question
Number of 
studies and 
quality (low, 
med, high)
Results
Conclusion
Chronic pain Moderate or severe chronic pain
15 
determinants 
of health care 
professional 
awareness of 
chronic pain
One study found:
Zwakhalen  
2007-low
Pain in elderly with dementia:
Nursing home staff respondents showed 
knowledge deficits about several aspects of 
pain, even though they were satisfied about 
the way pain was assessed and treated at 
their wards. Specific knowledge deficits 
were found regarding pain treatment and 
medication in elderly nursing home residents. 
Staff educational level seemed to influence 
their beliefs and knowledge about pain in 
elderly nursing home patients  
(Zwakhalen 2007)
It was unclear 
whether the sample 
of Zwakhalen 2007 
was representative 
and the quality was 
rated low
16 
main 
presenting 
symptoms 
and 
complaints
No studies were 
found
17 
frequency of 
drug, non-
drug and 
combined 
treatments
11 studies were 
found
Three were 
selected:
Breivik  
2006-med
Van Herk  
2009-low
Dieleman  
2008-med
Pain in nursing homes residents
75.2% were prescribed analgesics:
-  42.5% non-opioids
-  8.5% weak opioids
-  10.5% strong opioids 
(Van Herk 2009)
Neuropathic pain
53% prescribed medication
- 34.7% NSAIDs 
-  11.9% benzodiazepines
-  9.1% sedative/hypnotics
-  6.6% opioids
-  4.8% anticonvulsants
-  4.7% tricyclic antidepressants 
(Dieleman 2008)
General chronic pain
33% (n=99) were 
prescribed medicines:
-  36% NSAIDs
-  14% weak opioids
-  5% strong opioids
-  11% paracetamol
-  16% a COX-2 inhibitor
Non-drug treatments
-  21% tried acupuncture
-  52% tried physical 
therapy
-  17% tried massage. 
(Breivik et al. 2006)
 At least moderate 
pain in nursing home 
residents (n=88)
-  22% not prescribed 
medication
Intolerable pain in 
nursing home residents 
(n=41)
-  29% not prescribed 
medication
(Van Herk 2009)
None of the studies 
clearly used a 
representative 
sample
Breivik 2006 and 
Dieleman 208 were 
rated medium 
quality and Van 
Herk low-quality
Epidemiology of chronic pain in the Netherlands - Summary Table
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Question
Number of 
studies and 
quality (low, 
med, high)
Results
Conclusion
Chronic pain Moderate or severe chronic pain
18 
determinants 
of treatment 
choice 
between drug 
and non-drug 
treatments
NL
One studies 
found:
Kroese  
2008-low
Fibromyalgia:
Factors influencing choice of treatment for 
fibromyalgia differ per discipline. The choice 
is mainly made on the basis of subjective, 
professional group-bound factors such as 
EBM, protocols, courses, own experience and 
experiences of colleagues. For GPs, dynamic 
patient factors are an important motive in the 
management of FM
It was unclear 
whether the sample 
of Kroese 2008 was 
representative, the 
quality was rated 
low
19 
determinants 
of treatment 
choice 
within drug 
treatments
NL
No studies were 
found
20 
determinants 
of compliance 
to drug 
treatment
No studies were 
found
21 
patient 
satisfaction 
with drug 
treatment
One study found:
Van Herk  
209-low
Pain in nursing home residents (n=146):
Statement ‘‘I am satisfied about the pain 
treatment’:
-  60.3% agreed
-  21.2% did not agree
-  18.5% did neither 
(Van Herk 2009)
It was unclear 
whether the sample 
of Van Herk 2009 
was representative, 
the quality was 
rated low
Summary Table - Epidemiology of chronic pain in the Netherlands
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